How long have these symptoms been going on?
All chest pains should be treated that way, especially at your age.
And in addition to the fever,
Your blood cholesterol also needs to be tested.
And you're having a fever now?
And do you feel that chest pain right now?
And besides, do you have a hard time breathing?
And can you tell me what other symptoms you have besides this?
And how high is your temperature?
And I'm coughing, too.
I'm having a little cold and coughing.
I'm having some severe chest pain today.
And is this the right time for your hay fever?
There's chest pain.
And I think I have a little bit of fever.
And I want you to describe where I feel chest pain.
They're also having some fever.
And with your history of diabetes,
And, you know, I feel like my chest's gonna crash.
And, you know, people cough at me all the time.
And you're feeling chest pain.
And you said that's a pressure in your chest.
Any member of the family has a heart problem, heart disease, heart attack, high cholesterol, or high blood pressure.
Are there any other symptoms or problems you noticed besides muscle pain?
Are there any other members of the house with the same symptoms you have?
Do you feel any other symptoms?
Do you feel any shortness of breath?
Are you still feeling chest pain?
Because this is the flu season.
But we also shouldn't ignore the chest pain caused by heart disease.
But the most important problem now is this chest pain.
But I'm having a hard time breathing.
But I know a lot of people who are begging for me.
But we need to deal with every chest pain with the utmost seriousness.
But you're breathing right now, aren't you?
I totally forgot about that chest pain.
Do you feel like someone's pushing your chest?
Do you still have a sense of breathlessness?
Are they complaining of similar symptoms?
Do you have any other chronic disease like hypertension or anything like that?
Do you have any other chronic medical problems like diabetes?
Do you feel any respiratory distress with that chest pain?
Do you have high blood pressure?
Do you feel any shortness of breath with that?
Do you know the symptoms she was feeling?
Do you see the picture?
He drank a lot of fluid today.
Still, I'm running diabetes tests.
Still, she has exactly the same symptoms as I do.
How high is your fever?
What about your blood pressure?
If your fever keeps rising,
If you get to the fever, you have a hundred and two or higher.
If you think your symptoms or problems need to be examined better,
I had a fever yesterday.
I had a mild fever, too.
I had a fever yesterday.
I'm having severe chest pain here.
I'm also having a little trouble breathing.
I'll send you a picture.
I'm having some chest pain today.
I'm just having some headaches and fever today.
In my opinion, it's a flu.
In my opinion, it's a simple flu.
Does it look like someone heavy is sitting on your chest?
It all started with headaches and fever around the same time.
There's pain in the middle of my chest.
It's a pressure that looks like chest pain.
It's in my chest.
It's in the middle of my chest.
It's in the middle of the chest.
I felt a pain in my chest.
I'm so worried about that chest pain.
I need you to describe this chest pain to me.
Like hypertension or diabetes.
It's like he's right in the middle of the chest.
You can now have tachipirina for the fever.
Now, Mary, how many days have you suffered these symptoms?
Now you said you had chest pain.
I have chest pain every now and then.
Well, do you have any other symptoms besides that other than pain?
Or do you feel like someone's sitting on your chest?
It's pretty much like fever and cough headaches and muscle pain.
Right in the middle of my chest.
Specify where the pain feels on this picture.
Since you had a fever.
So do you think some of these symptoms might be associated with pregnancy?
So do your kids have some similar symptoms?
Tell me about your chest pain.
The fever increases at night.
The fever I've had in the last two days.
I started to increase the fever last night.
This is Dr. Porter in the emergency room at the casualty screening center.
Well, can you tell me more about your chest pain?
Well, I feel pain in the front of my body right here in my chest.
Well, I'm having a lot of pain in my chest.
Well, when I felt this pain in my chest,
What kind of chest pain do you have?
When did this chest pain start?
What's the location of the pain in your chest?
Where you feel this chest pain, you feel this chest.
You've got a feeling in your chest.
You know I have diabetes and other things.
You said you had this chest pain.
Rapidly increasing cumulative number of coronavirus disease (Coved-19) in the European Union/European Economic Area and the United Kingdom, January 1 through March 15, 2020
The cumulative number of coronavirus disease (Coved-19) shows similar trends in EU/EEA countries and the United Kingdom, which confirms that despite the different stage based on the state, the Covide-19 pandemic is rapidly worsening in all countries.
Based on Italy's experience, States, hospitals and intensive care units should increase their readiness to increase the number of Covide-19 patients who will need health care, particularly intensive care.
On December 31, 2019, a series of cases of pneumonia of unknown pathogens were reported in Wuhan City, Hubei Province, China.
On January 9, 2020, the Chinese Center for Disease Control and Prevention stated that the causative agent, the new Corona virus, is now referred to as the Corona 2 virus associated with severe acute respiratory syndrome (SARS-COV-2).
Since then, the disease caused by the Sars-Koff-2 infection has been named Coronavirus disease (Coved-19).
The evidence so far is that approximately 80% of individuals with code 19 suffer from a mild disease; that is, respiratory infection with or without symptoms, and most of these recover.
In approximately 14%, the incidence of Coved-19 increased to a more severe illness requiring hospitalization, while the remaining 6% suffer from a serious illness requiring intensive care.
The death rate of patients who stayed in hospital because of Coved-19 was about 4%.
In this study, we assess trends in the cumulative number of Coved-19s in each EU/EEA and UK countries and compare them with those from Hubei County, China.
We also compare the current number of Covide-19 cases in the EU/EEA and UK countries with the number in Italy between January 31 and March 15, 2020.
Coved-19 cases in the European Union/European Economic Area and the United Kingdom
After what happened in China, Covid-19 has increasingly spread geographically and followed the dynamics of the Covide-19 pandemic in the rest of the world at present.
On March 11, 2020, the Director-General of the World Health Organization (WHO) Kovid-19 was declared a pandemic.
In the Eurosorphilis issue of March 5, 2020, Spiteri et al. reported the first confirmed European Coved-19 cases as defined by the World Health Organization (WHO).
In the EU/EEA, the first three confirmed cases were reported by France on January 24, 2020 for people returning from Wuhan, Hubei Province, China.
As of March 15, 2020, Coved-19 cases were detected in all 30 EU/EEA countries and the United Kingdom (UK), as between December 31, 2019 to this date, 39,768 cases and 1.727 deaths were reported, with 17,750, and 1,441 deaths in Italy alone.
Accumulated number and cumulative rate of Coved-19 cases
At the European Center for Disease Control and Prevention (ECDC), the numbers of reported CFD-19 cases are updated in every country around the world, obtained only from official sources such as the Ministry of Health of countries, national and regional health bodies and the World Health Organization (WHO), daily at 8 a.m.
These data have been used to assess Covide-19 trends in the European Union/European Economic Area and the United Kingdom and to compare them with those in Italy.
As a measure of the prevalence of Coved-19 active cases, we calculated the cumulative number of Coved-19 intermittent cases within 14 days, thus taking into account the normal course of Coved-19, in all EU/EEA and UK countries, between January 1 and March 15, 2020.
We also presented the cumulative number of reported cases from each country as of March 15, 2020 at 8:00 a.m., compared to the number in Italy between January 31 and March 15, 2020.
Coved-19 trends in EU/EEA and United Kingdom States
Trends in the cumulative number of Koed-19 cases cut over a period of 14 days in EU/EEA and UK countries followed those of Hubei Province (China) (Figure 1).
For the European Union/European Economic Area and the United Kingdom in general, the cumulative number of Covede-19 began to increase on about February 21, then sharply on February 28, 2020 (supplementary material).
This was often driven by the rapid increase in the number of reported cases from Italy, but all EU/EEA and UK countries showed similar growth trends to the cumulative number of Coved-19 (supplementary material).
Figure 2 shows the cumulative number of Kovid-19 cases, in the EU/EEA and UK countries compared to Italy for the period January 31 to March 15, 2020.
Highlights that as of March 15, 8 a.m., 15 other EU/EEA and UK countries reported the total number of cases already similar to that found in Italy just 3 weeks ago or less.
Our findings indicate that the number of reported Covide-19 cases is rapidly increasing in the European Union/European Economic Area and the United Kingdom.
The observed trends in the cumulative number of Coved-19 indicate that the pandemic is increasing at a similar pace in all nations.
This is despite the fact that States are at different stages, despite different national public health responses, and possible differences in the definition of the situation in different States and protocols for the selection of patients who must be tested to confirm that they have been exposed to code 19, including follow-up testing.
In early March 2020, doctors in affected areas in Italy described the situation where approximately 10% of Coved-19 patients needed intensive care and media sources stated that hospitals and intensive care units in those areas had already reached their maximum capacity.
Data on hospitalization and/or intensive care units for CFD-19 cases are currently available at EU/EEA level for 6% and 1% respectively (data not presented).
However, they need to be systematically collected to complement existing surveillance data focusing on the number of cases reported and the number of deaths.
A 2010–11 study showed great diversity in the availability of intensive care and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 in Portugal.
This means that countries may have more or less resources than Italy (12.5 beds for intensive care and intermediate care per 100,000 people in 2010–11).
Modeling scenarios associated with the satisfaction of health-care capacity, with estimates for each EU/EEA and UK of the prevalence of Covide-19 cases that entered the hospital associated with the risk of fgt; 90% to exceed the capacity of intensive-care beds, are available in the sixth update of the Covide-19 rapid-risk assessment of the European Center for Disease Control and Prevention.
Given that the cases collected so far in certain regions of the EU/EEA and the United Kingdom, and the fact that hospitals and ICUs usually serve specific regional population groups, it would be preferable to provide information on the cases and ICUs at the level of naming the regional units of Statistics 2 (NUTS-2).
Italy's experience and current trends in other countries show that the Covide-19 pandemic is rapidly worsening in the European Union/European Economic Area and the United Kingdom.
States, hospitals and intensive care units should therefore prepare themselves for the scenario of a sustainable community transition of Saras-Koff-2 and an increase in the number of Covide-19 patients in need of health care, especially intensive care, such as in the affected areas of Italy.
As indicated in the European Center for Disease Control and Prevention rapid risk assessment, a proactive and comprehensive approach is essential to delay the deployment of Sars-Koff-2 with a shift from containment to mitigation, as the expected rapid increase in the number of cases may not provide policymakers and hospitals with sufficient time to understand and accept and adjust their response accordingly if it is not implemented in advance.
The rapid risk assessment also lists public health measures to mitigate the impact of the pandemic.
There is a limited opportunity for countries to increase their control efforts to slow the spread of SARS-KOV-2 and reduce the pressure on health care.
If this fails, EU/EEA health-care systems are likely to face an increase in the number of patients requiring focused care over the coming days or weeks.
The outbreak of the Corona virus disease 2019 (Coved-19), caused by the Corona virus 2 (Sars-Coff-2) causing severe acute respiratory syndrome (SARS), resulted in the death of more than 3,000 people and the injury of more than 80,000 people in China and elsewhere in the world, causing a humanitarian disaster.
Sars-koff-2 virus, similar to its own, Sars-koff virus, which caused thousands of people to have SARS disease in 2003, can also transition from bats and cause similar symptoms through a similar mechanism.
However, Covide-19 has a lower risk and mortality rate than Sars but is more transient and influential between older persons than young people and men than women.
In response to the rapidly increasing number of publications related to the emerging disease, this article seeks to provide a comprehensive and timely review of the rapidly evolving topic of research.
We will address the basics of the epidemiology, causes, virology, diagnosis, treatment, prognosis and prevention of the disease.
Although many questions still need to be answered, we hope that this review will help to understand and eliminate the threatening disease.
The Spring Festival on January 25, 2020 became an unprecedented and memorable memory of all Chinese who were urged to stay indoors throughout the holiday and for many weeks thereafter due to an outbreak of an emerging viral disease.
The virus is very similar to the Corona (Coff) virus which caused the outbreak of severe acute respiratory syndrome (SARS) in 2003; hence, it was named by the World Health Organization (WHO) Saras-Coff-2 on February 11, 2020, and the disease associated with Coved-19 (Coved-19) was named.
The epidemic began in Wuhan, China, and soon spread throughout the country, as well as nearly 50 other nations worldwide.
As of March 2, 2020, the virus has led to 80,000 confirmed cases of code 19, with more than 40,000 patients discharged from hospitals and more than 3,000 dead.
The World Health Organization warns that Coved-19 is "the enemy of the public #1" and is likely to be stronger than terrorism.
According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, more than 200 researches on Covid-19 have been published, including virus science, epidemiological, pathogens, diagnosis, and treatment, since the first report was released on January 7, 2020, which determined the sequence of the virus isolated through many patients.
The objective of this review is to summarize the research progress in the new and rapidly evolving subject area.
Whenever possible, we will seek to compare Covide-19 with a charris and another disease caused by Cove, Middle East Respiratory Syndrome (Mers, an outbreak that occurred in 2012).
We will also discuss what we have learned so far regarding the prevention and prediction of the disease as well as some pressing questions that remain.
Corona viruses were usually considered non-lethal pathogens in humans, mainly causing about 15% of the four common colds.
However, in this century we faced coronaviruses causing severe human diseases twice, i.e. Sars-Koff and Myrs-Koff, which caused an outbreak of the disease originally in China in 2003 and Saudi Arabia in 2012, respectively, and the disease soon spread to many other countries with alarming prevalence and mortality.
Therefore, the current Coved-19 is a third outbreak of Coronavirus in recorded human history.
As illustrated in figure 1.1, groups with unknown pneumonia were first reported by Wuhan on December 31, 2019 to the Chinese National Health Commission.
Seven days later, Coronavirus sequence was released.
On January 15, 2020, Wuhan reported the death of the first case.
Meanwhile, the epidemic spread rapidly to neighbouring cities, provinces and countries.
On January 20, infections were reported among health-care providers, indicating the possibility of transmission from one person to another.
On January 23, Wuhan City was closed down with all public transport blocked.
On January 24, the first clinical study on the disease stated that of the 41 confirmed cases of infection, only 21 patients were in direct contact with Wuhan Seafood Market, which considered the starting site of infection to be an unknown animal source.
On January 30, WHO announced the outbreak as a global health emergency.
At the time of this report, the disease has already spread throughout China and about 50 other countries worldwide (Figure 2).
As the situation develops rapidly, the final scope and gravity of the outbreak have yet to be determined.
On February 11, 2020, a multi-centre study conducted on 8,866 patients including 4,021 patients confirmed as having a more up-to-date epidemiological profile as follows (https://mp.wixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Sars-Koff-2 infected people of all age groups, but mainly those between 30 and 65.
Nearly half of the injured (47.7%) were over 50 years old, very few were under 20, and only 14 were under 10.
Sars-Koff-2 injured more men (0.31/100,000) than women (0.27/100,000).
Coved-19 expanded between groups in and around Hoby mainly.
Coved-19 took an average of 5 (2-9) days from starting the injury to diagnosis.
The average period of custody was 4.8 (3.0-7.2) days.
The average time of injury from onset to death was 9.5 (4.8.13) days.
The base reproduction number (base reproduction number) was 3.77 (the confidence range is 95%: 3.51-4.05), and the modified base reproduction number was 2.23-4.82.
The number of injured increased dramatically before January 23, 2020, in line with the many travels before the Spring Festival in China.
The death rate among confirmed patients was 1.44% (the confidence range is 95%: 1.10-1.86%), and the modified mortality rate for all patients was 3.06% (the confidence range is 95%: 2.02-4.59%).
The three main risk factors of Coved-19 were gender (male), age (*60) and acute pneumonia.
Coronaviruses are a species of large and coated viruses containing a single positive-direction DNA genome.
It can be divided into four races, alpha, beta, gamma and delta, and coronaviruses of alpha and beta nationality are known to infect humans.
The coated fork (S) of the sugar protein is associated with its cellular receptors, the converted enzyme of angiotense 2 (ACE 2) and the dibityl with peptidez 4 (DPB4) for Saras-Coff and Myrs-Coff, respectively, then the membrane merge occurs.
The viral ribose DNA genome is released to cytoplasm; after transcription of the viral genome, the genomic ribosy DNA is accompanied by diabetic membrane proteins and septum proteins with vironas, and it merges with the plasma membrane to release the virus afterwards.
The first Sars-Koff-2 gene sequence was reported on January 10, 2020.
Sars-Koff-2 was discovered to be a new genus of beta-koff with a genetic identity exceeding 99.98% among 10 serialized samples collected from the original outbreak site, the Huanan Seafood Market of Bohan.
Sars-koff-2 is genetically more like Sars-koff than Mirs-koff.
It was revealed through the electronic microscopic examination of the transition that Sars-Koff-2 is present in very thin sections of the human airstream surface.
It was revealed that the human enzyme converted to angiotensisine 2 is a future for Saras-Coff-2 as well as Sars-Coff.
Despite this, the S protein of Sars-Coff-2 is associated with the human enzyme converted to angiotensines 2 that is weaker than Sars-Coff, which is consistent with the fact that Sars-Coff-2 causes less severe infection in patients than Sars-Coff.
Sars-Koff-2 can also form a short new protein encoded by orf3b and a dissect protein encoded by orf8.
Orf3b in Sars-Coff-2 may play a role in viral pathogenicity and limit the expression of IFN′; however, ORf8 does not contain any range or pattern with a known function.
On February 18, 2020, Cho et al. reported on the structure of the complete length of the human enzyme converted to angiotensisine 2 under the super-cold electron microscope with a precision of 2.9 ai within a compound with a B0AT1 amino acid vector.
They discovered that the boat, which had open and closed structures, had assembled to form a demer and that the ACE2-B0AT1 compound could bind a protein S, providing evidence for the identification of Coronavirus and infection.
Sodium-based neutral amino acid carrier may become a therapeutic target for drug testing to inhibit the infection of Saras-Coff-2.
Original host and intermediate host
It has been known that both Sars-koff and Myrs-koff originated from bats and were transported to humans through yogurt and beauty cats, respectively.
By comparing Saras-Coff-2 synaptic development with other Corona viruses, bats were considered the original host of Saras-Coff-2, where the new virus corresponds 96% to the Corona virus resembling Sars of bats and are called bat-SL-CoVZX45 and bat-SL-CoVZX21.
Despite this, the intermediate host who helped the virus cross the divide between the factions remains unknown and has yet to explain the route of transition.
G and others proposed snakes as carriers of the virus from bats to humans which involved a similar recombination within the S protein.
According to a study, researchers in Guangzhou, China, suggested that ant eaters - long tongue-eating mammals mostly used in traditional Chinese medicine - were the potential intermediate host of Sars-Koff-2 based on 99% genetic symmetry in Coronavirus discovered in ant eaters and in Sars-Kov-2.
Despite this, the 1% difference spread over the genome is still significant; therefore, we are waiting for conclusive results with concrete evidence (Figure 33).
The physical and chemical properties of Sars-Kov-2 remain largely unknown.
Sars-Koff and Mirs-Koff can survive in the laboratory for 48 hours in a dry environment up to 5 days at temperatures below 20 °C and humidity between 40% and 50%.
Sars-Koff-2 may have similar characteristics.
Sars-Coff-2 is reported to be sensitive to UV radiation and heat at 56 °C for 30 minutes; ether, ethanol at 75% concentration, chlorine-containing disinfectants, pyroxyacetic acid, chloroform, and other fatty solvents, but not chlorohoxydine, can effectively inhibit the virus.
The entire human race generally lacks immunity against Sars-Koff-2, so they are more vulnerable to the new virus.
Currently, no detailed study on Sars-Kov-2's immune response is required.
Therefore, we can only refer to previous studies of other coronaviruses, particularly Sars-Koff and Mers-Koff (Figure 4).
In general, after the invasion of a host virus, the natural immune system is recognized by PRS pattern recognition receptors including type C linen-like receptors, TLR-like receptors, NLR-like receptors similar to the NLR-linked particle range, and RIG-I protein-like receptors (RLR).
Through different pathways, the virus induces the emergence of inflammation agents, the maturity of the immersion cells, and the installation of the I (IFN) interferon that reduces the spread of the virus and accelerates the large balmy cells of viral antigens.
However, the N protein in Sars-Koff can help the virus escape immune responses.
Adaptive immune response quickly joins the fight against the virus.
T lymphocytes, including T-cells CD4+ and CD8+, play an important role in defense.
T cells catalyze CD4+ B cells to produce antibodies dedicated to the virus, and kill T cells CD8+ cells directly infected with the virus.
T cells produce activated cytokinase aids for inflammation to help defensive cells.
Despite this, Coronavirus can reduce T cell functions by stimulating programmed death of T cells.
Mixture immunity, including complementary proteins such as C3a, C5a and antibodies, is also necessary in the fight against viral infection.
For example, isolated antibodies neutralized a recovering Mers-Koff patient.
On the other hand, the overreaction of the immune system generates a large number of locally free roots that can cause severe damage to the lungs and other organs, and, at worst, failure in multiple organ functions and death.
Sars-Koff-2 infection, which initially appeared in groups, is likely to affect older persons with multiple diseases and more pregnant women.
It is common for people who are exposed to a large number of viruses or whose immune functions have been affected to be more likely to be infected than others.
The estimated average length of Sars-Koff-2 custody is 1–14 days, or mostly 3–7 days, based on a study of the first 425 cases in Wuhan.
However, a study of 1.099 cases shows that the average period of custody was 3 days and ranged from 0 to 24 days.
A more recent study, as explained above, showed that the nursery period was 4.8 (3.0-7.2) days based on a demographic of 8,866 cases.
It is extremely important that health authorities adjust effective quarantine time based on the strictest period of custody, thus preventing people infected with the infection but without symptoms from transmitting the virus to others.
As a common practice, people exposed to or infected with HIV are usually required to be quarantined for 14 days.
Should quarantine time be extended to 24 days?
Fever is often the main and first symptom of Coved-19, and can not be accompanied by any symptoms or other symptoms, such as dry coughing, respiratory distress, muscle pain, dizziness, headache, throat infection, nasal thrombosis, chest pain, nausea and vomiting.
Some patients suffered from respiratory distress and/or hypoxia one week after the onset of the disease.
In severe cases, the condition of patients has evolved rapidly to suffer acute respiratory syndrome, septic shock, metabolic acid, and vegetative disease.
Patients with fever or respiratory symptoms and severe fever must be examined, even without a scan that reveals pneumonia, in search of the virus for early diagnosis.
A demographic study in late December 2019 showed that the percentages of symptoms were 98% for fever, 76% for dry cough, 55% for respiratory distress, and 3% for diarrhea; 8% of patients needed respiratory support.
Similar results have been reported in two recent studies of a group of family and group to which infection has passed from someone who has not shown symptoms.
By comparison, a 2012 demographic study showed that Myrs-Koff patients also suffered from fever (98%), dry cough (47%) and respiratory distress (55%) as major symptoms.
Despite this, 80% of them needed much more respiratory support than Coved-19 patients and agreed with the Mitters' highest rate of Coved-19.
Diarrhoea (26%) and throatitis (21%) were also observed in Mers patients.
In Sars patients, both fever (99%–100%), dry cough (29%–75%), respiratory distress (40%–42%), diarrhoea (20–25%) and throat infection (13–25%) were found to be the most important symptoms, and respiratory support was required for about 14%–20% of patients.
By February 14, the Covide-19 mortality rate was 2%, while confirmed cases were 66.576 worldwide.
In comparison, SARS' mortality rate by November 2002 was 10% of the 8,096 confirmed cases.
For Mers, the mortality rate was 37% of the 2,494 confirmed cases, based on a demographic study conducted in June 2012.
A previous study stated that the basic reproduction number of Saras-Koff-2 was as high as 6.47 with a CA confidence range of 95% from 5.71 to 7.23, while the basic reproduction number of Saras-Koff ranged from only 2 to 4.
A comparison of Sars-Koff-2 and Mirs-Koff and Sars-Koff in terms of their own symptoms, mortality rate, and the basic reproduction figure is shown in table 1.1.1.
The above figures indicate that Sars-Koff-2 has a greater diffusion potential than Mirs-Koff and Saras-Koff, but less lethal than the latter.
Therefore, the Sars-Koff-2 epidemic is much more difficult to control than the Meers-Koff and Saras-Koff epidemics.
The onset of the disease occurs mostly in the same family or from the same group or vehicle, such as a cruise ship.
Patients often have a history of travelling to or staying in Wuhan or other affected areas, or mixing people or patients within the last two weeks before the disease appears.
Despite this, people are said to be able to carry the virus without symptoms for longer than two weeks, and recovering patients who have left hospitals can carry the virus again, sending a warning to increase quarantine time.
Patients have a natural or low number of oceanic white blood cells (especially lymphocytes) at the early stage.
For example, the lack of lymphocytes was detected with the number of white blood cells < 4×109/L including the number of lymphocytes < 1×109/L, high levels of asphalt amine tanker and blood ferrets in 1.099 patients with cryptic-19.
The levels of liver enzymes, muscle and meglobin have risen in the blood of some patients, the increase in the reactive protein C and the red carcinomas in the blood of most patients.
In patients with severe conditions, the level of dimmer D, caused by fibrin fractures in blood, has risen, and the number of lymphocytes has gradually decreased.
Disorders in radiography appear in most Coved-19 patients and are characterized by double patchy shades or shades of glass classified in the lungs.
Patients sometimes suffer from atypical pneumonia, severe lung injury, and acute respiratory stress syndrome (ARDS).
When acute respiratory stress syndrome occurs, uncontrolled inflammation, fluid accumulation, and enhanced fibrosis strongly influence gas exchange.
The dysfunction of type 1 and type 2 pulmonary cells reduces the level of surface activation and increases surface tension, thus reducing the ability of the lungs to extend and increasing the risk of lung collapse.
So, the worst results of chest scans and the maximum severity of the disease are often compared.
On February 18, 2020, the first pathological analysis of Coved-19 showed the schizophrenia of the pulmonary cells, the formation of the healini membrane, the ecliptic lymphocytes, and the numerous anatomy cells in the lungs of a patient who died of the disease, in line with the pathology of viral infection and acute respiratory distress syndrome and similar to that of patients with SARS and Mers.
The detection of the riboze DNA of Sars-Coff-2 has been used through the serial polymerase reaction of the reverse transcription (PT-BCR) as a key criterion for the Covid-19 diagnosis.
However, due to the high rate of false negative results, which may accelerate the epidemic, the use of clinical appearances for diagnosis (which no longer relies individually on RT-BCR) began in China on February 13, 2020.
A similar situation also occurred in Sars' diagnosis.
Therefore, a combination of the history of disease, clinical appearances, laboratory tests, and radiography findings is essential and essential for an effective diagnosis.
On February 14, 2020, Feng Chang Group described a protocol to use the Krisper-based Cherlock technique to discover Sars-Coff-2, and discovers pieces of the Ripuzi DNA created by Sars-Coff-2 at a rate of 20×10–18 Molly/L to 200×10–18 Molly/L (10–100 copies per microulter of inputs) using dipping in less than an hour without the need for precision devices.
We hope that the new technology will be able to significantly improve sensitivity and suitability if it is verified in clinical samples.
Due to a lack of experience with the new Corona virus, doctors can provide mainly supportive care for Covid-19 patients, while experimenting with a variety of treatments previously used or proposed to treat other Corona viruses, such as Sars-Koff and Mers-Koff, and other viral diseases (table 2).
These include current and potential antiretroviral treatments, immunosuppressants, stimulants, plasma from recovering patients, Chinese medicine, and psychological support.
Even plasma from recovering patients was suggested to be used for treatment.
Pharmaceutical companies race to develop antibodies and antivirus vaccines.
Sars-Koff-2 primarily attacks the lungs at first, and may also, to a lesser extent, attack other organs that release the converted enzyme of angiotensisine 2, such as the digestive system, intestine and kidneys.
Nevertheless, respiratory dysfunction and failure represent the most serious threat to patients and the main cause of death.
Therefore, respiratory support is necessary to mitigate symptoms and save lives, and includes general oxygen therapy, high oxygen flow, non-saturated respirators, and synthetic respirators that are made based on the severity of the disease.
Patients with acute respiratory symptoms must be supported by an exterior membrane oxy (ACM Oh), a pulmonary heart-fiction technique used to treat heart failure or life-threatening respiratory failure.
In addition, the maintenance of fluid balance, the prevention and treatment of secondary infection and autonomies, and the protection of vital organ functions are also necessary for SARS-KOV-2 patients.
The cytokin storm is known to result from an overreaction of the immune system of Sars and Myrs patients.
The cytokin storm is a form of regular inflammation reaction characterized by the release of a series of cytokines including TNF*, IL-1°, IL-2, IL-6, IFN′, IFN′, IFN′, and MCP-1.
These cytokines induce immune cells to release a large number of free roots and are the main cause of acute respiratory stress syndrome and multiple organ failure.
Immune inhibition is essential in treating cytokin storms, especially for acute patients.
Activated hormones, Tosilizomap, and an anti-introlequin anti-arterloquin antibodies 6, were used to treat the cytokin storm.
Other cytokin inhibition treatments include modification of immune reaction directed at T-cells; IFN-8/IL-1 and TNF siege; inhibition of Janus Kinaz; Platumump; captor of cytokin 4 signals; and Heston Disteleles inhibitors.
Stimulants and immunosuppressants have been widely used in SARS treatment to reduce inflammation damage.
Despite this, steroids with larger doses were not useful with severe lung injury in Sars and Covid-19 patients.
Instead, it has caused severe side effects, especially vascular osteoporosis, which has a severe impact on disease prediction.
Nevertheless, it was recommended that short cycles of activated hormones be used at doses ranging from small to moderate with caution for critical Kovid-19 patients.
At the time of writing, no anti-retroviral treatment had been confirmed.
However, it was discovered that giving Rhymedsevir, the counterpart of New Clementi, was effective with an American patient Covid-19.
Remdycifer is an emerging antivirus developed initially by Guiliad to treat diseases caused by Ebola and Marburg virus.
Later, Rimdecifer also showed potential inhibition to other single-chain rebuzzi DNA viruses, including the Mers and Sars viruses.
Based on these viruses, Guiliad introduced the compound to China to conduct some experiments on individuals infected with SARS-COV-2, and the results are highly anticipated.
In addition, Parisienp, Interferon-Alpha, Lubinavir/Retunavir and Ripavirin were proposed as possible treatments for patients with acute respiratory symptoms.
Diarrhoea, nausea, vomiting, liver damage, and other reactions can occur after the Plupinavir/Retunavir combination therapy.
The interaction of these treatments with other medications used with patients should be carefully monitored.
Plasma from recovering patients and the generation of antibodies.
The collection of blood from patients who have recovered from a disease prepared to treat other patients suffering from the disease itself or to protect healthy individuals from the disease has a long history.
Indeed, recovering patients often have a relatively high level of antibodies against the pathogen in their blood.
Antibodies are immunoglobulin (iG) produced by abillary lymphocytes to control pathogens and other exotic objects, and they recognize and directly neutralize unique molecules in pathogens.
Based on this, the plasma was collected from the blood of a group of patients who recovered from Coved-19 and was injected into 10 seriously ills.
Their symptoms improved within 24 hours, accompanied by reduced inflammation, viral loads and improved oxygen saturation in blood.
However, verification and clarification are necessary to introduce this method for widespread use before specific remedies can be found.
In addition, given the therapeutic effects, some plasma-related defects have to be carefully taken into account.
For example, antibodies can induce the immune reaction to excessive stimulation and cause cytokin release syndrome, which is potentially life-threatening toxic.
The concentration of antibodies in blood is usually low, and the demand for plasma is high for treating patients with critical conditions.
It is difficult to develop and produce specific antibodies quickly enough to combat a global epidemic.
Therefore, isolating the B-cells from the recovered patients and identifying genetic codes that encode effective antibodies, or testing for effective antibodies against the essential proteins of the virus, is more decisive and practical.
This way, we can easily increase the production of antibodies.
Traditional Chinese medicine has been used to treat a variety of diseases in China for thousands of years.
However, its effects depend heavily on a variety of multiple components in a combination that varies according to the diagnosis of disease based on traditional Chinese medicine theories.
Most of the effective components remain unknown or obscure as they are difficult to extract and verify or optimize their composition.
Currently, due to the lack of effective and specific treatment for Coved-19, traditional Chinese medicine has become one of the important alternative treatments for patients with mild to moderate symptoms or those who have recovered from severe stages.
For example, the effectiveness of the Shaw Feng Ji Do and the Lean Hua King Win capsules was discovered to treat Coved-19.
The highest rates of healing in the treatment of Coved-19 patients were observed in several provinces of China using traditional Chinese medicine in 87% of their patients, including Ganzo (63.7%), Ningxia (50%), and Hunan (50%), while Hobei County, which used only traditional Chinese medicine with about 30% of Coved-19 patients in it, had the lowest rate of recovery (13%).
However, this is a very rough comparison, as many other impact factors such as the number and severity of patients must be included in the assessment.
On February 18, 2020, Paulie Chang and his co-workers published a study to compare the treatment of Western Medicine (WWM) solo with the treatment common to Western Medicine and Traditional Chinese Medicine.
They discovered that the lengths needed to recover from body temperature rise, the loss of symptoms, and hospital stay were much shorter in the Western Medicine + Traditional Chinese Medicine treatment group compared to the Western Medicine only treatment group.
More impressive, the rate of symptoms (ranging from light to severe) was much lower in the Western Medicine + Traditional Chinese Medicine group compared to the Western Medicine only group (7.4% versus 46.2%), and the mortality rate was lower in the Western Medicine + Traditional Chinese medicine group compared to the Western Medicine only group (8.8% versus 39%).
Despite this, the effectiveness and safety of traditional Chinese medicine is still awaiting more well-thought-out experiments on larger scales and in more centers.
It would also be interesting to describe the procedure mechanism and to clarify the effective components of traditional Chinese medicine treatments or their combinations if possible.
Patients suspected of, or confirmed to have, a code 19 often feel very afraid of a highly contagious disease and even fatal disease, and people under quarantine are bored, alone, and angry.
In addition, symptoms of infection such as fever, hypoxia, and cough, as well as negative effects of treatments, such as insomnia resulting from activated hormones, can lead to further anxiety and mental disorder.
In the first phase of the SARS outbreak, a range of psychiatric diseases including permanent depression, anxiety, panic attacks, motor psychosis, psychotic symptoms, delirium, and even suicidal tendencies were reported.
As part of public health responses to the Covide-19 outbreak, mandatory syndication and quarantine tracking can make people more worried and guilty about the effects of infection, quarantine, and stigmatisation of their families and friends.
Therefore, mental health care must be provided to Covide-19 patients, suspected persons, persons involved, as well as the general public who need it.
Psychological support must include the establishment of multidisciplinary mental health teams, clear contact points with regular and accurate updates on the SARS-KOV-2 outbreak and remediation plans, and the use of specialized electronic devices and applications to avoid direct mixing.
Effective vaccines to cut the HIV transmission chain from animal reservoirs and infected humans to vulnerable hosts are essential and often complementary to antiretroviral therapy in the fight against epidemics caused by emerging viruses.
Efforts have been made to develop protein-based S vaccines to generate neutral, effective, long-range antibodies and/or preventive immunity against Sars-Koff.
Defused living vaccines have been evaluated in animal models for the treatment of Sars.
However, the effectiveness of these candidate vaccines in the living body of older persons and lethal challenge models and their prevention of infection with animal-based virus was not determined before a clinical study began.
Maybe it's because Sars disappeared 17 years ago and no new cases have been reported since then.
In contrast, cases and scattered groups with Mers continue to emerge in the Middle East and spread to other areas due to the continued presence of animal sources in endemic areas.
The strategies for immunization against Mers were developed using an inactive virus, hypooxidic ribosy acid plasma, viral vectors, nanoparticles, virus-like particles, and subunits of the damaged protein, some of which were evaluated in animal models.
The development of a safe and effective vaccine against Sars-Koff-2 vulnerable individuals is an urgent and critical task to control the ongoing epidemic.
However, overcoming the difficulty is a challenge because of the length of time (an average of 18 months) needed to develop a vaccine and dynamic changes in Corona viruses.
Coved-19, as an emerging disease, has just begun to show its full clinical track through thousands of patients.
In most cases, patients can recover gradually without being punished.
However, Covide-19, similar to Sars and Mers, is also associated with high prevalence and mortality rates in severe patient cases.
Therefore, building a model of disease progression expectations is essential for health-care agencies to prioritize their services, especially in resource-limited areas.
Based on the clinical studies reported to date, the following factors may affect or be associated with the disease's life expectancy of Coved-19 patients (table 33):
Age: The age was the most important factor in determining the forecast of Sars' illness, which also applies to Covid-19.
The 30-65 age groups were mainly affected by code 19, with 47.7% of these patients exceeding the age of 50 in a study of 8,866 cases as described above.
Patients who needed focused care were more likely to be infected with latent co-infections and complications and were much older than those who did not (at an average age of 66 to 51), indicating age as a predictor of the results of Covid-19 patients.
Sex: Sars-Koff-2 has infected more men than women (0.31/10000 versus 0.27/100,000), as explained above.
Accompanying diseases and complications: Covid-19 patients who need intensive care are more likely to suffer from severe heart injuries and heart failure.
Cardiac accidents were also the leading cause of death in SARS patients.
Sars-Koff-2 is also reported to be able to bind positive zero cells to the angiotensis-transformed enzyme 2, which may lead to liver dysfunctions in Covid-19 patients.
It should be noted that age and latent disease are strongly associated and may overlap.
Unnatural laboratory results: The level of the reaction protein C (CRP) in blood reflects the severity of inflammation or tissue injury, and it is suggested that it be a predictor of disease, treatment response, and final recovery.
The correlation between the level of the reaction protein C and the severity of Coved-19 disease and the expectations of its passage was also suggested.
In addition to this, the competing height of the enzyme for LHC hydrogen, the amino aspartat carrier (AST), the transporter enzyme for the amine of allane (ALT), and the creatine kinase (CK) may also help predict the result.
These enzymes appear strongly in many organs, especially in the heart and liver, and are released during tissue damage.
Therefore, they are traditional signs of functional dysfunctions in the heart or liver.
Main clinical symptoms: Chest X-rays and progress of clinical symptoms have to be taken into account together along with other problems to predict Covid-19 results and complications.
Use of steroids: As explained above, steroids are immunosuppressants commonly used as an auxiliary treatment for infectious diseases to reduce the severity of inflammatory damage.
Since a high dose of activated hormones was widely used in SARS patients, many survivors have suffered anaerobic osteoporosis with lifelong disability and poor quality of life.
Therefore, steroids must be used at a low dose and for a short period in Coved-19 patients, if necessary.
Mental Stress: As explained above, during the Covide-19 outbreak, many patients suffered exceptional stress; they often endured long periods of quarantine, extreme uncertainty, and witnessed the death of close family members and their sick colleagues.
Psychological counselling and long-term support are necessary to help those patients recover from stress and return to normal life.
According to demographic studies to date, Coved-19 appears to have epidemiological features different from Sars.
In addition to reincarnation in the lower respiratory system, Sars-Koff-2 can effectively reincarnate in the upper respiratory system and cause mild symptoms or no symptoms in the early stage of infection, similar to other corona viruses that cause common colds.
Therefore, patients infected at the early stage or incubation period can produce a large amount of the virus during day-to-day activities, causing difficulty in controlling the epidemic.
However, SARS-Koff transmission was considered to occur when patients were in a severe state of illness, while most HIV transmissions did not occur at the early stage.
Therefore, the current outbreak of Coved-19 is much more severe and more difficult to control than the SARS outbreak.
Currently, strenuous efforts are being made in China, including the closure of Wuhan and surrounding cities and the constant quarantine of almost all residents in the hope of hindering Sars-Koff-2's transition.
Although these measures have severely affected the economy and other sectors of the country, the number of new patients is declining, indicating a slow epidemic.
The most optimistic estimate is that the outbreak will end by March and the decline phase will continue for three to four months.
However, some other experts do not have the same level of optimism.
Paul Hunter et al. estimated that Coved-19, which appears to be far more contagious than Sars, would not end in 2020.
Ira Longini and others created a model for predicting the outcome of the epidemic and suggested that Sars-Koff-2 might affect two thirds of the world's population.
A Canadian group reported that Sars-Coff-2 was detected in mid-coercive and throat surveys for patients who recovered and left the hospital two weeks ago, suggesting that the newly discovered virus could become a flu-like cyclic seizure.
Nevertheless, promising signs have emerged in China based on the number of new cases that are declining, suggesting that current strategies may have been working.
Ebola was originally expected to cause up to 1 million injuries with half a million deaths.
Despite this, the disease was eventually controlled by strict quarantine and isolation measures.
Like Sars-Koff, Sars-Kov-2 can become weaker in terms of causing infection and eventually disappear or become a less pathogenic virus coexisting with humans.
A comparison of the Covide-19 epidemic is given below (Figure 55).
Sars-Koff-2 travels at a higher rate through coughing or sneezing, and can also be transmitted through direct contact with HIV-contaminated substances.
The virus was also found in the feces, which evokes a new possibility of moving from feces to mouth.
A recent study of 138 cases reported that 41% of cases may have been caused by hospital infection, including 17 patients with other former diseases and 40 health-care providers.
Considerable precautions are therefore needed to protect human beings, especially health-care providers, social workers, family members, colleagues and even bystanders who have had contact with patients or injured persons.
Wearing face masks is the first line of defense that can be used to reduce the risk of infection; the use of both surgical masks and N95 respiratory masks (series No. 1860s) helps control the spread of viruses.
Surgical face masks prevent liquid droplets from a potentially infected person from moving through the air or sticking to the surfaces of the material, where they can be passed on to others.
However, the N95 masks (series No. 1860s) can only protect against inhalation of small phyrons by 10 to 80 nm, with only 5% of virions being able to fully penetrate; Sars-Koff-2 Sars-Koff is roughly 85 nm in size.
Since particulates can penetrate up to five surgical masks stacked together, directly-mixed health care providers must wear N95 masks (series 1860s) but not surgical masks.
In addition to masks, health-care providers must wear appropriate insulation robes to reduce communication with the virus further.
Viruses can also infect someone through the eyes.
On January 22, 2020, a Dr. Saras-Koff-2 was injured despite wearing a N95 mask; the virus may have entered his body through his inflamed eyes.
Therefore, health-care providers should also wear transparent face protections or glasses while working with patients.
For the general population in affected or potentially affected areas, it is strongly recommended that everyone wash their hands with more purified soap than usual, try to stay home for self-immunicated quarantine and reduce contact with potential individuals.
Three feet is an appropriate distance to keep people away from the patient.
These measures are effective ways to reduce the risk of infection as well as prevent the spread of the virus.
Although Sars-Koff-2 came as a new virus to the human world, its close resemblance to Sars-Koff as reported on January 7, 2020 would have caused a high alert in China based on its deep memory of the SARS outbreak in 2003.
Despite this, the Director of the Center for Disease Control in Wuhan did not reassure citizens until January 19, 2020 by saying that the new virus has a low infection rate and a limited human-to-human reproduction rate and there is no problem in preventing and containing the disease.
This message severely reduced the public's preparedness, especially when the entire state was preparing for the Spring Festival, and critical time was lost to contain the disease at its lowest range in Wuhan.
China's disease control agencies may benefit from this harsh lesson and implement substantial improvements in the future.
For example, these agencies must be (1) more cautious when issuing public statements because every word is important to citizens and can change their behaviour and decisions; (2) more sensitive and interacting with unusual information from clinics rather than waiting for official reports from doctors or officials; (3) more restrictive to contain a potential epidemic in its early stages rather than to try to reassure the public; and (4) more meaningful and effective training to raise public awareness of epidemic diseases and to test and periodically improve the response system of the community.
The Covide-19 outbreak caused by the new Sars-Koff-2 virus began at the end of December 2019.
It spread in less than two months throughout China and about 50 other countries globally at the time of writing these lines.
Given that the virus is very much like Sars-Koff and the symptoms are also similar between Coved-19 and Sars, the Coved-19 outbreak has triggered a sense of repeated SARS infection.
Despite this, there are some notable differences between Covid-19 and Sars, which are necessary to contain the epidemic and treat patients.
Covid-19 influences older individuals than young people and men more than women, and the rate of distress and mortality is also higher in older persons than in young people.
Sars has a higher mortality rate than Coved-19 (10.91% versus 1.44%).
Coved-19 patients transmit the virus even when they have no symptoms, while Sars patients usually do this when they are severely ill, causing greater difficulty in containing Coved-19's spread from Sars.
This partly explains why Sars-Koff-2 spread much faster and wider than Sars-Koff.
The normal rebuzzi DNA test for Sars-Koff-2 can be negative in some of Coved-19 patients.
On the other hand, recovering patients can be infected with the virus again.
These results greatly increase the risk of the spread of the virus.
With this rapid progress in research around Coved-19, there are still many critical issues to be resolved, as follows:
Where did Sars-Koff-2 come from?
Despite the discovery of 96% genetic symmetry between Sars-Koff-2 and Corona's similar virus to Sars in bats, we still cannot conclude that Sars-Kov-2 comes from bats.
What kind of animal was the intermediate that transmitted the virus from the original host, like bats, to humans?
Without knowing the answers for numbers 1 and 2, we cannot efficiently stop the transition, and the outbreak can come back at any time.
Although molecular modelling and biochemical tests have shown that Sars-Coff-2 is associated with the angiotensis-transformed enzyme 2, how exactly does the virus enter the airway cells and cause subsequent pathological changes?
Does the virus also bind to the dissected cells of an enzyme converted to angiotensisine 2 in the other organs?
Without clear answers to these questions, we cannot make a quick and accurate diagnosis and provide effective treatment.
How long will this plague last?
How does the virus develop genetically during human transmission?
Will it become a worldwide pandemic, fade like Sars, or return periodically like the flu?
It is necessary but it may take some time to look for answers to the above and many other questions.
However, at whatever cost it may take, we have no other choice but to stop the epidemic as soon as possible and bring our lives back to normal.
Animal assets of Corona human viruses
The mutation and adaptation lead the joint development of Corona viruses (Korona viruses) and their hosts, including humans, thousands of years ago.
Before 2003, it was known that two types of human coronaviruses (human coronaviruses) cause a mild disease, such as a cold.
The outbreak of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) led to the other face being shown to reveal how severe and life-threatening the infection of the Corona human viruses could be.
The appearance of Sarse Kove-2 in Central China at the end of 2019 led to a re-emergence of Corona viruses, and we were surprised by its rapid spread but with the ability to cause the disease compared to his brother Sars-Koff.
The Corona human virus is an animal disease created so our understanding of the animal assets of Corona human viruses would serve us well.
Most of Corona's human viruses come from bats where they were not pathogenic.
I've also known the intermediate repository hosts of some of Corona's human viruses.
The identification of host animals has a direct impact on the prevention of human diseases.
Exploring the interactive relationships between the Corona virus and the host in animals also offers an important insight into the emergence of Coronavirus disease in humans.
In this review, we provide an overview of available information on the seven Corona human viruses, focusing on the history of their discovery as well as their animal origins and interspecies transmission.
Most importantly, we compare and differentiate between the different human corona viruses from the perspective of the development of the virus and the reshaping of the genome.
The disease caused by the current Corona virus epidemic 2019 (Coved-19) is discussed in this context.
In addition, it also highlights the successful switchover requirements of the host and the impact of the complications of HIV development on the severity of the disease.
Coronaviruses (Koronaviruses) belong to the family of coronary viruses, which includes a group of coronaviruses with a single positive-direction riboze DNA.
These viruses contain the largest genome of rebuzzi DNA viruses with a base of 26 to 32 kilos and are called "televiruses" by that name because their composition resembles the crown under the electron microscope.
In terms of synthetic properties, Corona viruses contain undivided genomes that share similar regulation.
Nearly two thirds of the genome contains two large open-reading templates (ORF1a and ORF1b), which are converted to multi-replicated protein types pp1a and pp1ab.
Multiple proteins are additionally treated for the generation of 16 non-structural proteins, referred to as nsp1~16.
The remaining part of the genome contains open reading templates for structural proteins, including Spike (S), COVER (E), membrane (M) and nuclear protein (N).
Different strains of corona viruses also encode a number of additional proteins from special strains.
Based on the difference in protein sequences, Coronaviruses are classified into four species (the Corona Alpha virus, the Corona Beta virus, the Corona Jama virus and the Corona Delta virus), including the Corona Beta virus species, which include most of the Corona human viruses and are divided into four strains (a, b, c and d).
Evidence of genetic evolution has shown that bats and rodents act as the genetic origin of most corona-alpha viruses and corona-beta viruses, while birds are the main reservoir of corona-jama viruses and corona-delta viruses.
Over thousands of years, Corona viruses have consistently crossed species barriers and some have emerged as causes of serious human diseases.
So far, seven human corona viruses (human corona viruses) are known.
Among them is the Corona Human Virus .229E and the Corona Human Virus-NL63 which belong to the corona-alpha viruses.
The other five Corona Beta viruses include the Corona Human Virus-OC43, the Corona Human Virus-HKU1, the Coronavirus associated with SARS-Coff, the Coronavirus associated with the Middle East Respiratory Syndrome (Mers-Coff), and Sars Cove-2.
The Corona human virus .229E, the Corona human virus-OC43, the Corona human virus-HKU1 and the Corona human virus-NL63 usually cause mild symptoms, such as cold, diarrhea or both.
In contrast, Sars-Koff and Myrs-Koff and the newly identified virus Sars Cove-2 are all highly pathogenic, causing severe lower respiratory tract infection to a larger number of patients with a higher probability of acute respiratory distress syndrome (SARS) and non-pneumothoric symptoms.
It was isolated from the Corona human virus .229E, the first strain B814, from nasal secretions of cold patients in the mid-1960s.
Much information has been collected since then through extensive studies of the Corona Human Virus 229E and the Corona Human Virus-OC43, whose symptoms are spontaneously cured.
In fact, it was generally recognized that the infection with Corona's human viruses was harmless until Sars spread.
The SARS outbreak in 2003 is one of the most deadly epidemics in our present history, with 8,000 people infected with it with almost 10% deaths.
Ten years later, Middle East Respiratory Syndrome (MERS) spreads, creating a constant epidemic in the Arabian Peninsula with scattered spread to the rest of the world.
The new Corona human virus 2019 (the new Corona human virus 2019), renamed Sars Cove-2, is the driver of the current epidemic the Corona virus disease 2019 (Covid-19), which killed more than 3,120 people and infected more than 91,000 people on March 3, 2020.
The alarm rings and the world has to prepare for the next SARS Cove-2 pandemic.
All seven Corona human viruses have animal origins of bats, mice, or pets.
Multiple evidence supports that the evolutionary origins of all human coronaviruses from bats, where viruses are well adapted and not pathogenic but exhibit significant genetic diversity.
The Covide-19 pandemic posed enormous medical, scientific, social and ethical challenges to China and the world.
The tracking of the animal origins of the Corona human viruses showed a framework for understanding natural history, driving force and limiting factors for interspecies mobility.
This may also guide or facilitate the search for the warehouse, intermediate host and amplifier host animal (inflated host animals) of Sar Kove-2, with important impacts to prevent future repercussions.
In this review we present an overview of animal assets, interspecies transmission, and the causing of diseases by Corona human viruses.
In particular, we highlight and discuss the common belief that the original viruses of the Corona human viruses are usually not pathogenic in their natural stored hosts but become pathogenic after they move between species to a new host.
We also review the evaluation of the course of the Corona human virus, where the increase in its transportability is often accompanied by a decrease in the severity of the disease.
We are also discussing in this context the results of the current SARS Cove-2 outbreak.
Corona Animal Viruses have been known since the late 1930s.
Before the B814 strain was isolated for the first time from the nasal secretions of cold patients, various species of Corona viruses were isolated from various infected animals, including turkey, mice, cows, pig, cat, and dog.
In the past decades, seven species of Corona human viruses have been identified.
A brief summary of the history of the discovery of the Corona human virus in chronological order (table 1) would be educational and indicative.
The first strain of the Corona human .229E virus was isolated from the respiratory system for patients with upper respiratory infections in 1966, after which it adapted to live in the ranks of the WI-38 lung cells.
Patients with the corona human virus .229E suffer from common cold symptoms, including headaches, sneezing, dyslexia, sore throat, with fever, and coughing at approximately 10~20% of cases.
Later in 1967, the Corona Human-OC43 virus was isolated from the organ farm and the subsequent transition was in the brains of infant mice.
Clinical features of the corona-OC43 virus infection appear to be similar to those caused by the corona-human virus .229E, which cannot be distinguished by symptoms from other respiratory viruses such as influenza viruses and nose viruses.
Both the Corona Human Virus 229E and the Corona Human Virus-OC43 spread globally, and tend to move mostly during the winter season in temperate climate.
In general, the time of pre-schooling these viruses is less than one week, followed by a sense of disease for almost two weeks.
According to a human volunteer study, the infection of healthy individuals with the corona human virus 229E caused a mild cold.
Only a few HIV patients showed severe lower respiratory infection.
Sars, also known as "atypical pneumonia", is the first pandemic caused by the human coronavirus to be well documented in the history of mankind and its trigger factor was Sars-Coff, the third human coronavirus to be detected.
The first case of Saras' injury dates back to late 2002 in the Chinese province of Guangdong.
The SARS epidemic has resulted in 8,096 confirmed casualties and 774 deaths, spread across many countries and continents.
Regardless of the superconductor, it was estimated that a single case could lead to almost two secondary cases, with a 4 to 7-day nursery period and show the height of the viral load on the 10th day of the disease.
Sars-Koff's symptoms begin to appear with muscle pain, headache, fever, dyslexia, and chills, followed as late symptoms by difficulty breathing, coughing and respiratory distress.
The lack of lymphocytes, liver dysfunctions, and the height of creatine kinase are common laboratory disorders of Sars.
In SARS patients there is also widespread damage to schizophrenia, the reproduction of the apparent cells, and an increase in the number of lymphocytes.
About 20-30 percent of patients then require intensive care and artificial breathing.
In addition to the lower respiratory system, in severe cases many organs can also be infected, including the digestive system, liver and kidney, usually accompanied by a cytokin storm that may be particularly fatal in patients suffering from immunity.
The virus was first isolated from an open lung biopsy of a relative of the first case of injury who travelled from Guangzhou to Hong Kong.
Since then, considerable efforts have been devoted to researching the Corona human virus.
The Corona-NL63 human virus was isolated from a 7-month-old child from the Netherlands in late 2004.
Initially found to be common in young children, the elderly, and patients with respiratory diseases.
The cold, conjunctive inflammation, fever, and bronchitis are common symptoms of the disease caused by the human corona-NL63 virus.
Another independent study described the isolation of the virus itself from a sample of the nose of an 8-month-old child suffering from pneumonia in the Netherlands.
Although discovered in the Netherlands, it is globally widespread.
It is estimated that the Corona-NL63 human virus is responsible for approximately 4.7% of common respiratory diseases, with its peak occurring during early summer, spring and winter.
Corona's human-NL63 virus is associated with embolismal laryngitis, also known as the strangler.
The same year, Corona HKU1 virus was isolated from a 71-year-old man who was hospitalized for pneumonia and bronchitis in Hong Kong.
In addition to the anti-social pneumonia and bronchitis, it has been reported that the human corona-HKU1 virus is associated with the exacerbation of acute asthma attacks.
The HKU1-Korona human virus was found to be globally prevalent, causing mild respiratory diseases, similar to the CORona-NL63 and the Corona-H229E and Corona-OC43 human virus.
All four Corona human viruses acquired from society have adapted well to humans. Overall, there is little likelihood that they could cause diseases with high prevalence rates, but the coincidence has occurred for unknown reasons, as in the rare case of the fiercest subtype of the Corona human-NL63 virus, which has recently been reported to cause severe lower respiratory infection in China.
In general, when Corona viruses acquire this ability to move efficiently and continuously maintain themselves within humans, they also become less severe or pathogenic.
Mirs-Koff was first isolated in 2012 from the lung of a 60-year-old patient with pneumonia and kidney failure in Saudi Arabia.
While most confirmed cases are laboratory-based from the Middle East, in many European countries and Tunisia cases have been reported that have been brought from outside and a rare secondary transition of two close personal contacts.
Another secondary outbreak occurred in South Korea in 2015 resulting in 186 confirmed injuries.
The clinical symptoms caused by Mers are similar to those caused by Sars, and are characterized by aggravated acute pneumonia.
Unlike Sars, many of the people with Mers have also suffered severe kidney failure, which is what Mers features from other diseases caused by the Corona human virus.
More than 30% of patients suffer from gastrointestinal symptoms, such as diarrhea and vomiting.
On February 14, 2020, more than 2,500 laboratory confirmed cases were reported with a high mortality rate of 34.4%, making Mirs-Koff one of the most known destructive viruses known to humans.
From mid- to late December 2019, groups of pneumonia patients were later identified as the result of the SARS Cove-2 virus in Wuhan, Hubei Province, China.
The World Health Organization (WHO) has declared the current outbreak of lower respiratory infections due to the SARS Cove-2 virus as a public health emergency of international importance as called it Coved-19.
On March 3, 2020, 90,053 cases were confirmed worldwide, and the primary mortality rate was 3.4 per cent.
It should be noted that the mortality rate in the province of Hobei, China, is 4.2 per cent, while outside it it is 1.2 per cent.
Sars Cove-2 causes severe respiratory infection such as Sars-Coff and Myrs-Coff, and appears in the form of fever, coughing and respiratory distress.
Diarrhea also appears in some of the injured.
Pneumonia is one of the most serious symptoms and can rapidly develop into acute respiratory stress syndrome.
Although Sars-Koff and Sars Cove-2 are very similar due to the high homogeneity of the nucleotides sequence of 82%, they belong to different branches of the tree of the evolution of the strains.
Sars Cove-2 appears to be less severe but more infective than Saras-Coff and Myrs-Coff.
It has been reported that there are people who do not show symptoms despite being infected with SARS Kove-2 and these may contribute to its rapid spread worldwide.
Comparison and variation between Sars Cove-2 and the other six Corona human viruses revealed similarities and differences of great importance.
First of all, Corona's human viruses are similar in the pre-school and time period of the disease.
In this regard, Sars Cove-2 follows the general trend of the other six Corona human viruses.
Second, the severity of the symptoms of the Covide-19 infection falls between Sars-Coff and the four Corona human viruses acquired from society (i.e. the Corona Human Virus .229E, the Corona Human Virus-OC43, the Corona Human Virus-HKU1 and the Corona Human Virus-NL63).
On the one hand, the incidence of SARS Cove-2 shows features that are more common in cases of human coronaviruses acquired from the community, including the appearance of unspecified or minor symptoms or even the absence of symptoms.
On the other hand, a small subset of severe cases with Coved-19 can also be seen as in the case of SARS-Coff, although the ratio is slightly lower.
Third, Sars Cove-2's transmission shows interesting patterns of both Corona's human viruses acquired from the community and Sars-Koff.
On the one hand, Saras Cove-2's mobility is at least as high as that of corona human viruses acquired from society.
On the other hand, verification of whether SARS Cove-2 transportability decreases after human transport as in the cases of SARS-Coff and Mers-Coff.
Finally, Sars Cove-2 can be detected in the stool samples as in other Corona human viruses.
Further studies are still needed in the future to clarify whether Sars Cove-2's transition from the oral anal route plays an important role as in the case of Sars-Koff at least in some cases.
It is worthwhile to note whether Sars Cove-2 may show seasonal prevalence as in cases of corona human viruses acquired from society.
However, the features of Sars Cove-2, including the possibility of transition, and the mechanism of disease and sustainable spread after human transition, will have an impact on the ultimate fate of the current Coved-19 outbreak.
All four human corona viruses acquired from society and causing minor symptoms have adapted well to humans.
Another perspective, which may also be true, is that humans have adapted well to these four human corona viruses.
In other words, they may both be survivors of old Corona human virus epidemics.
Corona human viruses that cause severe diseases to humans, as well as humans who have contracted acute Corona human virus diseases, have been eliminated.
For this to happen, the human coronaviruses must be copied in humans enough to accumulate adaptive mutations that face the limiting factors of the host.
From this logic, the longer the SARS Cove-2 outbreak continues and the more infected it is, the greater the opportunity to adapt fully to humans.
If it adapts well, it is difficult to stop human transmission through quarantine or other anti-infection measures.
The four corona viruses acquired from society spread among human populations over many years, causing cold in people with good immunity.
These viruses don't need an animal warehouse.
On the contrary, Sars-Koff and Myrs-Koff, who cause severe illness to humans, have not adapted well, and have not been able to continue to move between humans.
They need to stay and reproduce in their animal reservoirs and then look for the right opportunity to move to the most vulnerable human targets, perhaps through one or more intermediate and inflated hosts.
Sars Cove-2 has similar features to those of Sars-Koff/Mers-Kov and the four Corona human viruses acquired from society.
He's as contagious as Corona's human viruses acquired from society, at least for the time being.
However, it causes the disease more than corona human viruses acquired from society and less than Sars-Koff or Mirs-Koff.
It is not yet clear whether they will adapt fully to humans and spread among them without the need for a warehouse or an intermediate animal host.
Before discussing the animal origins of the Corona human viruses, it would be useful for us to review the definitions and characteristics of evolutionary, natural, reservoir, intermediate and amplifier of the Corona human viruses.
The animal acts as the evolutionary host of the human coronavirus if it houses the virus's closely related origin and shares a large symmetry in the levels of nucleotides.
The original virus is usually well-adapted and undisturbed to this host.
Similarly, the repository host houses the Corona human virus on a continuous and long-term basis.
Either way, the hosts are naturally infected and the natural hosts of Corona's human virus or her father's virus are.
On the contrary, if Corona's human virus enters the newly mediated host just before or near it attacks humans, it does not adapt well to the new host and often causes morbidity.
This intermediate host can act as an animal source of human infection and also act as the amplifier host by allowing the virus to be copied temporarily and thus transmitted to humans to expand the range of infection among humans.
The infection of the Corona human virus may reach a dead end if the virus fails to transmit it from within the intermediate host.
On the contrary, Corona's human viruses can also adapt to the intermediate host and may even settle for a long time.
In this case, the intermediate host becomes the natural repository host.
Epidemiological data later revealed that Saras' first case had a history of contact with the prey.
The seroprevalence surveys then indicated that animal traders had a higher prevalence rate of anti-sars-coff IgG compared to ordinary people.
It was first determined that the masked palm yogurt (Pagoma larvata) and the raccoon dog in the live animal markets carry virus similar to Sars-Koff almost identical to Sars-Koff.
This indirectly supported the fact that no other cases of SARS injury were reported after all the yogurt cats were killed in the market.
However, it has been reported that the result of Sars-Koff's examination of masked palm yogurt living in the wild or farms without exposure to the markets of living animals was largely negative, indicating that the masked palm yogurt may be only an inflated intermediate host, but it is not Saras-Koff's natural repository.
It is noted that since 80% of the different animals in the Guanzu markets have anti-Sars-Koff bodies, the possibility that multiple species of small mammals also serve as the powerful intermediate host of Sars-Koff is not excluded.
Looks like all of these are hosts who don't move Sars-Koff.
The later search for Saras-Koff's animal natural host led to the detection of closely related Corona bat virus, called the Chinese horseshoe bat virus associated with HKU3 (the Chinese horseshoe bat virus associated with HKU3), which is found in the Chinese horseshoe bats.
The result of the examination of Sars-Koff antibodies in these bats and the sequence of the Chinese horseshoe bat gene associated with severe acute respiratory syndrome HKU3 was positive.
This virus and other Corona viruses for bats share a 88-92% symmetry of nucleotides with Sars-Coff.
These studies have laid the foundation for the new concept that bats are host to emerging human pathogens.
Many coronaviruses similar to severe acute respiratory syndrome (SARS) have been identified from bats, but none of them could be isolated as a live virus except for WIV1.
The human angiotensis-transformed enzyme (the angiotensis-transformed enzyme 2) is known as the receptor of Sars-Coff.
The WIV1 extracted from a bat feces sample proved to be using the angiotensis converted enzyme 2 in the bat, yogurt cat, and humans as a receptor to enter the cell.
Interestingly, the serum of those recovering from severe acute respiratory syndrome had the ability to equate WIV1.
So far, WIV1 represents the virus the most closely associated origin of Saras-Koff in bats, as they share 95% of the symmetry of the nucleotides.
Despite the high symmetry between these two viruses, it is generally believed that WIV1 is not the direct parent virus of Saras-Koff and that bats are not a direct repository of Saras-Koff.
The analysis of the development of the Mers-Koff strains combines in the Corona-HKU4 virus group in bats and Corona-HKU5 in bats themselves.
Corona-HKU4 virus is used in bats and Mers-Coff host receptor itself, bipeptideal peptidaz4 (dibutyl peptidaz4), to enter the virus.
The riboze DNA-based polymerase sequences of Mirs-Coff are closer in terms of the evolution of strains to their counterparts than Corona Beta viruses in bats identified in Europe and Africa.
It has not yet been discovered that Mirs-Koff lives in wild bats.
Mirs-Coff and Corona-HKU25 share in their nearest bats in the symmetry of the nucleotides by only 87%.
Therefore, the host bats may not be the direct repository of Myers-Coff.
On the other hand, studies in the Middle East have shown that single-scent sentences are positive for the anti-equities of Myrs-Coff, as well as sentences of Middle Eastern origin in many African countries.
Mirs-koff, the human-compatible neighborhood, was isolated from the synapses of single-sniffed camels, suggesting that camels serve as the host of Myers-koff's original warehouse.
It should also be noted that minor symptoms generally appeared in camels that were experimentally infected with Myrs-Coff, but a massive viral dispersion was observed.
The infected camels spread viruses noticeably not only by breathing but also through the oral anal road, which is the primary way to scatter the virus from bats.
However, questions remain because many confirmed cases of Mers do not have a history of contact with camels before symptoms appear, and these cases have been logically attributed to the transition from human to human or unknown modes of transport involving unidentified species of animals housing Mers-Coff.
Sars Cove-2 shares the Corona RATG13 virus in isolated bats from horseshoe bats in 96.2 percent neucleoids symmetry.
The sequence difference between Sars Cove-2 and RaTG13 is too long to determine the relationship with the father, as in the cases of Sars-Koff and Mers-Koff.
This means that bats may not be the host(s) of the direct depot of Sar Koff-2 unless Corona's bat viruses are found almost identical in the future.
The intermediate host animals of Saras Cove-2 are assumed to be among the species of wild animals sold and killed in Wuhan's seafood market, with which many initial cases of Coved-19 are associated, suggesting possible animal-to-human transmission.
Many recent studies based on metagenomy sequence suggested that a group of endangered small mammals known as an ant-eater (Manis javanica) could also shelter the native Corona beta viruses associated with Saras Cove-2.
The genomes of the new coronavirus for these ants and Sars Cove-2 share the symmetry of the nucleotides at 85-92%.
However, they are closely related to RaTG13 with a similarity of about 90% at the level of nucleotides.
Aggregate in two substrates of virus resemblance CF-2 in the tree of dynasty development, one of which shares a similar receptor (reception area) association with Sars Cove-2, with an amino acid sequence matching of 97.4%.
In stark contrast, the areas of attachment of the receptors to Saras Cove-2 differ widely from RaTG13, although the overall sequence of the genome is higher.
A previous study on a sick ant eater also revealed the presence of viral organisms from lung samples, and it turns out that they are similarly associated with the Cave-2 sars.
This study adopted different assembly methods and manual treatment to generate a partial genome sequence consisting of the viral genome of approximately 86.3% length.
We cannot rule out the possibility that an ant-eater is one of the intermediate host animals of Sars Kove-2.
However, there is currently no evidence in support of the fact that the sacral ant eater is the direct origin of Sars Cove-2 due to the variation of sequence between Sars Cove-2 and the Corona Beta viruses associated with the sars Cove-2 in the sacre ant eater.
In addition, the spacing between Sars Cove-2 and RaTG13 is less than the spacing between Sars Cove-2 and the Corona Beta viruses associated with Sars Cove-2 in ant-eater.
The evolutionary path of Sars Kove-2 in bats, abrasion ant eaters, and other mammals are still being designated.
While the highest serial symmetry has been found in the areas of receptor bonding between Sars Cove-2 and abrasion ant eaters, the Corona Beta viruses associated with Sars Cove-2 and Sars Cove-2 and RaTG13 share the highest symmetry of the full genome sequence.
It is a dominant speculation that the high degree of similarity between the areas of engagement of Sars Cove-2 receptors in the corona-viral ant eater and Saras Cove-2 are leaders of selective converging evolution.
There is a counterproposal that is likely to be reconstructed between Sars Cove-2 in the corona-beta and RaTG13 pharmacological ant eater in the third wild species.
The recombination is widespread among Corona Beta viruses as a driving force for development.
The direct animal origin of Sars Kove-2 has not yet been verified.
In addition to the highly pathogenic Corona human viruses, the animal origin of the Corona human virus 229E, the Corona human virus-OC43, the Corona human virus-NL63 and the Corona human virus-HKU1 has also been studied.
Evidence of dynasty development has suggested that both the corona-human virus-NL63 and the corona-human virus-229E may have originated from the corona viruses for bats, while the father viruses of the corona-OC43 and the corona-human virus-HKU1 have been found in rodents.
Coronavirus is reported to be in bats called ARCov2 (Coronavirus Appalach Heights) discovered in three-colour bats in North America closely related to the Corona Human-NL63 virus.
On the other hand, the corona human virus .229E was found to be genetically associated with another coronavirus in bats, called Hipposideros/Ghanakwam/19/2008, which was discovered in Ghana, and the appellations were also suspected to be its intermediate host.
To illustrate, the current information on the animal origins of the Corona human viruses known in figure 1 and table 2 is summarized.
Analysis of the evolution of strains has provided evidence of the human transmission of coronaviruses between species throughout history.
When the Corona Human-OC43 virus passed the species to infect humans from domestic cattle around 1890, the respiratory infection epidemic was recorded.
The history of the transmission of the corona-human .229E virus between species is still less clear.
Corona-alpha viruses in bats have been discovered to be closely related to the corona-human .229E virus.
They have an alpha coronavirus in the alpaca.
Many evidence supports the transmission of the virus from bats to humans directly.
First, humans, not alpaca, may have contact with bats in a shared environmental home.
Humans have close contact with the Alabama.
Second, the corona-human .229E virus belonging to corona-alpha viruses is in multiple bats and non-disease in bats, while the corona-alpaca virus causes respiratory diseases in infected animals.
Finally, the corona-alpha virus associated with the alpaca has not been detected in wild animals.
Therefore, the possibility that alpaca has been infected with the corona human virus .229E of the α-curona virus cannot be ruled out from humans.
In fact, bats are the direct source of viruses that cause diseases to humans including rabies virus, Ebola virus, Nebah virus, and Hendra virus.
So it's not surprising that bats may transmit the corona-human .229E virus directly to humans.
While the corona-alpha viruses in bats act as a gene pool of the corona-human .229E virus, alpaca and the single camels may act as intermediate hosts that transmit viruses to humans, just as in Mirs-Coff.
Mirs-koff gives an excellent example of interspecies transmission as it moves from bats to single camels and from single camels to humans.
Mirs-Koff's evolutionary origin of bats has been defined since the beginning of their identification and has also been enhanced through subsequent results.
Clearly, bats provide a rich pool of virus species to exchange genetic pieces within the same species and their transmission between species.
Bats are characterized by longevity, living in overcrowded colonies, close social interaction, and strong flying capacity, all of which are favorable conditions to make them an ideal "virus distributor".
On the other hand, Mirs-Koff moved to the single-scented camel for decades.
She adapted to these camels well until she switched from a middle-host to a natural and stable warehouse host.
Mirs-Koff causes a very minor disease and maintains a relatively low mutation rate in these animals.
His intermittent transmission to humans remains a coincidence and man is an untransmitted host for Myers-Koff where his transport cannot continue.
Unlike the camel's role in the Mers-Coff transfer, the role of an ant-eater, if any, in the Sars Cove-2 transition is different.
In particular, the corona beta viruses associated with abrasion ant eater make him seriously ill.
They may be non-transporting hosts for Sars Kove-2 of the Corona beta viruses, similar to the yogurt cat in the case of Sars-Coff.
Future studies will resolve many possibilities for Saras Cove-2 to move between species of animals to humans by either proving or excluding them.
First, the bats may be a repository of a virus associated with Sars Kove-2, which is mostly identical to Sars Kove-2.
Humans and bats may share environmental habitat through slaughter or coal mining.
Second, an engraved ant eater can be one of the intermediate amplifier hosts of the virus associated with the recently discovered Sars Kove-2.
Humans become infected by the slaughter and consumption of prey meat.
Many mammals, including pets, are likely to be exposed to the Cave-2 sars.
A survey of antibodies in pets and wilds is warranted.
Thirdly, as mentioned above, there may have been a remodeling and adaptation of Sar Koff-2 in a third species that has contact with bats and acupuncture ants.
The search for the animal origin of Sars Kove-2 is still ongoing.
Regardless of the different types of animal hosts, on the viral side there are three key factors that are also important in facilitating the infection of corona viruses to overcome species barriers.
First of all, her mutation rates are relatively high in the doubling of rebuzzi DNA.
The estimated rates of coronavirus mutations, compared to the other mono-chained ribosy acid viruses, can be considered to be "middle" or "high" with an average rate of exchange of ~10.4 substitutions each year for site 2, depending on how Coronavirus adapts to new hosts.
Coronaviruses include an external recmonoclias recombination enzyme, the deletion of which leads to a highly elevated or unevolved mutagenicity.
Interestingly, the remodecyver drug is the isotope of neucleotides known for its ability to suppress transcription of coronavirus through inhibition of the external ribonoclyase enzyme and ribozy acid polymerase based on ribozy acid.
Rhymedsevir is one of the anti-scarce Cove2 evangelizers to be tested in clinical trials.
However, Coronavirus mutation rates are about a million times higher than host rates.
In addition, the rate of mutation is often high when Corona viruses do not fit appropriately with the host.
The rate of mutations for Sars Kove-2 is remarkably low when compared to Sars-Koff with a high rate of mutation, indicating a higher level of human adjustment.
It seems he has already adapted to another near-human host.
In addition to Sars Cove-2, this also applies to Mirs-Coff, who has adapted well to the single camels.
In theory, genetic deviation is unlikely to help vaccines and antivirus drugs resist Sars Cove-2 by rapidly weakening its effectiveness.
Second, the massive ribose DNA genome in coronaviruses actively provides an additional dosage in mutation modification and recombination of genomes, thereby increasing the probability of interspecies development, which serves to create new coronaviruses when conditions become appropriate.
This is supported by unique, abundant open reading templates and coded protein functions near the end of 3% for the genome.
Third, Corona viruses randomly and repeatedly alter templates during the replication of ribozy DNA through the unique "selection of transcription" mechanism.
In a host that is like a mixing pot, sequence switching occurs frequently during the transcription of the ribozy DNA of the Corona virus.
High-symmetry, full-length and secondary genomic nuclear acids may reconstruct to generate new coronaviruses.
A special guide to the development of strains has been discovered for the natural reconstruction of the human corona-HKU1 virus and the human corona-OC43 virus, as well as the animal coronavirus as in the severe acute respiratory syndrome virus in bats and the Corona-HKU9 virus in bats.
The virus interacts with the host associated with the transition.
In addition to the three viral factors mentioned above, viral interaction with the host receptor is another key factor influencing interspecies transmission.
In this regard, we take the re-establishment of Sars-Koff as a typical example, which also showed evidence of positive selection during interspecies transmission events.
Based on a comparative analysis between isolated samples of Sars-Koff in humans and the yogurt cat, Sars-Koff was thought to be undergoing rapid adaptation in various hosts, particularly through mutations in the field of receptor bonding for protein S.
In general, the receptors' field of association for the coronavirus protein is interacting with the cellular receptor and is heavily selected through the anti-host body response.
In Sars-Koff, receptor bonding occurs in amino acids from 318 to 510 in S1 piece, which is associated with the angiotensis-transformed enzyme 2 as well as auxiliary receptors for entry into the virus.
The SARS-Koff receptor association area is able to identify the receptors of the angiotensis-transformed enzyme 2 aid in various animals, including bat, yogurt cat, mouse and tanuki dog, which allows transmission of the virus between species.
In fact, the remains of only 6 amino acids were observed that were different from the insulated viral samples of humans and yogurt cats in receptor bonding, and 4 of them are found in the sequence pattern of association with the receptor to interact with the receptor of an enzyme converted to angiotensines 2.
The K479N and S487T mutations are found in the area of sars-coff receptor association in the yogurt cat, which can increase the probability of Spyke protein reaction in the receptor of the human angiotensisine-transformed enzyme 2.
In other words, these two types of amino acid alternatives may be critical to human viral adaptation.
It is noteworthy that Sars Cove-2 shares the same cellular receptor as Sars-Koff.
There is a 30% difference between Sars Cove-2 and Sars-Coff in the S1 unit of the S1 protein, which implies that the probability of an S protein being associated in the human angiotensisine-transformed enzyme has changed.
Indeed, a study with the super-cold electron microscope indicated that there is a probability of about 10 to 20 times higher than this correlation compared to that between the human angiotensis2 convertor enzyme and the protein S in Sars-Coff.
It is also interesting to determine whether any other type of auxiliary receiver may be necessary for Sars Cove-2 to move.
It is also interesting that the human corona-NL63 virus is also associated with the angiotensis-transformed enzyme 2 but in a different part of the protein S.
There are many other human coronavirus receptors, such as the protein analyst of the corona human virus .229E, and sialic acid 9-O of the human corona-OC43 virus.
They may also be responsible for the successful adaptation of these corona viruses in humans after moving between species of their animal hosts.
In addition to cellular receptors, the result of interspecies transmission of Corona human viruses is also controlled by other dependencies and host constraints.
The coronation of these host proteins between humans and natural depot hosts of coronaviruses, such as bats, single camels and rodents, may constitute a barrier to interspecies transmission.
Corona's human viruses need to control host reliability factors and weaken host constraints factors to implement successful interspecies transmission.
In this regard, molecular determinants in this important area of HIV interaction with the host remain detectable and identifiable.
The extensive, unbiased examination of the genome can be used to examine the reliability and host constraints of Sars Kove-2 using the advanced Cresper technique.
Emerging Corona human viruses: back to the starting point
The diversity of Corona viruses in bats offers ample opportunities for the emergence of emerging Corona human viruses.
From this logic, Corona viruses in bats are a genetic complex of Corona human viruses.
In addition, the rapid mutation and genetic recombination also drive the process of evolution of the Corona human virus and are important points in this process.
For example, the acquisition or loss of emerging protein encryption genes involves the ability to significantly modify viral apparent patterns.
Among Sars-Koff's regulatory proteins, ORF8 was thought to be important in adapting to humans, as Sars-Koff was isolated associated with viruses in bats but was found to encode different ORF8 proteins.
The 29 properties of the deletion of the sars-coff nucleotide were found to exist in isolated strains at the beginning of the human epidemic.
This deletion has led to the division of ORF8 into ORF8a and ORF8b, and is believed to be a quantum mutation that enhances host switching.
In addition, Sars-Koff is characterized by a history of possible remodelling through the strains of corona-alpha viruses and gamma, with a large number of small recombination areas being identified in riboze DNA polymerase.
Restructured sites were also identified in nsp9, most nsp10, and parts of nsp14.
In a similar way, research has shown that the Mirs-Koff epidemic has seen recombination between different strains, which occurred in the single camels in Saudi Arabia.
In addition to Sars-Koff and Mirs-Koff, recombination cases were also observed in other Corona human viruses, where the Corona human viruses were installed with other Corona animal viruses in their non-constructive genes.
It should be noted that artificial selection can also help unintended changes in the viral genome, most of which are likely to result from the virus being rid of selective pressures, such as by the host's immune system.
The loss of an ORF4 protein of full length in the phenotype strain of the corona-human .229E virus due to the deletion of two nucleotide is an example of these effects.
Although the proper ORF4 can be observed in camel viruses and bats associated with the corona human virus .229E, the corona-alpha virus that infects the albica is shown to be a single neolyotide stitches, leading to the mutation of the diaphragm frame.
Last but not least, the evolution of the new Corona viruses is also driven by selective pressure in their own storage hosts.
Cases with no symptoms or only mild symptoms have been detected when bats are infected with Corona viruses, indicating mutual adaptation between Corona viruses and bats.
She showed that bats adapted appropriately to coronavirus anatomically and physiologically.
For example, weak activation of the pro-inflammation response in bats has been reduced by the efficacy of pathogens triggered by coronaviruses.
In addition, natural lethal cellular activity in bats has been suppressed due to the increased rate of inhibiting NKG2/CD94 ' s natural killer cellular receptor and the low level of expression of the main tissue compatibility compound particles Class I.
Furthermore, the high level of reactive oxygen compound species (interactive oxygen compound species) caused by the high metabolic activity of bats can lead to both inhibition that reproduces the Corona virus and influence rectification by external ribonuclias enzyme, thus providing selective pressure for the emergence of highly pathogenic strains of the virus when a new host is infected.
Additional pathogenic strains may arise from the coronavirus by recombination, which leads to the acquisition of new proteins or protein properties to adapt to the host.
Accordingly, it is no coincidence that three new Corona human viruses have emerged over the past two decades.
Corona viruses are not pathogenic or cause mild symptoms in stored hosts such as bats and camels.
They copy hard without eliciting a strong immune response from the host.
Here lies the secrets that explain why the virus carriers who do not show symptoms and the causes of acute cases of human infection are seen.
The acute symptoms are mainly caused by hyperinvigorating immune response and cytokin storm where the stronger the immune response, the more severe the lung damage is.
On the contrary, in the case of the disease-bearers without symptoms, the immune response is separated from the transcription of the Corona virus.
A strategy similar to immune response separation may have beneficial effects in the antitherapeutic treatment of Sars Kove-2.
The interferon response is particularly strong in bats.
Thus, interferon type I ingestion can be used at least in the first stage of the infection with the Kauf-2 sars in humans.
In addition, the activation of the NLRP3 erythrocyte particle in bats is weak.
With this mental reasoning, inhibition of the encephalitis particle NLRP3 using MCC950 inhibitor is useful in treating Cowid-19.
The creation of Sars Cove-2 follows the general idea of Sars-Koff and Myrs-Koff.
At the time it was discovered that the Corona Beta virus in the bats shared 95% neucleoid homology, there was also the Corona virus in the bats sharing 96% neoclyotide homology with Sars Cove-2.
While it was discovered that yogurt cats and other animals on the market housed viruses similar to Sars-Koff they did not discover the intermediate direct hosts of Sars Kove-2.
The Corona beta viruses have been detected in the sacral ant eater and are very much homogenous with Sars Cove-2, suggesting that the ant eater animals may be intermediate hosts or that Corona Beta viruses in the ant eater have contributed genetic pieces, leading to the final release of Sars Cove-2.
Although questions remain, there is no evidence that Sarse Cove-2 is man-made, not intentionally or by accident.
Corona viruses have returned to the focus of attention due to the recent outbreak of Sars Kove-2.
The study of Corona viruses in bats and other animals has greatly changed our idea of the importance of the origins of animal-born diseases and the animal reservoirs of Corona human viruses in human transmission.
The overwhelming evidence has shown that Sars-Koff, Mers-Koff and Saras Cove-2 all have their origin in bats and have moved to humans through intermediate hosts.
Based on the fact that the Basars-Koff infection originated from contact between humans and yogurt cats on the market, the closure of fresh product markets and the killing of yogurt cats were supposed to effectively end the SARS epidemic.
With the same mental logic, the pets of the ant-eater should be disposed of from fresh product markets to prevent the transmission of the animal-born disease, in the light of the discovery of multiple genealogy of the corona beta in the ant-eater which is very close to Sars Cove-2.
However, whether or not Sarse Cove-2 moved to humans, as well as whatever their mode of transport, through the animals of ant-eaters and other mammals, his transport remains a subject that needs to be clarified in future research.
On the other hand, Mirs-Koff was found in the only camels for a long time.
These camels are an important means of transportation as well as a major source of meat, milk, leather, and wool products for local citizens.
It is widespread throughout the Middle East and Africa region.
It is therefore impossible to sacrifice all camels to control Mirs, as did officials in China's wildlife markets to prevent the spread of Sars-Koff and Saras Kove-2.
In order to stem the frequent outbreaks of Myrs, a comprehensive approach should be taken to develop effective Myrs-Koff vaccines for camels, as well as other anti-infection actions.
Because we can't eradicate these viruses once and for all, new genetic patterns can arise and cause outbreaks.
A variety of corona viruses associated with animal-born diseases are found in wildlife.
In particular, Corona viruses are very diverse in bats that have the potential to cause animal-origin diseases.
There are many opportunities for the emergence and recombination of corona viruses associated with animal-born diseases, resulting in new, more transferable and/or deadly corona viruses in humans in the future.
A wildlife eating culture should be abandoned in some places in China to reduce unnecessary contact between humans and animals.
In the light of the plights of humanity caused by Sars, Mers and Covid-19, a preparedness plan and an appropriate response should be prepared.
The fact is that many viruses have taken their place on the planet for a very long time.
They live in their own natural depots until they have a chance to spread and multiply.
Although bats carry many properties that are likely to spread viruses, human contact with bats and other species of wild animals can be reduced if humans adopt a culture that obliges them to move away from them.
Monitoring mammals in an ongoing manner is a necessary measure to gain a better understanding of the environment of Corona viruses and their natural hosts, which demonstrates its usefulness in preventing their transmission from animals to humans and preventing future appearances.
In conclusion, the best way to prevent viral diseases of animal origin is to move humans away from the environmental sites of natural reservoirs of viruses that cause diseases of animal origin.
The mystery of the origin of the animal-born disease of Sars Kove-2 is still surrounded by many questions that need to be answered.
First, if bats transmit the virus native to Saras Cove-2 to the entourage eater, it is important to know the conditions that have been set for the sharing of bats and pets of the ant eater with similar environmental location.
Second, if bats play a more direct role in the transmission of disease to humans, then the way humans communicate with them should be determined.
Thirdly, if a third type of mammal serves as a real intermediate host, then it should be clarified how it interacts with different species, including humans, bats and sacral ant eaters.
Finally, since many mammals, including pets, may be suspected of carrying Saras Kove-2, both monitoring and experimental infection should be conducted.
Whether the host is a bat, ant-eater or other mammals, it is expected to identify Sars Cove-2 or parent viruses from which he branches and which are almost identical in their future natural hosts.
Ongoing research in this area will reveal the evolutionary path of Sars Kove-2 in animals, with important actions to prevent and combat Koide-19 in humans.
Need to update the “suspected case” and “confirmed case” standard when diagnosing Kovid-19
On February 6, 2020, our team published a quick guidance on the diagnosis and treatment of the new Corona virus 2019 (the new Corona virus 2019), which provided our experience and provided appropriate reference information to combat the pandemic worldwide.
Although Coronavirus disease 2019 (Coved-19) is a new disease, our consciousness and knowledge are gradually increasing based on the results of ongoing research and clinical practice experiences; hence diagnostic and treatment strategies are constantly updated.
In this speech, we responded to a comment on our guidance and presented the latest diagnostic criteria, which are "suspected case" and "confirmed case", which is in accordance with the latest Coved-19 Diagnostic and Treatment (Seventh Release) Guidelines of the National Health Committee of the People's Republic of China.
In December 2019, Corona's new virus spread 2019 (Korona's new virus 2019), which is now officially known as the 2019 Corona virus disease (Covid-19) and named the virus Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove-2).
On March 11, 2020, the World Health Organization (WHO) described Covid-19 as the pandemic.
To combat Sars Cove's infection, our team drafted a quick guidance directive and posted it online in the Milliary Medical Research magazine on February 6, 2020.
He's had a lot of interest since his release.
Please note that, although Coved-19 is a new disease, our consciousness and knowledge are gradually increasing based on the results of ongoing research and clinical practice experiences; hence, diagnostic and treatment strategies are also constantly updated.
For example, the Covid-19 Diagnostic and Treatment Directives of the National Health Commission of the People's Republic of China (http://www.nhc.gov.cn), between January 16, 2020 and March 3, 2020, issued seven overall releases with some contexts fundamentally changed.
Our guidance is now answered by a comment from Chu and others, who have made a simple proposal for grade monitoring based on clinical experience.
Their efforts added a new guide to our guidance and also became a valuable reference to this pandemic throughout the world.
We support their great effort and express our appreciation.
However, their work also needs to be updated in accordance with the latest Covid-19 Diagnostic and Treatment Guidelines (Expert Release 7) and recent studies.
According to release VII (3 March 2020), confirmation of the suspected case requires the combination of any of the elements of the characteristics of the epidemiological history with two clinical appearances to arrive at a comprehensive analysis, or needs to verify three clinical appearance elements in the absence of a clear epidemiological history:
Epidemiological history: 1) A date that includes travel to Wuhan City and surrounding areas, or other communities with which Koved-19 cases were reported to have occurred or resided, during the last 14 days before symptoms began; 2) a date that includes communication with cases with SARS Cove-2 infections (with positive results of DNA testing); 3) a date that includes contact with patients with fever or respiratory symptoms from Wuhan City, surrounding areas or other communities with whom Koved-19 cases were reported to have occurred during the last 14 days before symptoms began; 4) a date that includes communication with a group of confirmed cases (2 or more cases with fever and/or respiratory symptoms that occurred during 2 weeks in small areas, such as the home, office, school segregation, etc.).
Clinical appearances: 1) fever and/or respiratory symptoms; 2) with properties proved by the photographic examination of Covid-19 infection; 3) show the total number of white blood cells normal, little, or low number of lymphocytes in the early stage of onset of infection.
The diagnosis of the confirmed case must be based on the suspected case involving any of the elements of the evidence of the presence of pathogens or blood serum reactions as follows: (1) positive as a result of the real-time PCR test for Sar Coff-2; (2) high homology of the entire viral genome sequence with the properties of the known emerging Corona viruses; (3) positive results of the testing of the IgM antigen and the qualitative antibody IgG for Saras Cov-2 in the serum; or the change of the qualitative antibody IgG for Saras Cov-2 from negative to positive, or that the high calibration in the recovery phase is equal to or more than four times that level in the acute phase.
We see that the real-time testing of the sequenced polymerase reaction of DNA in the respiratory tract or blood samples was added to version 2 (18 January 2020) and third (22 January 2020).
The detection of pathogens in the blood sample was added to the fourth (January 27, 2020) and fifth (February 8, 2020); then the blood serum reaction manual was added to the seventh version.
These adjustments have relied on the continuing work of researchers to arrive at the design of an ideal tool kit for detection via DNA for rapid diagnosis, as well as respiratory tract samples including blood samples, which has increased the availability of different samples, supporting the transfer of the positive antigen to confirmed case standards.
Besides, there is growing evidence to caution us when dealing with patients with unusual symptoms and unsuspecting cases.
Therefore, the content of the information flow scheme should be updated for Cho et al., where they classified a person free of clinical symptoms at the "low risk" degree.
The scoring system also needs to be validated in practice and additional clinical studies.
In conclusion, we hope to get more direct evidence and invite readers to provide us with their comments.
To diagnose the "suspected case" and the "confirmed case", we call for tracking and adherence to the newer instructions issued by home states.
Our team will also update our guidance in time to help.
Bangladesh accounts for five new deaths due to Coved-19, the highest daily rate
Bangladesh yesterday confirmed five new deaths due to Coved-19 disease that day.
This is the highest number of deaths in one day due to the virus.
The Institute of Epidemiology, Disease Control and Research (IEDCR) in Bangladesh reported that, as of yesterday, 114 registered cases of infection were active and 33 were in the home.
17 deaths have been recorded.
The Director of the Institute of Epidemiology, Disease Control and Research, Dr. Mirjadi Sabrina Flora, stated at an online press conference that deaths included four males and one females.
According to Dr. Mirjadi, there were two cases aged over 60, two cases aged between 51 and 60, and one case aged between 41 and 50.
She also said that two deaths were from Dhaka.
The World Health Organization (WHO) declared Covid-19 a pandemic on March 11.
An official of the Anatolia Agency Hospital, a local news agency, said that one of the deceased was Jalal Saif Rahman, the director of the Bengali Anti-Corruption Commission, who was receiving care at the Kuwait Mytry Hospital.
The Minister of Land Transport and Bridges of the State of Bangladesh, Abd al-Qadir, said in a video statement via the Internet on Saturday that public transport would stop longer than initially planned, until next Saturday.
The disruption of public transport began initially on March 26 and was scheduled to end on Saturday April 4.
The transport of commodities, namely, medical products, fuel and food, is still allowed.
The first cases of Coved-19 disease were recorded in Bangladesh on March 8, for two people who returned from Italy, as well as for one of them's wife.
The three had already recovered by March 19.
The number of SARS Cove-2 virus infections exceeded 1 million worldwide
Data released by Johns Hopkins University on Thursday indicated that the total number of cases of the coronavirus causing severe acute respiratory syndrome (SARS) was exceeded and abbreviated (Sars Cove-2) was known as one million around the world.
Covid-19's disease caused Coronavirus in at least 52,000 deaths.
This dangerous development came on the same day that Malawi confirmed the first cases of the Corona virus, and the first associated death was recorded in Zambia.
North Korea claimed that, from Thursday, it was one of the few nations still free of Coronavirus infections.
The World Health Organization (WHO) announced 1051635 confirmed cases, as of yesterday, of which 79332 were in the 24 hours preceding 10 a.m. Central European time (0800 hours UTC) on April 4.
More than 244,000 cases of coronavirus were recorded in the USA, with at least 5,900 deaths associated.
CBS News, according to Johns Hopkins University data, reported over 1,000 deaths in the United States on Wednesday caused by coronavirus infection.
States around the world have announced stricter measures to prevent the spread of the disease.
Mr. Sergei Sobianin, Mayor of Moscow, announced on Thursday that the city's closure period would be extended until May 1.
Nationwide, President Vladimir Putin announced that salary payments to Russians would continue without going to work until April 30.
The Portuguese Parliament voted to extend the state of national emergency for 15 days; the vote was approved by 215 votes, with 10 abstentions, and one vote was opposed.
Saudi Arabia extended the curfew in the cities of Mecca and Manurah to all day; it was only from 3 p.m. to 6 a.m.
Thailand intends to impose a curfew from 10 p.m. to 4 a.m.
Ohio State Governor, Mr. Mike de Wayne, announced that the state extended the order to stay at home until May 1.
Australia's stores reduce the limit on the purchase of toilet paper per transaction
Australian Store Series Wallworths and Coles on Saturday and Sunday evening stressed the restrictions of buying toilet paper to reduce it to two rolls from Wallworth Stores and one roll from Coles Stores for each transaction in all branches nationwide.
I also identified Aldi's stores for one roll, on Monday.
These purchase restrictions were published as letters at pay points in store chains and on their Facebook pages.
It has been reported that buyers stored them because of concerns about Cowid-19's disease in case people need self-segregation.
Wallworths on Wednesday introduced restrictions on the delivery of toilet paper to homes to become one roll per purchase order.
These changes came after previous restrictions approved by Wallworths and Coles stores on March 4 by allowing the purchase of only four rolls per transaction.
Coles stores reported in their 8 March media statement that despite the application of the four scroll restrictions, "many stores continue to sell all their items within one hour of receipt", and the application was described as "unprecedented", as did Aldi stores in a Facebook publication on Tuesday as "unexpected".
Sales increased "substantially" last week, according to the spokesman for Wallworth's stores.
Costco's store in Canberra also determined last week that the amount allowed to be purchased is two rolls.
To alleviate the shortage, Coles stores asked suppliers for larger rolls and increased delivery frequency, and Wallworth stores asked for additional stock, while Aldi stores made available their stock for special offers scheduled for Wednesday early.
Russell Zimmerman, Executive Director of the Australian Retailer Association, said retailers were trying to increase inventory, but local council restrictions on the timing of truck delivery make it difficult.
Production costs are expected to rise, as suppliers try to meet demand, with few private offers.
On Tuesday, Aldi's stores announced that as a result of the early availability of stock, some stores would not be able to provide their own Wednesday show.
Dr. Gary Mortimer, retail expert at the University of Queensland Tech, reported in a report on News.com.au, that stores fill stores every night.
He pointed out that toilet paper was a large commodity, resulting in a lower quantity of stock in numbers, and when sold in full, large empty spaces were left on shelves, reinforcing the feeling of shortage.
Russell Zimmerman stated, according to ABC News, that "Colls and Wallworths stores have a view that if many goods are available on shelves, and if products such as toilet rolls and sterilizers can be [purchased] and supplied in large quantities, it may reduce panic".
Who Gives a Crab, which produces recycled toilet paper, reported last Wednesday that its stock was depleted.
According to the News.com.au website report, Kimberly-Clark, which produces clinks toilet paper, and Solaris Pepper, which produces sorbent napkins, confirmed that they are working 24/7 to continue providing their products.
Domain.com, a real estate site, indicated that some real estate sellers were providing free toilet paper to the first bidder at auctions in Melbourne, while fewer auctions were held because buyers stopped working on the long weekend of Labor Day.
The Thursday edition of NT News, a daily publication in Darwin City, included an eight-page advertising fold that could be cut and used as toilet paper.
Stores initially hesitated about imposing restrictions, according to a report released by ABC Australia on March 3, where stores stated that they had no plans to impose restrictions on purchases.
Russell Zimmerman added that there was also a great demand for other products, including muzzles, sterilizers, dried goods, handwashing and flour.
Similarly, outside Australia, on Sunday evening it was noted that a British online store named Okado identifies the purchases of toilet paper Andres with two pots of 12 rolls.
The World Health Organization (WHO) announces that Kovid-19 is a pandemic.
The World Health Organization (WHO) announced on Wednesday that the constant outbreak of Covid-19 - a disease caused by the Corona virus associated with severe acute respiratory syndrome (SARS) and known for short as Sars Cove-2 - has reached the epidemic level.
Although the word “against” refers only to the extent of the disease and not to the seriousness of specific situations, WHO has noted the need to prompt Governments to take the necessary measures:
“All countries can still change the course of this epidemic.
The Director-General of the World Health Organization, Tidros Adhanom Gebresus, said: "If countries discover, test, treat, isolate, track, and mobilize to confront people."
"We are all very concerned by the alarming levels of proliferation and danger as well as alarming levels of inaction".
According to Dr. Tom Frieden, the former director of the United States Centers for Disease Control and Prevention, this pandemic is "unprecedented".
It was mentioned in statements published by CNN in February, "No other respiratory virus has been traced from the beginning of its appearance to the ongoing global spread, other than influenza".
Gepresus expressed a similar view, saying, "We've never had an epidemic caused by one of Corona's viruses."
He continued: "We've never seen a pandemic that can be controlled at the same time."
The new situation is described as a pandemic following the decision of the World Health Organization (WHO) in January to declare the outbreak a public health emergency of international concern.
The Director of the National Institute of Sensitivity and Infectious Diseases of the United States, Dr. Anthony Fawchi, said about the outbreak of disease: "The bottom line is that things will get worse."
The Associated Press reported that there were at least 126,000 Kovid-19 cases worldwide from Thursday, and over 4,600 deaths.
The Coronavirus pandemic 2019-20 is an ongoing pandemic for Coronavirus disease 2019 (covid-19), caused by Coronavirus 2 associated with severe acute respiratory syndrome (SARS Cove-2).
The outbreak was identified in Wuhan, China, in December 2019, and declared a public health emergency of international concern on January 30, 2020, recognized as a pandemic on March 11, 2020.
As of April 10, 2020, about 1.61 million cases of Coved-19 cases were reported in 210 countries and territories, resulting in about 97,000 deaths.
About 364,000 people recovered.
China's mortality rate was estimated at 4%, while globally it ranged from 13.04% in Algeria to 0.08% in New Zealand.
Common symptoms include fever, cough and respiratory distress.
Complications may include pneumonia and acute respiratory stress syndrome.
The period between exposure to infection and symptoms usually amounts to about five days, but may range from two to fourteen days.
There's no known vaccine or specific anti-virus treatment.
The basic treatment is supportive and symptom-based, and recommended preventive measures include handwashing, coughing mouth coverage, maintenance of interpersonal spacing, monitoring and self-insulation of persons suspected of being infected.
Authorities around the world respond to this threat by imposing travel restrictions, quarantine, curfews, workplace risk controls and closure of installations.
This pandemic has led to severe global socio-economic disruption, postponement or cancellation of sporting, religious, political and cultural events, and a large-scale shortage of supplies exacerbated by the panic of procurement.
Schools and universities were closed either nationally or locally in 193 countries, affecting about 99.4 percent of the world's student population.
Misinformation about HIV has spread online, and there have been incidents of xenophobia and discrimination against Chinese, other people of East and South-East Asian origin and appearance, and other areas where major HIV infections have emerged.
As a result of reduced travel and closure rates for heavy industries, there was a reduction in air pollution and carbon emissions.
Health authorities in the city of Wuhan (the capital of Hubei Province) of China reported a series of cases of pneumonia for an unknown cause on December 31, 2019, and the investigation began in early January 2020.
Cases are often associated with Wuhan's seafood market for sale by mass, so the virus is thought to have an animal origin.
The virus that caused the outbreak is known as Saras Cove-2, a newly discovered virus closely associated with Corona viruses in bats, Corona viruses in herpes ant eaters, and Sars-Coff. It was later discovered that the first person to show symptoms contracted the disease on December 1, 2019, and this person had no clear contact with the later discovered wet market group.
Of the early cases reported in December 2019, two thirds were found to be market related.
On March 13, 2020, an unverified report published by the Morning Journal of South China indicated that a case dating back to November 17, 2019, 55 years old from Hobei County, was probably the first. On February 26, 2020, the World Health Organization (WHO) reported that although new cases in China had declined, they had suddenly risen in Italy, Iran, and South Korea, with new cases outside China surpassing the number of new cases within for the first time.
There may be a significant underreporting of cases, especially among those with mild symptoms.
By February 26, relatively few cases were reported among young people, with 19-year-olds and under 2.4% of cases worldwide. The UK’s chief scientific consultant, Patrick Valance, estimated that 60% of British would need to be infected before effective herd immunity could be achieved.
Cases refer to the number of people who have been examined for Kovid-19, and confirmed for injuries in accordance with official protocols.
As of March 23, no country tested for more than 3% of its population, and many countries had formal policies on not testing only for those with mild symptoms, such as Italy, the Netherlands, Spain, and Switzerland.
A study published on March 16 found that, as of January 23, an estimated 86% of the cases of Coved-19 had not been detected in China, and that these unrecorded injuries were the source of infection for 79% of the cases recorded.
A statistical analysis published on March 30 estimated that the number of injuries in Italy was much higher than the recorded cases.
Preliminary estimates of the basic reproduction number (R0) of Coved-19 ranged from 1.4 to 2.4.
A study published by the Center for Disease Control and Prevention in the United States concluded that it could be 5.7.
Most people with code 19 recover.
For those who do not recover, the period from deterioration of symptoms to death takes between 6 and 41 days, the most common being 14 days.
As of April 10, 2020, Coved-19 caused about 97,000 deaths.
As of February 5, around 80% of deaths in China were concentrated in those over 60 years of age, and 75% had pre-existing illnesses, including cardiovascular diseases and diabetes. Official statistics on deaths from the Covide-19 pandemic generally refer to those who died who were found to have a code according to official protocols.
The real number of deaths from Covide-19 may be much higher, as it may not include people who die without testing – for example; at home, in nursing homes, etc.
Partial data in Italy revealed that the number of excess deaths during the pandemic exceeded the official number of Koved deaths recorded by a factor of 4.5x.
US CDC spokeswoman admitted "We know that [the number of deaths declared] reflects less than reality", a statement supported by narrative reports indicating inaccuracies in the US. Such underestimation occurs in pandemic cases; such as the 2009 H1N1 swine flu pandemic was the first confirmed death in Wuhan on January 9, 2020.
It was the first death out of mainland China on February 1, in the Philippines, and the first death out of Asia in France on February 14.
By February 28, more than a dozen deaths were recorded outside the mainland of China in both Iran, South Korea and Italy.
By March 13, more than 40 countries and territories reported deaths, on all continents except Antarctica. Many measures are commonly used to determine mortality.
These figures vary by region and over time, and are affected by the size of the tests, the quality of the health-care system, treatment options and time taken from the onset of the outbreak, and population characteristics such as age, sex, and public health. The mortality/injury ratio reflects the number of deaths divided by the number of cases diagnosed over a given period of time.
Based on Johns Hopkins University statistics, the global mortality to injury ratio is 6.0% (97,039/1,617,204), as of April 10, 2020.
The number varies by region.
In China, the estimated mortality rate for injuries has decreased from 17.3% (for those with symptoms from 1 to 10 January 2020) to 0.7% (for those with symptoms after 1 February 2020). Other measures refer to the CFR mortality rate, which reflects the percentage of those who died from disease, and the IFR mortality rate, which reflects the percentage of those who are infected (those who are found to be infected and those who are not) who die from a disease.
These statistics do not have a time frame and follow a specific population from injury to fate.
A number of academics have attempted to calculate these numbers for certain population groups.
The Oxford University Center for Evidence-based Medicine estimates the infection mortality rate for the pandemic as a whole to be between 0.1% and 0.39%.
The higher estimate of this range is consistent with the results of the first randomised Koved-19 test in Germany, and with a statistical study analysing the impact of the test in case mortality estimates.
The World Health Organization (WHO) emphasizes the possibility of controlling the pandemic.
The peak of the outbreak and its maximum duration are uncertain and may vary by location.
Massage Pony of Pennsylvania State University stated: "The outbreak of infectious diseases that are left uncontrollable usually peaks and begins to decline afterwards when the disease does not find available hosts.
But it's almost impossible to reach any logical expectation now about the timing of this".
Chinese government chief medical adviser Chung Nanshan stated that "it could end by June" if all countries could be motivated to follow WHO advice on measures to stop the spread of the virus.
On March 17, Adam Kocharsky of the London School of Hygiene and Heat Medicine stated that Sars Cove-2 "would be spread out possibly for a year or two".
According to a study conducted by the Imperial College of London under world supervision by Neil Ferguson, we will need to rely on physical spacing and other measures "until a vaccine becomes available (perhaps 18 months or more)".
William Shafner of Vanderbilt University said, "I think this Corona virus is unlikely to disappear completely – because it is easily transferable), and it may "be transformed into a seasonal disease – so that it returns every year."
The fierceness of return will depend on collective immunity and the extent of transformation.
Covid-19's symptoms may be relatively indeterminate and may not show symptoms on the injured.
The two most common displays are fever (88%) and dry cough (68%).
The less common symptoms include fatigue, respiratory pygmy secretion, loss of smelly sense, respiratory distress, muscle and joint pain, throat inflammation, headaches, chills, vomiting, blood jet, diarrhea, or glaucoma.
The CDC in the US has limited the symptoms to respiratory difficulty, persistent chest pain or pressure, sudden confusion, difficulty waking up, and facial or lip glaucoma. Immediate medical care is advised if these symptoms appear.
Some of the injured, who do not have clinical symptoms but whose injuries are confirmed by the results of the tests, may not show symptoms, so specialists have given advice that mixed persons should be closely monitored and examined for cases that have been confirmed to exclude infection.
Chinese estimates of the incidence without symptoms range from a few to 44%.
The usual period of custody (between injury and symptoms) ranges from one day to 14 days; it is often five days. As an example of confusion, the proportion of those with code 19 who initially lost a sense of smell was estimated to be 30%, and the rate recently fell to 15%.
Some details of how the disease spread are still under consideration.
The disease is thought to spread mainly during mixing or through scattering spray at coughing, sneezing or talking; when mixing at a distance of 1 to 2 m (3 to 6 ft).
Studies have shown that coughing without mouth cover may be saved by spray scattered from 4.5 m (15 ft) to 8.2 m (27 ft).
Some see that the virus may also be transmitted by long-standing spray in the air, which may be produced in the course of speech. It may also produce respiratory spray during the exhalation process, including when speaking, although the virus is not generally airborne.
Spray may fall on the mouths or noses of persons close to or be inhaled into the lungs.
Some medical procedures such as tubeging and CPR (CBR) may cause respiratory discharges to be released in the form of spray and thus cause proliferation by air.
It may also spread when one touches a contaminated surface, including skin, and then touches his eyes, nose, or mouth.
Although there are concerns about the probability of spreading from feces to mouth, that risk is thought to be limited.
China’s government denied the possibility of Saras Kove-2 moving from feces to mouth. The virus is more infected during the first three days of symptoms, although it may spread before any symptoms appear and during later stages of the disease.
People were found to have contracted the disease up to three days before symptoms appeared, indicating that it was possible to move before severe symptoms appeared.
There are only a few reports of cases without laboratory confirmed symptoms, but no symptoms have been identified by some countries during conjugation tracking surveys.
The European Center for Disease Control and Prevention (ECCDC) asserts that despite some ambiguity about how easily the disease spreads, one person can be infected from two to three more in general. The virus remains on the surface from hours to days.
Specifically, the virus was found to be detectable for up to three days on plastic (Polyproplin) and stainless steel type 304, one day on cardboard, and up to four hours on copper.
However, this varies based on humidity and temperature. Pets and other animals have been confirmed as having been infected with code-19.
There is no evidence that animals can transmit the virus to humans, yet British authorities are advised to wash hands after mixing animals, as when touching other surfaces that may have been touched by one of the injured.
The Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove-2) is an emerging virus, with the first time isolated from three people who were suffering from bronchitis mixed with a group of cases of acute respiratory disease in Wuhan.
The Sars Cove-2 virus shares all its properties with the corona viruses found in nature. Outside the human body, home soap kills the virus, where its protective membrane is melted. The Sars Cove-2 virus is closely associated with the original Sars Cove virus.
It's thought to have animal origin.
Genetic analysis revealed that Coronavirus meets genetically with the genus of the Corona beta virus, and falls under the subgenus of the Corona Sarby virus (b strain) plus two strains originating from bats.
96% at the entire genome level corresponds to other samples of Corona viruses in bats (Bat Cove Rat G13)
In February 2020, Chinese researchers discovered only one variation in amino acids in certain parts of genome sequences between viruses originating from the ant-eater and viruses originating from man.
A comparison of the entire genome to date has resulted in the discovery of at most 92% of genetic material that is associated with the Corona virus to eat ant-sacrifice and the Sars Cove-2 virus, which is insufficient to prove that an ant-sacrifice eater is the intermediate provider of this virus.
HIV infection can be diagnosed temporarily on the basis of symptoms, although the confirmation is eventually done by the serial polymerase reaction of RRT-PCR to infected secretions or computerized CAT scans.
A study in Wuhan City comparing the reaction of serial polymerase to computerized CAT scans indicated that computerized CT is more sensitive than serial polymerase reaction, although less accurate, with many of its imaging properties interfering with pneumonia and other pathological stages.
As of March 2020, the American Radiography College recommends "no use of computerized CT scans to detect Covid-19 or consider it a preliminary examination of the diagnosis of the disease".
The World Health Organization (WHO) published several protocols for the testing of ribosi DNA for the SARS Cove-2 virus for the first time on January 17.
The test uses the reaction of the RRT-BCR in real time polymerase series.
Test can be performed on respiratory or blood samples.
Results are generally available within a few hours to days.
This test is generally performed by a nasal float, and can also use a socket from the throat. A number of laboratories and companies develop serum tests that detect antibodies.
As of April 6, 2020, none of them proved sufficiently accurate to be widely used.
A serum test developed by Selix received accreditation for emergency use in the United States only in certified laboratories.
Characteristics of radiophotograms and CT CT for people suffering from symptoms of disease include an asymmetric endosterosis such as a stained glass blur and a disorientated crystal filter.
The Italian Radiation Society compiles an international online database of case-confirmed imaging results.
Radiography without a sequenced polymerase reaction is a limited procedure in relation to the discovery of Covid-19; due to its overlap with other diseases such as glandary virus infection.
A major study in China compared the results of computerized chest CT scans with sequenced polymerase reaction and demonstrated that although the CT scan is less accurate in terms of injury proof, it is faster and more sensitive, suggested as a screening tool in epidemiological areas.
Artificial IQ-based synaptic neuronetic networks have been developed to detect the properties of viral imaging in both radiophotograms and computerized CAT scans.
Strategies for preventing the transmission of disease include maintaining generally good personal hygiene, washing hands, avoiding eye, nose or mouth contact with unwashed hands, and using a napkin at cough or sneeze and then disposing of it by throwing it directly into the trash can.
Those who are already infected are advised to wear a medical mask in public.
Physical spacing is also recommended to prevent transmission. Several governments have banned unnecessary travel to and from countries and regions affected by the outbreak or advised not to travel.
However, the virus has reached the stage of spread throughout society in large parts of the world.
This means that the virus spreads within communities, and some individuals do not know where or how they were infected. Health-care providers, who take care of a potentially infected person, are advised to use perceived measures and precautions to mix and protect the eye.
The use of mobile locator data by Governments for tracking has raised privacy concerns, with Amnesty International and more than 100 other organizations issuing a statement demanding that such surveillance be restricted.
Many mobile phone applications were designed or released for voluntary use, and as of April 7, 2020, more than a dozen specialized groups worked to find privacy-sensitive solutions, such as using Bluetooth to record the user's proximity to other mobile phones.
Users then receive a message if they approach someone who is proven to have been exposed to a code-19. Misperceptions about how to prevent infection are promoted; for example, nosewashing and gargoyles with mouthwash are not a viable solution.
There is not yet a vaccine for Coved-19, although many organizations have worked to produce a vaccine.
Handwashing is recommended to prevent the spread of the disease.
The Center for Disease Control and Prevention recommends that people repeatedly wash their hands with soap and water for at least twenty seconds, especially after going to the toilet or when the dirt appears on the hands, before eating, and after emptying the nose, cough or sneeze.
This is because home soap kills the virus outside the body; it destroys its protective membrane.
The Center for Disease Control and Prevention also recommended the use of a hand sterilizer containing at least 60% alcohol when water and soap are not available.
WHO advises people to avoid touching eyes, nose or mouth with unwashed hands.
The surfaces can be disinfected using several disinfectants (within one minute of putting the disinfectant on the stainless steel surface), including ethanol 62–71%, isopropanol 50–100% and sodium hepochlorite 0.1%, hydrogen peroxide 0.5%, and iodopovidone 0.2–7.5%.
Other disinfectants, such as benzalconium chloride and chlorhexadine glucone, exist with less efficacy.
The Center for Disease Control and Prevention recommends that if a person is suspected or confirmed to have been injured in a facility as an office or care centre, all places such as offices, bathrooms, common spaces, shared electronic devices such as tablets, touch screens, keyboards, remote controllers and ATMs used by the patient must be sterilized.
Health organizations have recommended that people cover their mouths and noses when coughing or sneezing either bend the elbow and put it in front of the mouth and nose or use a paper towel and immediately dispose of any napkins.
It is recommended that those who are likely to be infected use medical masks, as wearing the mask reduces the size of the respiratory spray and the distance it travels when scattered due to speech, sneeze and cough.
WHO has issued instructions on when and how to use masks.
According to Stephen Griffin, a virus scientist at Leeds University, "The mask of [persons'] desire to touch their faces can be reduced, which is a major source of infection if the hands are not properly cleaned." Those who take care of people who are likely to be infected with the disease are recommended using masks.
The World Health Organization (WHO) recommended that healthy masks should only be worn if they are exposed to high risk of injury, such as those who care for a cryptic-19 sufferer, although it also recognizes that wearing masks may help people avoid touching their faces.
Several countries began to encourage ordinary people to wear face masks.
The U.S. Center for Disease Control and Prevention recommends wearing a non-medical face mask made of cloth. China specifically recommended the use of disposable medical masks, especially in the case of mixing people (1 m (3 ft) or less) directly.
Hong Kong recommends wearing a medical mask when using public transport or staying in crowded places.
Thai health officials encourage individuals to make masks of cloth at home and wash them daily.
The Czech Republic and Slovakia prohibited going out to public places without wearing a mask or covering the nose and mouth.
On March 16, Vietnam asked everyone to wear masks when going to public places to protect themselves and others.
The Austrian government required anyone entering a grocery store to wear a mask.
Israel asked all residents to wear masks in public places.
Taiwan, which has produced 10 million masks daily since mid-March, demanded that train passengers and inter-city buses wear masks on April 1.
Panama made wearing a face mask when exiting necessary, also recommending making face masks at home for those who cannot buy face masks.
Face masks are also widely used in Japan, South Korea, Malaysia, and Singapore.
Social spacing (also known as physical spacing) includes anti-infection measures aimed at slowing the spread of the disease by minimizing interpersonal mixing.
Roads include quarantine; travel restrictions; and closure of schools, workplaces, playgrounds, theatres, or shopping malls.
Individuals can apply social spacing methods by staying at home, limiting travel, avoiding crowded areas, exchanging greetings without touching, and physically spaced from others.
Many governments currently impose or recommend social spacing in areas affected by the outbreak.
The maximum size recommended by U.S. government bodies and health organizations was quickly reduced from 250 people (if the prevalence of Coved-19 in the area was not detected) to 50 people, and 10 later.
Older persons and those suffering from chronic diseases such as diabetes, heart disease, respiratory disease, hypertension, and weak immune systems face an increased risk of serious illness and complications and have been advised by the Center for Disease Control and Prevention to stay at home as much as possible in areas of inter-community disease outbreak. In late March 2020, WHO and other health bodies began replacing the term “social distance” with the term “physical distance,” explaining that the goal is to reduce physical contact while maintaining social ties, either hypothetically or at a distance.
The use of the term "social distance" has led to the suggestion that people should engage in complete social isolation, rather than encourage them to communicate with others through alternative means. Some authorities have issued sexual health directives for use during the pandemic.
This includes recommendations to only have sex with someone you live with who is not HIV-positive or suffering from symptoms.
Self-segregation is recommended in the home for those who have been affected by Coved-19 and those who are suspected of being injured.
Health agencies have issued detailed instructions for proper self-segregation. Several Governments have imposed or recommended quarantine for all people living in affected areas.
The strongest quarantine instructions were issued to those most at risk.
Those who have dealt with a person with code 19 and those who have recently travelled to a country or area where the infection is widely transmitted are advised to be self-infected for 14 days from another time.
Strategies for controlling disease outbreaks are containment or inhibition and reduction of proliferation.
Containment is applied in the early stages of the outbreak and aims to track and isolate the infected as well as to introduce other measures to combat infection and vaccines to prevent the disease from spreading to the rest of the population.
When the spread of the disease is not possible, efforts are then directed to the mitigation phase: measures are taken to slow the spread down and mitigate its effects on the health-care system and society.
A combination of both containment and mitigation measures can be undertaken at the same time.
Restriction requires more stringent measures to reverse the pandemic by reducing the number of basic reproduction to less than 1. Part of the management of infectious disease outbreaks is trying to reduce the peak of the epidemic, while the epidemic's curve is known to be flattened.
This reduces the risk of straining health services and saves more time to develop vaccines and treatments.
Non-pharmacological interventions that may address the outbreak include personal protective measures, such as hand-cleaning, wearing masks, and auto-sanitation; community actions aimed at physical spacing such as closing schools and cancelling major gatherings; community solidarity to encourage acceptance and participation in such interventions; as well as environmental measures such as surface-cleaning. More stringent measures have been taken to contain the outbreak in China once the severity of the outbreak is clear, such as the application of quarantine to entire cities and a strict travel ban.
Other countries have also taken a variety of measures aimed at reducing the spread of the virus.
South Korea introduced mass tests and local quarantine, and issued alerts on the movement of the injured.
Singapore provided financial support to those who isolated themselves and imposed large fines on those who did not.
Taiwan has increased the production of masks and criminalized the hoarding of medical supplies. The simulations of the United Kingdom and the United States show that mitigating (delaying rather than halting the spread of the epidemic) and curbing (reflecting the growth of the epidemic) face significant challenges.
Optimal mitigation policies may reduce the peak demand for health care by 2/3 and mortality by half, but they continue to lead to hundreds of thousands of deaths and strain health systems.
Constriction may be preferable but it must be maintained as long as the virus spreads in humans (or until the vaccine becomes available, if it happens first), as on the other hand the transition is quickly reversed when the measures are relaxed.
Long-term intervention to curb the pandemic causes social and economic costs.
There are no specific antiretroviral drugs approved for Coved-19, but development efforts are ongoing, including testing of existing medicines.
Taking medications to treat colds that are released without prescription and drinking liquids and rest may help alleviate symptoms.
Depending on the severity, Oxygen therapy, venous fluids, and respiratory support may be required.
The use of steroids may exacerbate the results.
Many pre-approved compounds are subject to treatment for other viral diseases for use in the Covid-19 treatment.
WHO also stated that some "traditional and home-based treatments" could provide mitigation of symptoms caused by Sars Coved-19.
Increased capacity and adaptation of health-care centres to provide for the needs of Covid-19 patients were described by WHO as essential measures to respond to the outbreak.
The European Center for Disease Control and Prevention and the WHO European Regional Office have issued guidelines for hospitals and primary health-care services for the transfer of resources at multiple levels, including focusing laboratory services on the Kovid-19 test, eliminating optional procedures as far as possible, separating and isolating those affected by Coved-19, increasing intensive care capacities through staff training and increasing the number of artificial respirators and beds available.
There are multiple theories about where the first case arose (so-called patient zero).
The first known case of the Corona virus may date back to December 1, 2019 in Wuhan, Hobei, in China.
Within a month, the number of Coronavirus cases in Hoby gradually increased.
This was mostly linked to Wuhan's seafood market for wholesale sale, which also sells live animals, and one theory states that the virus came from one of these species of animals; in other words, it has an animal origin. A group with pneumonia was observed for an unknown reason on December 26 and was handled by Dr. Zhang Jishian at Hobei County Hospital, who reported to the Center for Disease Control in Jianghan Bohan on December 27.
On December 30, a group of doctors at Wuhan Central Hospital warned their colleagues of the "Korona-like virus Sars".
Police alerted eight of these doctors, including Lee Wen Liang, to spread false rumours, and another physician, Iven, was reprimanded by her superiors to raise the alarm.
The Wuhan Municipal Health Commission later issued a public notice on December 31 and reported to WHO.
Sufficient cases of unknown pneumonia were reported to the Wuhan health authorities, prompting the investigation to begin in early January. During the early stages of the outbreak, the number of cases doubled almost every seven and a half days.
In early and mid-January 2020, the virus moved to other Chinese provinces, with the help of movements during China's New Year's and being a transport hub and the junction point of the main railway lines.
On January 20, China reported approximately 140 new cases in one day, including two people in Beijing and one in Schengen.
As of March 26, the US has surpassed China and Italy with the highest number of confirmed infections in the world. As of April 9, 2020, more than 1.61 million cases were reported worldwide, with over 97,000 deaths and more than 364,000 recovery.
About 200 States and territories registered at least one case.
Because of the pandemic in Europe, many countries in the Schengen region have restricted freedom of movement and imposed border controls.
National reactions included containment measures, such as quarantine (known as stay-at-home orders, shelter orders, or closure) and curfews. As of April 2, nearly 300 million people, or about 90% of the population, have been subjected to closure in the United States, more than 50 million have been subject to closure in the Philippines, about 59 million have been subject to closure in South Africa, and 1.3 billion have been subject to closure in India.
On March 26, 1.7 billion people worldwide were subjected to one form of closure, which rose to 2.6 billion two days later – about one third of the world's population.
The first confirmed Koved-19 case dates back to December 1, 2019 in Wuhan; one unconfirmed report indicates that the first case was on November 17.
Dr. Zhang Jisyan observed a series of cases of unknown pneumonia on December 26, following which her hospital reported to the Center for Disease Control in Jianghan Bohan on December 27.
An initial genetic test of patient samples on December 27, 2019 indicated the presence of a coronavirus resembling Sars.
Wuhan Municipality Health Commission issued a public notice on December 31.
Reported to WHO on the same day.
With these notices in place, the doctors in Wuhan were warned by the police about "dissemination of rumours" about the outbreak.
The Chinese National Health Commission initially claimed that there was no "clear evidence" of a person-to-person transition.
In late January, the Chinese government launched a radical campaign that was later described by Chinese Communist Party Secretary-General Xi Jinping as a "popular war" to contain the spread of the virus.
As described as "the largest quarantine in human history", a health cordon was announced on January 23 to stop travel to and from Wuhan, extending to a total of 15 cities in Hobei, affecting about 57 million people.
The use of private vehicles in the city was banned.
New Chinese New Year's Celebrations (January 25) were cancelled in several places.
Authorities also announced the construction of a temporary hospital, Houshinchan Hospital, which ended in 10 days.
Another hospital was built afterwards, Lechenchan Hospital, to deal with additional patients.
In addition to newly established hospitals, China has also transformed 14 other facilities in Wuhan, such as convention centers and playgrounds, into temporary hospitals. On January 26, the government took other measures to contain the Covide-19 outbreak, including health announcements for passengers and the extension of the Spring Festival holiday.
Universities and schools have also been closed throughout the country.
The Hong Kong and Macau regions have taken several measures, particularly with regard to schools and universities.
Telecommuting measures have been taken in several Chinese regions.
Travel restrictions were imposed both inside and outside Hoppy.
Public transportation has been modified, and museums have been temporarily closed throughout China.
Public movement was controlled in several cities, and it is estimated that some 760 million people (more than half of the population) were subjected to one form of exit restriction. After the outbreak became global in March, the Chinese authorities took vigorous action to prevent the virus from being "bringed" into it from other countries.
For example, Beijing imposed a 14-day mandatory quarantine on all those returning to the city from other countries. On March 23, one case moved locally in mainland China over the past five days, via a traveller returning to Guanzu from Istanbul.
On March 24, 2020, Chinese State Council Chairman Li Kah Chiang announced that the spread of locally transmitted infections and the control of outbreaks in China had declined.
Travel restrictions in Hobei were eased the same day, with the exception of Wuhan, two months after the closure was imposed. The Chinese Ministry of Foreign Affairs announced on March 26, 2020 the suspension of visa or residence permit holders from March 28 onwards, with no specific details as to when this policy would end.
Those wishing to enter China will have to apply for visas at Chinese embassies or consulates.
The Chinese government urged companies and factories to resume work on March 30, and introduced a corporate monetary stimulus package. The state council announced a three-minute blacksmith’s day of silence on April 4 at 10:00, coinciding with the Qing Ming Festival, although the central government called on families to show their respect online for physical spacing to avoid a renewed Covide-19 outbreak.
Covide-19's move from China to South Korea was confirmed on January 20, 2020.
The National Health Agency announced a significant increase in confirmed cases on February 20, largely attributed to a gathering in Daeju for a new religious movement known as the Shinchionji Church of Jesus.
Shinchiungi's followers visiting Daeju from Wuhan were suspected to be the source of the outbreak.
As of February 22, 1,261 people or about 13% of the 9.336 church followers reported symptoms. South Korea declared the highest level of preparedness on February 23, 2020.
On February 28, over 2,000 confirmed cases were reported in Korea, rising to 3,150 on February 29.
All South Korean military bases were quarantined after tests confirmed that three soldiers were infected with the virus.
South Korea applied a program that was considered the world's largest and best-organized to screen people for the virus, isolate any infected, as well as track and quarantine their mixture.
The screening methods included mandatory personal reporting of symptoms by new international arrivals via mobile phone application, HIV testing of people inside their cars with test results available the following day, and increasing testing capabilities to 20,000 people per day.
South Korea’s program represents a success in controlling the outbreak despite the failure to apply quarantine to entire cities. South Korean society was initially divided around President Moon Jae In’s response to the crisis.
Many Koreans have signed petitions either demanding the isolation of Moon, claiming the government's mishandling of the outbreak, or commending his response.
On March 23, it was announced that South Korea had the lowest overall cases in one day within four weeks.
On March 29, it was reported that as of April 1, all new arrivals from abroad would be subject to the Stone for two weeks.
According to media reports on April 1, South Korea received requests from 121 different countries to help test the virus.
Iran reported the first confirmed case of SARS-Cove-2 virus on February 19 in Qom, where two people died later the same day, according to the Ministry of Health and Medical Education.
Early actions announced by the government included the cancellation of concerts and other cultural and sports events, Friday prayers, the closing of universities, institutes of higher education, and schools.
Iran has allocated 5 trillion rials to fight the virus.
President Hassan Rouhani stated on February 26, 2020 that there was no plan to quarantine areas affected by the outbreak, and individuals would be isolated only.
Plans to reduce inter-city travel were announced in March, although heavy inter-city traffic continued before the New Persian Year of Norse.
Shia shrines remained open to pilgrims until March 16, 2020.[citation needed] During February, Iran became the center of the spread of the virus after China.
In the midst of allegations of Iran's cover-up of the extent of the outbreak, more than a dozen countries followed up on their cases from Iran as of February 28, indicating that the extent of the outbreak might exceed the 388 reported by the Iranian Government to date.
The Iranian Parliament was closed, with 23 of its 290 members reported HIV-positive on March 3.
On March 12, Human Rights Watch called on Iranian prison authorities to release unconditionally human rights defenders detained for peaceful opposition, and also to temporarily release qualified prisoners.
She stated that there was a high risk of the spread of the virus in closed settings such as detention centres, which also lacked adequate medical care.
On March 15, the Iranian government announced 100 deaths in one day, the highest number recorded in the country since the outbreak began.
At least 12 Iranian politicians and former government officials died of the disease by March 17.
By March 23, Iran was recording 50 new infections per hour, and one death every ten minutes due to the Corona virus.
According to a WHO official, the number of cases in Iran may be as high as five times what has been announced.
It is also believed that American sanctions against Iran may affect the state's financial capacity to respond to the outbreak of the virus.
The Office of the United Nations High Commissioner for Human Rights (OHCHR) has called for the reduction of economic sanctions against the States most affected by this pandemic, including Iran.
The outbreak in Italy was confirmed on January 31, when the Sars-Koff-2 tests of Chinese tourists in Rome came positive.
Situations began to increase sharply, prompting the Italian government to suspend all flights to and from China and declare a state of emergency.
An unrelated group of Coved-19 cases was later discovered, starting with 16 confirmed cases in Lombardia on February 21. On February 22, the cabinet announced a new law decree to contain the outbreak, including quarantine for more than 50,000 people from 11 different municipalities in northern Italy.
Prime Minister Giuseppe Conte said, "He will not be allowed into or out of the outbreak areas.
Work activities and sports events in those areas have already been ordered suspended.” On March 4, the Italian government ordered the complete closure of all schools and universities throughout the country where deaths in Italy were 100 cases.
All major sporting events, including first-class football league matches, were scheduled to be held behind closed doors until April, but on March 9, all sports events were suspended entirely for at least one month.
On March 11, Prime Minister Conte ordered the cessation of almost all commercial activities, with the exception of supermarkets and pharmacies. On March 6, the Italian College of Anaesthetics, Densification, Recovery, and Focused Care (SIARTI) published medical ethics recommendations for usable screening protocols.
On March 19, Italy outstripped China as the country with the highest number of deaths associated with the Corona virus in the world after reporting 3,405 deaths due to the pandemic.
On March 22, Russia sent nine military aircraft carrying medical equipment to Italy.
As of April 5, confirmed cases were 128,948, deaths were 15,887, and 21,815 cases were recovered in Italy, most of which were in the Lombardia region.
The CNN report suggested that a combination of a large number of older persons and the inability to test all people living with HIV to date in Italy may have contributed to the high mortality rate.
The UK's response to the virus first emerged as the most relaxed among the affected nations, and as of March 18, 2020, the British government did not impose any form of social spacing or comprehensive quarantine measures on its citizens.
As a result, the government received criticism for its perceived lack of speed and intensity in responding to public fears. On March 16, Prime Minister Boris Johnson issued a statement advising that unnecessary travel or social mixage should be avoided, suggesting that people should work from home as much as possible and avoid several places, such as bars, restaurants, and theaters.
On March 20, the government announced that it would close all entertainment facilities such as bars and gymnasiums as soon as possible, and promised to pay up to 80% of workers’ wages up to £2,500 a month to reduce unemployment in times of crisis. On March 23, the Prime Minister announced stricter social-diversion measures, prohibiting gatherings for more than two people and restricting travel and activity outside the home except as strictly necessary.
Unlike previous measures, these restrictions were implemented by the police by issuing fines and dispersing assemblies.
Most companies were ordered to close, with the exception of "necessary" businesses, including supermarkets, pharmacies, banks, hardware stores, petrol stations, and garages.
On January 20, the first known case of Covid-19 virus was confirmed in Washington State Northwest Pacific for a returning man from Wuhan on January 15.
The White House Task Force to Combat Coronavirus was prepared on January 29.
On January 31, Trump announced a public health emergency, and imposed restrictions on the entry of passengers from China.
On January 28, 2020, the Center for Disease Control – the U.S. government's leading public health institute – announced that he had developed his own test set.
Despite doing so, the US slowed down in starting the test, blocking the real extent of the outbreak at the time.
The test was marred by a defective test group produced by the federal government in February, the lack of federal government approval of non-government test groups (by academia, companies, and hospitals) until the end of February, and the restrictive criteria for people to qualify for the test until early March (the doctor's order was then required).
By February 27, Washington Post reported that less than 4,000 tests had been conducted in the United States.
By March 13, the Atlantic reported that less than 14,000 tests had been conducted.
On March 22, Associated Press stated: "Many people who have suffered symptoms and have a doctor's order are waiting for hours or days to be tested." After reporting the first death in the United States in Washington State on February 29, Governor Jay Insley declared a state of emergency, a procedure that was quickly followed by other states.
Schools in Seattle City cancelled school on March 3, and by mid-March, schools across the country were closed. On March 6, 2020, the United States was informed of the prospects for the impact of the new Corona virus on the country by epidemiologists at Imperial College London.
On the same day President Trump signed the Corona HIV Preparedness and Response Supplemental Appropriations Act, which provided emergency funding to federal agencies for $8.3 billion to respond to the outbreak.
Companies imposed travel restrictions on employees, cancelled conferences, and urged employees to work from home.
On March 11, Trump announced travel restrictions on most of Europe, except the UK, for 30 days, starting March 13.
The following day, restrictions were extended to the United Kingdom and Ireland.
On March 13, he declared a national emergency, which allowed federal funds to be used to respond to the crisis.
As of March 15, many companies have closed or reduced their working hours across the United States in an effort to reduce the spread of the virus.
By March 17, the epidemic was confirmed in all 50 states and in Columbia County. On March 23, 10,700 cases of Coronavirus were reported in New York City, more than the total number of cases in South Korea.
On March 25, the governor said that social spacing seemed to have been a success, with estimates showing a slower doubling of cases from 2.0 days to 4.7 days.
As of March 28, 32,308 confirmed infections in New York City, 672 people died of the virus. On March 26, more confirmed cases of Coronavirus were reported in the US than any other country in the world, including China and Italy.
According to media reports on March 30, U.S. President Trump decided to extend social spacing directives until April 30.
On the same day, USNS Comfort, a hospital ship with about 1,000 beds, docked in New York.
On April 3, the United States recorded 884 deaths due to Coronavirus within 24 hours.
In New York State, the number of cases exceeded 100,000 on April 3. The White House was criticized for underestimating the threat and controlling news circulation by directing health officials and scientists to coordinate public data and publications on HIV with the office of Vice President Mike Pence.
Trump's management of the crisis was not universally welcomed, creating widespread polarization among the parties.
Some U.S. officials and commentators criticized the U.S.'s reliance on importing essential materials, including essential medical supplies, from China.
Analysis of air travel patterns was used to map and predict deployment patterns and was published in the Journal of Travel Medicine in mid-January 2020.
Based on information from the International Air Transport Association 2018, Bangkok, Hong Kong, Tokyo and Taipei had the largest number of passengers from Wuhan.
Dubai, Sydney and Melbourne were also reported as famous destinations for travelers from Wuhan.
Bali was reported to be the least capable of over 20 popular destinations in terms of preparedness, while cities in Australia were considered more capable. Australia released its emergency response plan for the new Corona virus (Coved-19) on February 7.
She stated that not much had yet been discovered about the Covide-19 virus, and that Australia would place emphasis on border control and communications in its response to the pandemic.
On March 21, a state of human biosecurity emergency was declared in Australia.
Given the impact of effective quarantine on Wuhan and Hobei, several countries planned to evacuate their nationals and diplomatic personnel from the region, primarily through charter flights from their home countries, with permission provided by the Chinese authorities.
Canada, the United States, Japan, India, Sri Lanka, Australia, France, Argentina, Germany and Thailand were among the first countries to plan the evacuation of their citizens.
Pakistan has announced that it will not demonstrate any of its citizens from China.
On February 7, Brazil evacuated 34 Brazilians or family members plus four Poles, one Chinese person, and an Indian citizen.
Polish, Chinese and Indian citizens landed from the plane in Poland, where the Brazilian aircraft stopped before resuming its route to Brazil.
Brazilian citizens who went to Wuhan were isolated at a military base near Brasilia.
On the same day, 215 Canadians (176 from the first plane, 39 from a second aircraft chartered by the U.S. government) were evacuated from Wuhan to the Canadian Forces Base Trenton to be isolated for two weeks.
On February 11, another 185-Canadian aircraft landed from Wuhan at the Canadian Forces Base Trenton.
The Australian authorities evacuated 277 citizens on 3 and 4 February to the Christmas Island Detention Centre, which was reused as a quarantine facility, where they stayed for 14 days.
A New Zealand evacuation flight arrived in Auckland on February 5, and its passengers (including people from Australia and the Pacific) were isolated at a naval base in Wanjabarawa, North Auckland.
On February 15, the United States announced that it would show the Americans who were aboard the cruise ship Diamond Princes.
On February 21, a plane landed at Trenton, Ontario carrying 129 Canadian passengers evacuated from the Diamond Princes.
In early March, the Indian government began evacuating its citizens from Iran. On March 14, a South African Airlines aircraft chartered by the South African government returned 112 South Africans.
A pre-departure medical examination was conducted, and four southern Africans who showed signs of the Corona virus were left to mitigate the risks.
Southern Africans were returned whose test results were only negative.
The test results proved that South Africans, including flight crews, pilots, hotel staff, police and soldiers involved in the humanitarian mission who, as a precautionary measure, remained under surveillance and quarantine at Ranch Resort for 14 days, were uninjured.
On March 20, the United States began to partially withdraw its troops from Iraq due to the pandemic.
On February 5, the Chinese Ministry of Foreign Affairs reported that 21 countries (including White Russia, Pakistan, Trinidad and Tobago, Egypt and Iran) had sent assistance to China.
Some Chinese students at American universities joined together to send assistance to HIV-positive areas in China, and according to a joint group in the Greater Chicago region, 50,000 N95 masks were sent to hospitals in Hoby County on January 30. Humanitarian Aid sent Direct Relief, in coordination with FedEx, 200,000 face masks with other personal protective equipment, including gloves and hospital clothing, via the Air Emergency Bridge, to Wuhan Union Hospital by January 30.
On February 5, Bill and Melinda Gates announced a $100 million contribution to WHO to fund vaccine research and treatment efforts, along with the protection of "at-risk populations in Africa and South Asia".
Entraxion reported that the Chinese government donated 200,000 masks to the Philippines on February 6, after Senator Richard Gordon shipped 3.16 million masks to Wuhan.
On February 19, the Singapore Red Cross announced that it would send $2.26 million in aid to China.
Japan donated 1 million face masks, Turkey sent medical equipment, Russia sent more than 13 tons of medical supplies to Wuhan, Malaysia pledged 18 million medical gloves to China, Germany delivered several medical supplies, including 10,000 protective suits, and the US donated 17.8 tons of medical supplies to China, and promised another $100 million in financial support to the affected countries. After the cases settled in China, the country was sending assistance to the various countries affected by the pandemic.
In March, China, Cuba and Russia sent medical supplies and experts to help Italy deal with the Corona virus outbreak.
Businessman Jack Ma sent to Addis Ababa, Ethiopia 1.1 million test kits, 6 million face masks, and 60,000 protective suits where they were distributed by the African Union.
He later sent 5,000 test kits, 100,000 face masks and five artificial respiration devices to Panama.
The Netherlands, Spain, Turkey, Georgia, and the Czech Republic expressed concern about masks and test kits made in China.
For example, Spain withdrew 58,000 test kits for the Corona virus made in China that were only 30% accurate, and in the meantime, the Netherlands returned 60,000 face masks made in China that were defective.
Belgium returned 100,000 unusable facial masks that were thought to be from China, but were actually from Colombia.
On the other hand, parts of Latin America and Africa welcomed the receipt of Chinese assistance well. On April 2, the World Bank launched emergency support operations for developing countries.
WHO commended the efforts of the Chinese authorities in managing and containing the epidemic.
WHO noted the difference between the SARS outbreak between 2002 and 2004, in which Chinese authorities were accused of obscuring prevention and containment efforts, and the current crisis, in which the central government provided "regular updates to avoid panic before the Lunar New Year's holiday".
On January 23, in response to the central authorities' decision to implement the transport ban in Wuhan, the WHO representative Gooden Galia noted that while this was “not certainly a recommendation from WHO”, it was “a very important indication of the commitment to contain the epidemic in its heavily concentrated place”, describing it as “unprecedented in public health history.” On January 30, after confirming the move from one person to another outside China, and the increase in the number of cases in other countries, WHO declared the outbreak as a public health emergency of international concern (BHEA), the sixth public health emergency to be of international concern since the first resort to this action during the 2009 swine flu pandemic.
The Director-General of the World Health Organization (WHO) said that the consideration of the outbreak as a public health emergency was a matter of international concern due to “the risk of global proliferation, especially in low- and middle-income countries without strong health systems.
In response to the implementation of travel restrictions, Tedrus stated that “there is no reason to take measures unnecessarily inconsistent with international travel and trade” and that “WHO does not recommend limiting trade and mobility”.
On February 5, WHO appealed to the international community to contribute $675 million to strategic funds developed in low-income countries, noting the urgent need to support those countries that "do not have systems to detect people living with HIV, even if they appear".
Tydros also made statements declaring that "Our strength is measured by the power of our weakest person" and urging the international community to "invest today or pay a large price later." On February 11, the World Health Organization (WHO) called the disease, at a press conference, Coved-19.
On the same day, Tidros stated that United Nations Secretary-General Antonio Guterres had agreed to provide "the full response potential of the United Nations system".
As a result, a United Nations crisis management team has been set up, allowing the coordination of the entire United Nations response, and WHO will allow it to "focus on health response while the experience of other agencies can be used to learn about the social, economic and broader developmental impacts of the outbreak".
On February 14, a WHO-led joint mission team was prepared with China to provide international and WHO-based experts on the ground in China to assist in local governance and to assess “the severity and the mobility of the disease” by hosting workshops and meetings with key national institutions, and conducting field visits to assess “the impact of response activities at the provincial and city levels, including urban and rural areas.” On February 25, WHO announced that “the world needs to do more to prepare for the potential Corona virus pandemic”, noting that it is too early to describe it as a pandemic, but that countries should be “in the preparedness phase.”
In response to the outbreak in Iran, WHO sent a joint mission team there to assess the situation. On February 28, WHO officials said that global assessment of the Corona virus threat would rise from "high" to "very high", which is its highest level of warning and risk assessment.
Mike Ryan, Executive Director of the WHO Health Emergency Programme, warned in a statement that "This is a real test for every government on Earth: so we have to be ready.
This virus may be on its way and you must prepare for it," and urged that the right response measures be taken that can help the world avoid "what's worse".
Ryan also stated that current data do not justify public health officials declaring disease as a global pandemic, saying that such a declaration means "that we basically accept that every human being on this planet will be exposed to this virus."
On March 11, the World Health Organization (WHO) announced the outbreak of a virus corona as a pandemic.
The Director-General said that WHO “is deeply concerned about alarming levels of prevalence and severity, and worrying levels of inaction.” WHO faced severe criticism of what is perceived to be an inadequate treatment of the pandemic, including delays in declaring a public health emergency, and classifying the virus as a pandemic.
Violent reactions included a petition for resignation by WHO Director-General Tidros Adhanom, signed by 733,000 people as of April 6.
On March 26, 2020, dozens of United Nations human rights experts affirmed respect for the rights of every individual during the Covide-19 pandemic.
The Group of Experts stated that everyone has the right to life-saving interventions and that the Government has this responsibility.
The group stressed that lack of resources or health insurance should not justify discrimination against a particular group.
Experts emphasized that everyone has the right to health, including persons with disabilities, persons belonging to minorities, older persons, internally displaced persons, homeless persons, persons living in extremely poor conditions, detainees, as well as refugees and other non-specified groups requiring government support.
Intergovernmental organizations address the economic and social impacts of the Coved-19 crisis.
OECD has launched a platform to provide timely and comprehensive information on policy responses in countries around the world, as well as views and advice.
One of the policies of strengthening health systems and the global economy to address the effects of closure and travel restrictions is the digital hub, which includes a State policy tracking tool, aimed at helping countries learn from each other and facilitating a coordinated global response to the Corona virus.
The Chinese government was criticized by the United States, British Cabinet Secretary Michael Gov, and Edward Paulonaro the son of Brazil's President Geir Bolsonaro for the way she dealt with the pandemic, which began in the Chinese province of Hobei.
A number of China Communist Party (CPC) directors were dismissed at a cross-sectoral level for dealing with quarantine efforts in central China, indicating dissatisfaction with the political institution's response to the outbreak in those areas.
Some commentators believe that this move was intended to protect Chinese Communist Party general secretary Xi Jinping from public resentment over the outbreak of the Corona virus.
Some Chinese officials, for example Chow Lijian, rejected a previous admission that the Corona virus outbreak had begun in Wuhan, in favour of conspiracy theories claimed by the United States or Italy with regard to the Covide-19 virus.
The US administration Donald Trump described Corona's virus as a "Chinese virus" or "Wohan virus", saying that China had "enforced a blackout on the news that exacerbated the virus that is now a global pandemic", which some critics criticized for being racist and "distracting [the attention] from his administration's failure to contain the disease".
Daily Best acquired a U.S. government telegram reviewing the communications scheme with clear sources in the National Security Council, with a strategy stating that "It's all about China.
We were asked to seek and publish these messages in any way possible, including press conferences and television appearances. "News sources such as Politico, Fortín Polisi and Bloomberg claimed that China's efforts to send assistance to countries affected by HIV are part of my advocacy for global impact.
EU foreign policy official Josip Burrell warned of the existence of a "political geo-component that includes a struggle for influence through the practice of bypassing and policies of generosity".
Burrell also said, "China is strongly pushing the message that, unlike the United States, it is a responsible and trusted partner."
China also called on the United States to lift its sanctions against Syria, Venezuela, and Iran, while reportedly sending aid to the last two countries.
U.S. sanctions banned Jack's donation of 100,000 masks to Cuba on April 3.
The U.S. authorities were also accused of transferring aid to other countries to their countries.
There were mask disputes reported between other States, such as Germany, Austria, Switzerland, the Czech Republic and Italy.
In addition, Turkey has seized hundreds of artificial respirators destined for Spain.
In early March, the Italian government criticized the EU's lack of solidarity with Italy affected by the Corona virus.
Mauritsu Masari, Ambassador of Italy to the European Union, said "China responded only bilaterally.
Surely, this is not a good sign of European solidarity".
On March 22, after a telephone call to Italian Prime Minister Giuseppe Conte, Russian President Vladimir Putin prepared the Russian army to send military paramedics, special purge vehicles, and other medical equipment to Italy.
The Italian newspaper La Stampa reported a "high-level political source" whose name was not mentioned that 80% of Russia's aid was "nil or of little use to Italy".
The source accused Russia of embarking on a "geographical and diplomatic" attack.
The President of Lombardy, Atilio Fontana, and the Italian Foreign Minister Luigi de Mayo denied the press reports and expressed their gratitude.
Russia also sent a cargo plane carrying medical aid to the United States.
The Kremlin spokesman Dmitry Pskov said that "when providing assistance to his American colleagues, Putin assumes that when American manufacturers of medical equipment and materials are activated again, they will also be able to repay favors if necessary".
NATO's planned military exercises "2020 cannons" will take place in Germany, Poland, and the Baltic States, the largest NATO war maneuver since the end of the Cold War on a narrow scale.
Nuclear disarmament campaign secretary-general Kate Hudson criticized the 2020 defender training, saying: “In the current public health crisis, training not only endangers the lives of troops from the US and many participating European countries but also the populations of the countries in which they are to be conducted.”
Iranian President Hassan Rouhani wrote a public letter to world leaders on March 14, 2020 asking for help, saying that his country is struggling to fight the outbreak of the disease because of the lack of access to international markets as a result of US sanctions against Iran. The outbreak triggered calls for the US to adopt common social policies in other rich countries, including comprehensive health care, comprehensive childcare, paid family leave, and higher levels of public health funding.
Political analysts predicted that this could have a negative impact on Donald Trump's chances of re-election in the 2020 presidential election. Diplomatic relations between Japan and South Korea deteriorated due to the pandemic.
South Korea criticized Japan's "mysterious and negative quarantine efforts" after Japan announced that anyone coming from South Korea would be quarantined at certain government locations for two weeks.
South Korean society was initially polarized to President Moon Jae In's response to the crisis.
Many Koreans signed petitions calling either for Mon to be isolated because they claimed that the government had mishandled the outbreak or praised its response. The pandemic allowed states to pass emergency legislation in response.
Some commentators expressed concerns that this might allow Governments to tighten their control over power.
In Hungary, Parliament voted to allow Prime Minister Victor Urban to rule by decree indefinitely, suspend Parliament as well as elections and punish those who spread false information about the virus and the government's handling of the crisis.
The outbreak of the Corona virus has been blamed for many supply shortages due to the growing global use of equipment to combat outbreaks, panic-driven procurement and disruption of factories and logistics operations.
The U.S. Food and Drug Administration issued warnings about the shortage of medicines and medical equipment due to increased consumer demand and the stopping of suppliers.
Many areas also saw panic procurement, which resulted in shelves being free of essential grocery items such as food, toilet paper, and water bottles, causing shortages of supplies.
The technology industry in particular warned against delays in shipments of electronic goods.
According to WHO Director-General Tedros Adhanom, the demand for personal protection tools has increased 100 times.
This demand caused prices to rise by up to 20 times the normal price and also caused medical supplies to be delayed by four to six months.
It also caused a lack of personal protection tools worldwide, warning WHO that this would put health workers at risk.
In Australia, the pandemic provided a new opportunity for Diego's shoppers to sell Australian products in China.
The activity led to a shortage of infant milk in some supermarkets and was later banned by the Australian government. Despite the widespread occurrence of Covide-19 cases in northern Italy and the Wuhan region, and the subsequent high demand for food products, the two regions survived severe food shortages.
The actions taken by China and Italy to combat the storage and illicit trafficking of bio-products have successfully avoided the severe food shortage expected in Europe as well as in North America.
Northern Italy has not experienced a significant decline in its agricultural production, but prices may rise according to the expectations of industry representatives.
Food shelves were temporarily empty, even in Wuhan City, while Chinese government officials released pork stocks to ensure adequate nutrition for the population.
Similar laws exist in Italy that require food producers to keep stocks for such emergencies.
China felt the damage to the global economy: according to a media report on March 16, China’s economy was severely affected in the first two months of 2020 by government actions to reduce the spread of the virus, and retail sales fell by 20.5%.
Since China’s mainland is a major economic and industrial center, the spread of the virus has been noted as a major destabilizing threat to the stability of the global economy.
Agatha Demares expected the economic intelligence unit to keep the markets volatile until a clearer picture of the potential results emerged.
In January 2020, some analysts estimated that the economic repercussions of the epidemic on global growth could exceed those of the SARS outbreak between 2002 and 2004.
An expert at Washington University in St. Louis estimated that the global supply chain was affected by over $300 billion which could last until two years.
The Organization of Petroleum Exporting Countries (OPEC) was reported to have experienced “disorder” after a sharp decline in oil prices due to declining demand from China.
The global stock markets declined on February 24 due to a significant rise in the number of Kovid-19 cases outside the mainland of China.
On February 27, due to growing fears about the Corona virus outbreak, several American equity indicators, including NASDAK-100, Standard & Poors 500, and the Dow Jones industrial average recorded their greatest decline since 2008, with Dow 1,191 points falling, the largest one-day decline since the 2007–08 financial crisis.
The three indicators ended the week with a drop of more than 10%.
On February 28, Scoop Ratings confirmed JMPH's sovereign credit rating for China, but maintained negative expectations.
The stocks retreated again due to fears of the Corona virus, and the biggest decline was on March 16.
Many believe that economic recession is possible.
Economist Mohamed Al-Arian commended the timely emergency measures taken by central banks and States.
Central banks respond faster than they did with the 2008 financial collapse.
Tourism is one of the sectors most affected by the travel ban, the closure of public places including tourist attractions, and the warning of governments to travel around the world.
As a result, many airlines cancelled their flights due to low demand, including British Airways, East Chinese Airlines, and Cants, while the British regional airline, Fly P, collapsed.
The impact on the industry of cruise lines was at an unprecedented level.
Many train stations and ferry ports have also been closed.
The epidemic coincided with the springtime travel season known as Chunyun, the main travel season associated with the New Chinese New Year's Holiday.
National and regional governments have cancelled a number of large crowd events, including New Year's Eve celebrations, with private companies also shutting down their shops independently and tourist attractions such as Disneyland Hong Kong and Disneyland Shanghai.
Many events of the Lunar New Year and tourist attractions were closed to prevent large gatherings, including the forbidden city of Beijing and traditional temple fairs.
In 24 of the 31 provinces, and in municipalities and regions of China, the authorities extended New Year's Holiday until February 10, and instructed most workplaces not to reopen until that date.
These regions account for 80% of the country’s gross domestic product (GDP) and 90% of exports.
Hong Kong raised the level of response to infectious diseases to the highest level and declared a state of emergency, closing schools until March and cancelling New Year's celebrations.
Visits to retailers in Europe and Latin America decreased by 40%.
North American and Middle East retailers experienced a decline of between 50 and 60 percent.
This also led to a 33% to 43% drop in pedestrian traffic to shopping malls in March compared to February.
Shopping centre operators around the world have imposed additional measures, such as increased hygiene, installation of thermal scanners to check shoppers’ temperature, and elimination of efficiencies. According to the United Nations Economic Commission for Latin America (ECLAC), the recession caused by the pandemic could leave 14 to 22 million people in extreme poverty in Latin America more than they would have experienced without the pandemic.
In January and February 2020, during the peak of the epidemic in Wuhan, about 5 million people in China lost their jobs.
Many of China’s nearly 300 million rural migrant workers were trapped in their homes in the interior provinces, or in Hoby County. In March 2020, more than 10 million Americans lost their jobs and applied for government assistance.
The spread of the Corona virus could cost 47 million jobs in the United States, and the unemployment rate could reach 32%, according to the Federal Reserve Bank’s estimates in St. Louis. The closure in India has left tens of millions of Indian migrant workers (paid through daily wages) unemployed.
During the second half of March, 4 million French workers applied for temporary unemployment benefits and 1 million British workers applied for a comprehensive credit scheme. Approximately half a million companies in Germany sent their workers on government-supported short-term business plans known as Corzarbett.
France and Britain adopted the German short-term employment compensation scheme.
The theatre arts and cultural heritage sectors have been deeply affected by the pandemic, affecting the operations of organizations as well as individuals - workers and independents - globally.
Institutions in the arts and culture sector have sought to support their mission (often funded by the government) to provide access to the cultural heritage of society, to preserve the safety of their employees and the public, and to support artists as much as possible.
By March 2020, worldwide and to varying degrees, museums, libraries, performance venues and other cultural institutions were closed indefinitely with exhibitions, events and performances cancelled or postponed.
In response, there have been intensive efforts to provide alternative services through digital platforms. Other recent, accelerating consequences of the disease include the abolition of religious services, major sports events, and other social events, such as music festivals, concerts, technological conferences, and fashion shows.
The film industry also suffered a halt. The Vatican announced the cancellation of the Holy Week celebrations in Rome, which take place during the last week of the Christian penitence season in Big Tomato.
Many parishes recommended older Christians stay at home instead of attending Mass on Sundays; some churches made church services available via radio, live webcasting or television while others offered worship without leaving their cars.
With the closure of the Catholic Diocese of Rome in Rome its churches and church chapels, and the evacuation of St. Peter's Square from Christian pilgrims, other religious bodies have also abolished limited public services and gatherings in churches, mosques, synagogues, temples, and gourdwara.
The Iranian Ministry of Health announced the cancellation of Friday prayers in the areas affected by the outbreak and the shrines were then closed, while Saudi Arabia banned the entry of foreign pilgrims as well as their inhabitants into holy places in Mecca and the city.
This pandemic has caused the biggest imbalance in the world's sports calendar since World War II.
Most major sporting events were cancelled or postponed, including the European Champions League 2019-20, the Super League 2019-20, the European League 2020, the American Professional Basketball League season 2019-20, and the National Hockey League season 2019-20.
The outbreak disrupted plans for the 2020 Summer Olympics, which were scheduled to begin at the end of July, and the International Olympic Committee announced on March 24 that the event "will be rescheduled beyond 2020 but no later than the summer of 2021". gambling clubs and other playspaces around the world were closed and direct gambling tournaments postponed or cancelled.
This has led many gamblers to move to play online, with many online gambling sites reporting significant increases in new subscription rates. The entertainment industry has also been affected, with different music groups suspended or concert tours cancelled.
Many large theaters like those on Broadway have suspended all performances as well.
Some artists have discovered ways to continue producing and sharing the work online as an alternative to traditional direct performances, such as live broadcasts or the creation of online "celebrations" of artists to perform, distribute and publish their works.
Many Internet memes about the Corona virus have spread on the Internet where many have turned into humor and entertainment under uncertainty.
Since the Coved-19 outbreak, extreme prejudice, xenophobia and racism have been observed against people of Chinese and East Asian descent, and against people from hotspots in Europe, the United States and other countries.
Incidents of fear, suspicion and hostility have been observed in many countries, particularly in Europe, East Asia, North America and the Asia-Pacific region.
Reports released in February (when the majority of cases were still confined to China) documented racist sentiments expressed by various groups around the world towards the Chinese that they deserved the virus or received what was claimed to be justified punishment.
Anti-China sentiment has also seen a rise in some African countries.
Many people of Wuhan and Hobei reported discrimination on the basis of their territorial origin.
There was support for Chinese both online and offline, and for those living in HIV-affected areas.
After the outbreak in new hot spots, people from Italy, the first country in Europe to experience a severe outbreak of Covede-19, may be skeptical and xenophobic. Citizens in countries including Malaysia, New Zealand, Singapore, and South Korea initially signed petitions for pressure to prevent Chinese from entering their country in an effort to stop the disease.
In Japan, Hashtag issues CheneseDuntComtoJapan# Twitter.
Chinese as well as other Asians in the United Kingdom and the United States reported increasing levels of racial violations, as well as attacks.
U.S. President Donald Trump faced criticism about the reference to the Corona virus as a "Chinese virus", a term that critics considered racist and anti-Chinese.
Protesters in Ukraine attacked buses carrying Ukrainians and foreigners being evacuated from Wuhan to Novi Sanzari.
Students from northeastern India, sharing the border with China, studying in major Indian cities, faced harassment due to the Corona virus outbreak.
Bharatiya Janata party unit chief in West Bengal state Dileep Ghosh stated that the Chinese destroyed nature and "that's why God avenged them."
The Chinese Consulate in Kolkata later condemned these statements, calling them “wrong.” In China, the pandemic led to increased xenophobia and racism against non-Chinese residents, with foreigners being described as “foreign garbage” and targeted for “disposal”.
Many newspapers have removed subscription-paid pages for some or all of their coverage of Coronavirus.
Many scientific publishers made available scientific papers on the outbreak for open access.
Some scientists chose to share their results quickly on preprint servers such as BioRxiv.
Emerging infectious diseases – infectious diseases are often emerging pathogens, emerging in terms of the extent of their outbreaks or the mode of transmission.
Globalization and disease – an overview of globalization and disease transmission
List of pandemics and pandemics - List of deaths from infectious diseases
Wildlife Smuggling and Animal Diseases – Health Risks Associated with Trade in Strange Wild Animals
The laboratory test of the 2019 (Coved-19) Corona Respiratory Virus and its associated SARS-Cov-2 virus include ways to detect the presence of the virus where antibodies produced in response to infection are identified.
RTT-BCR confirms the presence of viruses in the samples, where the riboze DNA of the Corona virus is detected.
This test is accurate and designed only for the detection of the riboze DNA of the SARS-KOV-2 virus.
It is used to confirm very recent or active infections.
Antibodies detection (immunology) is used for diagnosis and population control.
Antibody tests show the number of people who contracted the disease, including those whose symptoms were too simple to report or who did not show symptoms.
The exact mortality rate of the disease and the level of collective immunity among the population can be determined based on the results of this test.
Due to the limited testing, no country had reliable data on the spread of the virus among its population in March 2020.
On March 23, no country examined more than 3% of its population, and there is considerable variation in the number of tests conducted by different countries.
This disparity is also likely to have a significant impact on reported mortality rates, which are likely to be significantly overstated in some countries.
Using the instant polymerase reaction of the reverse transcription RRT-BCR, an examination can be performed on respiratory samples obtained in various ways, including the nasal lymphoma or pygmy sample.
Results are generally available within a few hours to two days.
RTT-BCR, which is performed using throat swabs, is only used in the first week of the disease.
The virus may disappear from the throat afterwards as it continues to reproduce in the lungs.
For injured persons who are examined in the second week, a sample of deep airways can instead be taken through a cipher catheter or use coughing material.
One of the early PCR tests was invented in Charté in Berlin in January 2020 using the instant polymerase reaction of reverse versions (RRT-BCR), and formed the basis for 250,000 test sets distributed by the World Health Organization (WHO).
The UK also developed a test on January 23, 2020. The South Korean company Kogenebiotech also invented the PowerChek Coronavirus for SARS-Coff-2 virus suitable for safe clinical use and dependent on PCR on January 28, 2020.
In China, BGI Group was one of the first companies to obtain emergency use approval from China's National Administration for Medical Products for a PCR-based SARS-2 detection kit. In the United States, CDCs distribute a diagnostic plate of the new 2019 Corona virus (the new 2019 Corona virus) to its own public health laboratories through the International Detector Supply Authority.
One of the three genetic tests in the old versions of the test sets produced inconclusive results due to defective detectors, and one of the testing stages was delayed from another in the CDC in Atlanta; this led to the successful completion of less than 100 samples per day on average throughout February 2020.
Tests using two components were not trusted until February 28, 2020, and so far government and local laboratories were not allowed to start testing.
The Department of Food and Medicine approved the test under the emergency permission for use. U.S. commercial laboratories began testing in early March 2020.
On March 5, 2020, LapCorp announced the availability of the Covide-19 test across the country based on RT-PCR.
Similarly, Quest Diagenostex made it possible to test Coved-19 nationwide as of March 9, 2020.
No quantitative restrictions have been announced; the sampling and processing process must be conducted in accordance with the requirements of the CC.
In Russia, the State Centre for Research in Virus Science and Biotechnology (CSP) invented and produced Victor's Coved-19 Test.
On February 11, 2020, the Federal Health Care Surveillance Authority recorded the test. On March 12, 2020, it was reported that Mayo Clinique had developed a test to detect Coved-19 infection. On March 13, 2020, Roche Diagenostex obtained FDA approval for a test that could be performed within 3.5 hours on large numbers, allowing one machine to conduct nearly 4128 tests over 24 hours.
On March 19, 2020, the Department of Food and Medicine granted emergency use permission (EUA) to Abbott Laboratories to conduct a test on the Abbott M2000 system; previously the Department of Food and Drug granted a similar permit to Lab Corp and Thermo Fisher Scientific.
On March 21, 2020, Sevid received a similar emergency permission to use from the Food and Drug Administration for a test that takes about 45 minutes.
The Food and Drug Administration agreed to a test that uses the technique of equal-heat DNA amplification instead of the PCR.
Since this does not require a series of consecutive temperature cycles, this method can show positive results in less than five minutes and negative results in 13 minutes.
There are currently about 18,000 of these machines in the United States and Abbott expects to increase manufacturing to conduct 50,000 tests a day. Taiwan is also developing a test using a single-cyst antibody that is particularly linked to the protein N nuclear cage protein of the new Corona virus, hoping to achieve results within 15 to 20 minutes such as a rapid flu test.
A review of studies in March 2020 concluded that "the chest beams have little diagnostic value in the early stages, while the results of CT [computed CT] may be clear even before symptoms appear".
The usual properties that appear in computerized CAT scans include polygonal-grade glass floats with an oceanic, asymmetric and posterior distribution.
Underside prevalence develops, showing irregular patches and intensifys as the disease develops.
A study in Wuhan City comparing PCR to computerized CT with respect to the origin of the current pandemic indicated that computerized CT scans are more sensitive than PCR, although less accurate, with many of its photographic properties interwoven with cases of pneumonia and other pathological stages.
In March 2020, the American Radiography College recommends "no use of computerized CAT scan to detect Covide-19 or consider it a primary test to diagnose the disease." In March 2020, CDC recommends the use of PCR for initial screening.
Part of the immune response to infection involves the production of antibodies, including IgM and IgG.
They can be used to detect individual injury during a period starting 7 days or after symptoms appear, to determine immune potential, and in the case of population surveillance. The analyses can be performed at CLT central laboratories or by testing the clinical care point (BCT).
Superperforming automated systems in many clinical laboratories will be able to perform these analyses, but their availability will depend on the rate of production per system.
For central laboratories, a single sample of ambient blood cells is usually used, although successive samples can be used to follow up on immune response.
For the clinical care point test one blood sample is usually pulled by skin puncture.
Unlike PCR routes, a pre-screening extraction step is not necessary. On March 26, 2020, the Food and Drug Administration identified 29 entities that gave notice to the agency in accordance with requirements and thus could distribute their antibody tests.
On April 7, 2020, the Food and Drug Administration adopted only one test under their emergency permission. In late March 2020, Euroimmun Medical Laboratory Diagnostics and Epitope Diagnostics acquired European credits for their test crews, which can detect IgG and IgA antibodies in blood samples.
The test completes several hundred samples within hours and is therefore much faster than the conventional PCR analysis of viral riboze DNA.
The antibodies can often be detected 14 days after the infection began.[citation needed] In April, the UK discovered that the antibodies test crews it purchased were not good enough to use.
Hong Kong has developed a plan under which patients suspected of being injured can stay at home, “the emergency department gives a sample tube to patients,” spits in the tube, and re-takes it back to get the test results after a simple period. The British National Health Services has announced that it is experimenting with a plan to test cases suspected of being infected at home, thus excluding the risk of transmission from the injured when they come to the hospital or the need to sterilize the used ambulance.
In Germany, on March 2, the National Association of Legal Health Insurance Physicians said that it had been able to conduct approximately 12,000 daily outpatient tests and 10,700 people had been tested last week.
The costs are borne by the health insurance if a doctor orders the test.
According to the head of the Robert Koch Institute, Germany has a total capacity of about 160,000 weekly tests.
On March 19, intra-car virus detection tests were made available in many major cities.
As of March 26, 2020, the total number of tests conducted in Germany was unknown, as only positive case results were announced.
A preliminary laboratory study revealed that, starting from the 12/2020 calendar week, at least 483.295 samples had been tested by the end of the week 12/2020, with 33.491 samples (6.9%) positive for SARS-KOV-2. In Israel, researchers at the Rimbam Hospital had devised and tested a method for testing samples taken from 64 patients at the same time, by collecting samples and not conducting further tests until the sample was found to be positive.
With Wang Jian, the founder of BGI, overseeing the construction work and taking 5 days into it, modelling processes showed that the cases in Hobei would have increased by 47% and the associated quarantine costs would double if that testing capacity had not been achieved.
Wuhan's laboratory followed the immediate establishment of Huo-Yan laboratories in Shenjin, Tianjin, Beijing and Shanghai and in 12 cities across China.
By March 4, 2020, total daily productivity was 50,000 tests per day. Origami Assays released open-source, multi-transmission designs that could test up to 1122 samples of a patient to detect Covide-19 using only 93 tests.
In March, the shortage and inadequacy of reagents caused trouble when a large number of tests were conducted in the European Union, the United Kingdom and the United States.
This led some specialists to explore sampling protocols that include the heating of samples at 98 °C (208 °F) for 5 minutes to free the ribozy acid genome for further testing. On March 31, it was announced that the United Arab Emirates is at the top of the world in terms of the rate of coronavirus testing of its population, and is on its way to raising the test level to most of the population.
This was through a combination of in-car testing capability activation, and the purchase of a high-productivity laboratory with a population-friendly range from Group 42 and BGI (based on their emergency detection laboratories Huo-Yan in China).
The laboratory was established within 14 days, where tens of thousands of RTTCR tests are allowed daily and is the world's first laboratory of this size to operate outside China.
Various testing methods were devised targeting different parts of the genetic characteristics of the Corona virus in China, France, Germany, Hong Kong, Japan and the United States.
WHO has adopted the German crew industry plan, which is sent to low-income countries without the resources to invent their own crews.
The German plan was announced on January 17, 2020; the protocol developed by the U.S. Centers for Disease Control and Prevention was not available until January 28, delaying the tests available in the US. China and the US faced problems regarding the reliability of test kits early in the outbreak, and these countries and Australia were unable to provide adequate kits to meet demand and follow the test recommendations made by health experts.
In contrast, experts have stated that the abundance of testing in South Korea has helped to reduce the spread of the new Corona virus.
The South Korean government has significantly enhanced testing capacity in private sector laboratories over several years.
On March 16, the World Health Organization (WHO) called for the intensification of testing programmes as the best solution to curb the progress of the Covide-19 pandemic. The increased demand for testing caused hundreds of thousands of tests to accumulate in private American laboratories, and the supply of scans and chemical detectors was eroded.
In March 2020 China reported problems with the accuracy of its test crews.
In the United States, "defects" were found in the testing crews created by CDC; thus the government removed bureaucratic barriers that prevented the testing in particular. Spain purchased test crews from Chinese company Shinzhen Bioace Biotechnology Limited, but found the results inaccurate.
The company explained that the incorrect results may be due to failure to collect samples or to improper use of crews.
The Spanish Ministry announced that it would back up the purchase of the crews that gave incorrect results, and replace them with other test sets from Shinzhen Bioacey. 80% of the test crews purchased by the Czech Republic from China gave false results. Slovakia purchased 1.2 million test sets from China that turned out to be inaccurate.
Prime Minister Matović proposed to throw them into the Danube. Professor H. Kara of the Turkish Ministry of Health reported that the test kits purchased by Turkey from China had a "high error rate" and had "prevented their use."
The tests, followed by a quarantine for those found to have been injured and those who had mixed up with Saras-Koff-2, yielded positive results.
Researchers working in the Italian city of Fu, which experienced the first death of Coved-19 in Italy, tested the entire population of about 3,400 twice, and this took about ten days at a time.
Nearly half of the people tested positive did not show symptoms, as all detected cases were isolated.
As a result of the ban on movement between towns, new injuries were completely eliminated.
Singapore's 2020 Coronavirus pandemic has seen a significant decline in prevalence compared to other developed countries, but without severe restrictions such as forced closure of restaurants and retail facilities; through strict combination tracking and restrictions on internal travel, testing and quarantine.
Many events were cancelled, and Singapore has already begun to urge residents to stay at their homes on March 28, but schools were reopened on March 23 on time after the leave expired.
Several other countries have also taken control of this pandemic by strictly tracking the mixtures and imposing restrictions on internal travel, testing and quarantine, but with less stringent closure decisions, such as in Iceland and South Korea.
A statistical study has revealed that States that have conducted more tests, compared to deaths, have significantly lower mortality rates, perhaps because these countries are better able to detect only those with mild symptoms or no symptoms.
WHO recommends that countries that do not have the capacity to conduct tests or have local laboratories with limited experience of Covide-19 send the first five positive samples and the first ten negative samples of Covide-19 to one of the 16 WHO-approved laboratories to confirm testing.
Of the 16 certified laboratories, 7 are in Asia, 5 in Europe, 2 in Africa, 1 in North America and 1 in Australia.
In the next diagram, the column "positive by % of tests" is influenced by the state's policy of conducting the test.
The State that tests only persons transferred to the hospital will have positive cases that are % higher than the State that tests the entire population, whether or not they show symptoms, considering that the other factors are equal.
Handwashing (or handwashing), also known as hand-cleaning, is the process of cleaning hands for the purpose of removing garbage, grease, microorganisms or other unwanted substances.
The continuous washing of hands with soap at certain "necessary times" during the day prevents the spread of many diseases, such as diarrhea and cholera, which travel through the oral anal road.
People can also be infected with respiratory diseases such as flu or cold, for example, if they do not wash their hands before touching their eyes, noses or mouths (i.e. mucous membranes).
The five necessary moments during the day when washing hands with soap is important include: before and after defecation, after cleaning the baby's ass or changing diapers, before feeding the child, before eating, before preparing food or dealing with meat, fish, or raw poultry.
If water and soap are not available, the hands can be cleaned with ash. WHO recommends that the hands be washed:
Before the food is prepared, during, and after.
Before and after taking care of a sick person.
After changing diapers for a child or cleaning it after using it for the toilet.
After cleaning your nose, coughing, or sneezing.
After touching animals, or their feeds, or their waste.
Hand hygiene refers to hygiene practices associated with medical procedures.
Handwashing before giving medication or providing medical care can prevent or limit the spread of the disease.
The main medical purpose of handwashing is to clear hands of pathogens (bacteria, viruses, or other microorganisms that can cause disease) and chemicals that can cause damage or diseases.
This is particularly important for people who deal with food or work in the medical field, but it is also an important procedure for the general public.
Handwashing has many health benefits, including reducing the prevalence of influenza, Coronavirus and other infectious diseases, preventing diarrhoeal infectious diseases and reducing respiratory infections.
Reduced infant mortality rates at home.
A 2013 study showed that improved handwashing practices may lead to minor improvements in height growth in children under the age of five.
In developing countries, child mortality rates for respiratory diseases and diarrhoea can be reduced through simple behavioural changes, such as hand washing with soap.
This simple measure can reduce the mortality rate from these diseases by almost 50%.
Measures that encourage handwashing from diarrhea can be reduced by approximately one third, similar to the provision of clean water in low-income areas.
Handwashing with soap is the only most effective and least expensive way to prevent diarrhoea and acute respiratory infections (ERE) when applying spontaneous behaviour in homes, schools, and communities around the world.
Pneumonia, one of the major acute respiratory infections, is the leading cause of death among children under the age of 5, killing about 1.8 million children annually.
Diarrhea and pneumonia together cause the death of about 3.5 million children annually.
According to UNICEF, turning handwashing with soap before eating and after using the toilet into an inherent habit can save more lives than any vaccine or medical intervention, reducing deaths from diarrhoea by almost half, and deaths from acute respiratory infections by about a quarter.
Handwashing is usually combined with other hygiene measures as part of water, sanitation and hygiene (water, sanitation and hygiene) programmes.
It also protects handwashing from herpes that are transmitted through direct physical contact.
A simple harmful effect of handwashing is that repeated handwashing can result in skin damage due to its drying.
A Danish study in 2012 revealed that excessive handwashing can lead to a skin state of peeling and itching known as eczema of the hand or inflammation of the hand, which is particularly common among health care workers.
Handwashing is also often viewed too often as one of the symptoms of OCD.
There are five necessary moments during the day when handwashing with soap is important to reduce the transmission of diseases across the oral anal route: after using the bathroom (pee, poop), after cleaning the baby's ass (touch change), before feeding the child, before eating, before/after preparing food or dealing with meat, fish or raw poultry.
The correct handwashing method should be practiced in other cases in order to prevent transmission of the disease, including before or after being treated for cutting or wound, after sneezing, coughing or cleaning your nose, after touching or dealing with animal waste, and after touching garbage.
In many countries, the rate of handwashing with soap is low.
A study on handwashing in 54 countries found that, on average, 38.7% of families wash their hands with soap. A 2014 study showed that Saudi Arabia has the highest rate of 97 per cent, the US is approaching the middle by 77 per cent, and China by 23 per cent.
The “Basic Health Care Programme” implemented by the Department of Education of the Philippines is an example of widespread action to promote children's health and education.
The treatment of worms twice a year, as well as the daily washing of hands with soap, and the daily cleaning of teeth, is at the heart of this national program.
It was also successfully implemented in Indonesia.
The addition of soap or detergents to water enhances the removal of microorganisms from the skin.
The main effect of soap and detergents is to reduce decomposition barriers, and increase solubility.
Water alone is an inefficient sanitizer of the skin because fat and proteins, which are organic soil components, do not readily decompose in the water.
However, the flow of an appropriate amount of water helps to purify...
Because of its reusable nature, solid soap may carry bacteria acquired from previous uses.
A few studies that have observed bacterial transmission from contaminated solid soap have concluded that transport is unlikely because bacteria are washed with foam.
Centers for Disease Control and Prevention continue to state that "liquid soap is preferred from non-touched devices to pump soap".
Anti-bacterial soap was widely promoted to healthy consumers.
So far, there is no evidence that the use of recommended disinfectants or steroids is chosen to eliminate antibiotic-resistant organisms in nature.
However, anti-bacterial soap contains common anti-bacterial factors such as Tricklosan, which do not affect a large number of strains of organisms.
Therefore, if antibacterial soap does not affect antibiotic strains, it may not be as effective as it is marketed to it.
Apart from the surface stress reduction and the skin protection factor, sophisticated formulations may contain acids (acetic acid, ascorbic acid, lactic acid) as an acid regulator, active antimicrobial benzoic acid and other skin refreshments (ceiling, vitamins, ethanol, plant extracts). A comprehensive analysis by the University of Oregon's Public Health Faculty indicated that normal soap is as effective as antibacterial soap in the consumer category containing triclosan in preventing disease and removing bacteria from the hands.
The hot water to wash hands isn't hot enough to kill bacteria.
Bacteria grow much faster at body temperature (37 °C).
However, warm water and soap are more effective than cold water and soap in the removal of natural oils that retain soil and bacteria.
Contrary to common belief, scientific studies have shown that the use of warm water has no effect in reducing the microbial load on the hands.
Sanitizer or hand sterilizer is a non-water-based substance to clean hands.
In the late 1990s and early 21st century, non-water-based alcoholic hand-cleaners sterilized across the hip (also known as a handwasher with alcohol composition, purified handwash or hand sterilizers) began to gain popularity.
Most of them depend on isopropyl alcohol or compound ethanol with a thickening agent such as carbomer (acrylic acid polymer) in a gel, or humid like glycerine in a liquid, or foam for ease of use and reduction of the effect of alcohol-induced drought.
Adding diluted hydrogen peroxide increases antimicrobial activity. Hand sterilizers containing alcohol are prepared at least 60-95% effectively for germs.
Alcoholic steroids across the hip eliminate bacteria, multi-drug-resistant bacteria (golden cluster coils resistant to methicillin and phencomic-resistant intestinal ingredients), tuberculosis, some viruses (including HIV, herpes, respiratory cellular virus, nasal viruses, obscurity, influenza, hepatitis) and fungi.
Alcoholic steroids containing 70% alcohol across the hip consume 99.97% (a 3.5-minute reduction in logarithmic, similar to a 35-minute reduction in decibel) of the bacteria on the hands 30 seconds after their placement and 99.99% to 99.999% (a 4–5 reduction in logarithmics on the hands 1 minute after their placement). Hand sterilizers are more effective against bacteria and less effective against some viruses.
Alcoholic hand sterilizers are almost completely ineffective against the Norovirus (or Norwalk), the most common cause of infection-induced stomach and intestinal inflammation. Sufficient manual disinfection or alcohol scrub must be used to wet or fully cover both hands.
The front and back part is rubbed to the hands and between all the fingers and their limbs for about 30 seconds until the liquid, foam, or gel drys.
The U.S. Center for Disease Control and Prevention recommends handwashing with hand sterilizers, especially when the hands are clearly dirty.
The increasing use of these detergents is due to their ease of use and rapid activity in eliminating microorganisms; however, they should only be an alternative to washing the right hands if water and soap are not available.
The repeated use of alcohol steroids can cause the skin to dry unless the rain or skin refreshments or both add to the composition.
The effect of alcohol on the dry skin can be reduced or eliminated by adding glycerin or other rain or both to the composition.
Clinical experiments have shown that alcohol hand sterilizers containing hammers cause less irritation and skin drying than soap or antimicrobial detergents.
Skin inflammation rarely occurs sensory, sensibilized arthritis syndrome, alcohol hypersensitivity, or additives found in alcoholized handwashers.
The low susceptibility to the occurrence of irritating pyrrhitis has become a attraction compared to the washing of hands with water and soap.
Despite the effectiveness of unwater-based detergents, they do not purify hands from organic materials, but simply sterilize them.
For this reason, hand sterilizers are not as effective as soap and water in preventing the spread of many pathogens, where pathogens remain on the hands.
The effectiveness of the alcohol-free hand sterilizer depends heavily on the ingredients and composition, and historically the effect of which has been significantly less than that of alcohol and which depends on alcohol being rubbed.
Recently, formulations using benzalconium chloride have been shown to have a cumulative and continuous effect as an antimicrobial after-use, unlike alcohol, which proved to be less effective after repeated use, possibly due to progressive reverse skin reactions.
Many individuals in low-income communities cannot afford to buy soap and use ash or dirt instead.
Ash or dirt may be more effective than water alone, but may be less effective than soap.
One concern is that if the dirt or ash is contaminated with microorganisms, they may increase the spread of the disease rather than reduce it.
Ashes are also, like soap, a disinfectant because they form a alkali solution when they touch water.
WHO recommended using ash or sand as an alternative to soap when it is not available.
The method of washing the right hands recommended by the United States Centers for Disease Control to prevent transmission includes the following steps:
Wet hands with warm or cold running water.
The use of running water is recommended because existing basins may be contaminated, while water temperature does not seem to make a difference.
Make foam on the hands by rubbing them with a plentiful amount of soap, including the back of the hands and between the fingers and under the nails.
Soap removes germs from the skin, and studies show that people tend to wash their hands well when using soap only instead of water.
Rub for at least 20 seconds.
The rub creates friction, which helps remove germs from the skin, and removes the rub for longer periods of more germs.
Rinse well under the running water.
Rinsing the hands inside the tub may lead to recontamination.
Dry with a clean towel or leave it to dry in the air.
The most common parts that are overlooked are thumbs, wrists, areas between fingers, and under nails.
Artificial nails and cleavage of cracked nails may contain microorganisms.
It is often recommended to use moisturized luchen to prevent the drying of hands, the drying of skin can cause damage and may increase the risk of transmission.
Different low-cost options can be provided to facilitate handwashing in developing countries, where tap water and/or soap are not available, such as pouring water from a suspended bowl or pulverizing with appropriate holes and/or using ash if necessary. In places with limited water supply (e.g. schools or rural areas in developing countries), there are solutions to rationalize water consumption, such as “Tibee Hanfia” and other low-cost options.
Tippee tap is a simple technique that uses a needle hanging with a rope, and a foot-powered control arm to pour a small amount of water on the hands and a piece of soap.
Effective hand drying is an essential part of the hand-cleaning process, but there is some controversy over the most effective form of drying in public toilets.
An increasing number of research indicates that paper towels are more healthy than electric hand dryers found in many toilets.
In 2008, the University of Westminster in London conducted a study, sponsored by the European Textile Symposium on paper towels, to compare the levels of cleanliness provided by paper towels, warm air hand dryers and fresher jet air hands dryers.
After washing hands and drying them with warm air dryer, the total number of bacteria was found to increase on average on the inside of the fingers by 194 percent and on the palm of the hand by 254%.
Drying using the jet air dryer increased the average total number of bacteria on the inside of the finger by 42% and on the palm of the hand by 15%.
After washing hands and drying them with a paper towel, the total number of bacteria on average on the inside of the fingers decreased by as much as 76% and on the palm of the hand by 77%, and scientists also conducted tests to determine whether there was a risk of transmission of infection to other toilet users and the toilet environment as a result of each type of drying method.
The jet air dryer, which pushes the air out of the unit at speeds of up to 180 m/s (650 km/h; 400 mi/h), is capable of blowing microorganisms from the hands and the device, and may infect other toilet users and the toilet environment up to 2 metres away.
The use of warm air dryer spreads microorganisms about 0.25 metres from the dryer.
Paper towels showed no significant proliferation of microorganisms.[citation needed] In 2005, a study by TöV Product und Umwilt assessed different hand drying methods.
The following changes in bacterial numbers were observed after drying of hands:
There are many manufacturers of different hand dryers, and hand dryers have been compared to paper towels.
Handwashing using hand sterilizer napkins is an alternative during travel due to lack of soap and water.
Alcoholic hand sterilizer must contain at least 60% of alcohol.
Medical handwashing became compulsory for a long time after Hungarian doctor Agnats Similvis discovered its effectiveness (1846) in preventing diseases in the hospital environment.
There are electronic devices that offer notes to remind hospital staff to wash their hands once they are forgotten.
One study found low rates of infection using it.
Medical handwashing is for at least 15 seconds, using abundant amounts of soap, water or gel to make foam and rub each part of the hands.
The hands must be rubbed together and the fingers are tangled.
If there is crap under the fingernails, a rough hair brush can be used to remove it.
Since germs may stay in the water on the hands, it's important to rinse them well and dry them with a clean towel.
After drying, the paper towel must be used to close the water (and open any exit door if necessary).
This avoids contacting the hands again from those surfaces.
The purpose of handwashing in a health care place is to remove pathogenic microorganisms ("grains") and avoid their transfer.
New England Journal Medical journal New England Journal of Medicine reports that not washing hands is still at unacceptable levels in most medical environments, with large numbers of doctors forgetting to wash their hands routinely before touching patients, thus moving microorganisms.
One study showed that proper handwashing and other simple actions can reduce cascading-related blood flow infections by 66 per cent, and WHO published a newspaper explaining how to wash and rub hands in the health care sectors.
The draft guidance document for the organization's hand-cleaning can also be found on its website available for public comment.
Whitby and others conducted a related review.
Commercial devices can measure and verify the cleanliness of hands, if required to prove compliance with regulations.
WHO has "five moments" to wash hands:
After exposure to blood/body fluids
Before a sterilisation mission,
Adding disinfectant chemicals to soap ("medicine" or "antimicrobial") gives an exterminator an exterminator element to the handwasher.
This element of extermination may be desirable before surgery is performed or in places where antibiotic-resistant organisms are most prevalent. When "shaking" someone’s hands to perform surgery, a tap that can be operated and stopped without touching hands, some chlorhexadine or iodine washing, sterile towels to dry hands after washing, a sterile scrub brush, and another sterile tool to clean under nails.
All jewels must be removed.
This procedure requires washing hands and forearms until the elbow, usually 2 to 6 minutes.
Long rub (10 minutes) is not necessary.
Upon rinsing, the recoil of water must be prevented from the bellies to the hands.
After finishing the handwashing, the hands dry with a sterile cloth and wear a surgical dress.
To reduce the spread of germs, it is best to wash hands or use a sanitizer for the hand before and after taking care of a sick person.
To control CCM infection in hospitals, the greatest benefit of manual clearance was found to have come from the first 20% of laundry, and he gained very little added benefit when the frequency of hand cleaning increased to over 35%.
Regular soap washing leads to more than three times the rate of bacterial infectious diseases that travel to food compared to anti-bacterial soap washing. Compared with alcoholized hand rubs with handwashing with anti-bacterial soap for an average of 30 seconds, alcohol rubs have been found to reduce bacterial contamination by 26% more than anti-bacterial soaps.
But water and soap are more effective than alcohol handwash to reduce H1N1 influenza virus and hard-to-hand motifs. Measures to improve hand hygiene in health-care settings may include educating employees about handwashing, increasing availability of alcohol handwashing, and written and verbal reminders to employees.
Further research is needed to find out which of these measures is the most effective in different health care settings.
In developing countries, hand washing with soap is recognized as an essential and affordable tool for achieving good health, as well as good nutrition.
However, the lack of reliable water supply, soap, or hand-washing facilities in homes, schools and workplaces makes it difficult to arrive at general hand-washing behaviours.
For example, in most rural areas of Africa taps are rarely found to wash hands near each private or public toilet, although there are cheap options for building handwashing stations.
However, low handwashing rates can be the result of ingrained habits rather than soap or water deficiency.
Promoting and advocating handwashing with soap can influence political decisions, increase awareness of the benefits of handwashing, and change the long-term behaviour of the population.
For this to work effectively, monitoring and evaluation are essential.
A systematic review of 70 studies found that community-based approaches are effective in increasing hand-washing in middle-income countries of the lower segment, while social marketing campaigns are less effective. One example of promoting hand-washing in schools is the “three-star approach” designed by UNICEF to encourage schools to take simple and inexpensive steps to ensure that students wash their hands with soap, among other health requirements.
When minimum standards are achieved, schools can move from one star until they eventually reach three stars.
The construction of hand-washing stations can be part of the promotion campaigns for hand-washing to reduce diseases and child mortality.
World Handwashing Day is another example of consciousness-raising campaigns that are trying to bring about behavioral change. Because of the Corona virus pandemic 2019-20, UNICEF has encouraged the adoption of an expression symbol for handwashing.
A few studies have considered the overall cost-effectiveness of handwashing in developing countries and its relationship to disability-adjusted years of life.
However, one review suggests that promoting hand washing with soap is significantly more cost-effective than other water and sanitation procedures.
The importance of hand-washing for human health was first recognized – especially for people in critical circumstances such as mothers who were just born or injured soldiers in hospitals – in the mid-19th century of two hand-cleaning pioneers: Hungarian physician Agnes Similvis who worked in Vienna in Austria, and English Florence Nightingale "Modern Nursing Founder".
Most people at the time still believed that the infection was caused by foul smells called meazaz.
In the 1980s, food-borne outbreaks and health-care-related infections prompted the United States Centers for Disease Control and Prevention to promote cleaner hands more effectively as an important way to prevent the spread of infection.
The 2009 swine flu outbreak and the 2020 Coved-19 pandemic raised awareness in many countries of the importance of handwashing with soap to protect themselves from these infectious diseases.
For example, posters containing "right ways of washing hands" were suspended next to handwashing pools in public toilets and in the toilets of office buildings and airports in Germany.
The phrase "washing hands from" means something that is declared to be unwilling to take responsibility for something or to participate in complicity in it.
It originates from a biblical paragraph in Matthew where Pilate of the Pontius washed his hands of the decision of the crucifixion of Jesus Christ, but has become a much wider term in some English societies.
In the play Macbeth Shakespeare, Ms. Macbeth begins to wash her hands excessively in an attempt to purify a place of fiction that represents her guilt for the crimes she committed and for the crimes that she urged her husband to commit.
It was also found that people, after referring to or considering immoral acts, tend to wash hands more often than others, and tend to appreciate handwashing tools more.
Moreover, those who are allowed to wash their hands after this study are less likely to participate in other “clean-up” compensatory actions, such as volunteering.
The symbolic handwashing, using water without handwashing soap, is part of the handwashing rituals that have emerged in many religions, including the Bahá’í, Hindu, and Tevilah faith, handwashing in Judaism, and washing in Christianity and light in Islam. Religions also impose the washing of healthy hands, especially after certain actions.
Hinduism, Judaism and Islam impose handwashing after using the toilet.
Hinduism, Buddhism, Sikhism, Judaism and Islam impose handwashing before and after each meal.
Coved-19 risk controls in the workplace
Coved-19 workplace risk control controls are the application of occupational safety and health methodologies for risk control controls to prevent the 2019 Corona virus disease (Coved-19).
Proper controls of workplace risk control depend on the workplace and the job function, based on an assessment of the risk of exposure sources, the risk of disease in society, and the risk factors that threaten working individuals who may be at risk of being exposed to code-19.
According to the U.S. Department of Occupational Safety and Health (OSHA), low-risk work involves minimal communication with the public and other co-workers, a situation in which basic procedures for infection prevention are recommended, including handwashing and encouraging workers to stay home if they are ill, taking into account coughing and sneezing ethics, and maintaining normal practices for cleaning and cleaning the work environment.
Jobs with moderate exposure risks include those that require frequent or close communication with unknown or suspected individuals with code 19, but may be infected by ongoing transmission in society or international travel.
This includes workers who have reached out to the public as in schools, high labour-intensive working environments, and some large-scale retail places.
Risk control controls for this group, in addition to basic procedures for the prevention of infection, include ventilation using high-efficiency air filters, sneezing barriers and the use of personal protective equipment available in the case of dealing with a person with a code-19.
The Occupational Safety and Health Department considers health-care workers and body preservation who are exposed to a person known to be exposed to or suspected of having been exposed to high levels of risk of exposure, which increases the risk of very high exposure if the workers carry out aerosol generation procedures, or collect or deal with samples from a known or suspected person affected by a controlled substance-19.
Appropriate risk control controls for these workers include engineering controls such as passive pressure airing rooms, and personal protective equipment suitable for the job.
Covid-19 outbreaks can have multiple effects in the workplace.
Workers may be absent from work due to illness, the need to care for others, or fear of potential exposure.
Patterns of trade may change, both in terms of the quality of the goods required, and the ways in which they are obtained (e.g. shopping in non-freight hours or through delivery or shopping services without leaving the car).
Finally, shipments of goods from heavily affected geographical areas may cease. The preparedness and response plan for infectious diseases can be used to guide preventive action.
The plans address risk levels associated with different workplaces and functions, including sources of exposure, risk factors from home and community locations, and risk factors for individual workers such as old age or chronic medical conditions.
It also sets out the necessary controls to address those risks, and contingency plans for situations that may arise as a result of the outbreak.
Preparedness and response plans for infectious diseases may be subject to national and subnational recommendations.
The objectives of the response to the outbreak include reducing staff transmission, protecting people most at risk of negative health complications, maintaining business processes and reducing negative impacts on other entities in their supply chains.
The severity of the disease in the society in which the business takes place affects the responses taken.
The hierarchy of risk control controls is a framework that is widely used in the field of occupational safety and health to classify risk control by effectiveness.
Due to the inability to eliminate the risks of Covid-19, the most effective controls are engineering controls, followed by management controls, and finally personal protective equipment.
Engineering controls include isolating staff from labour-related risks without relying on worker behaviour, and can be the most cost-effective solution in terms of implementation.
Administrative controls are changes in employment policy or procedures that require action by the worker or employer.
Personal protective equipment (BBE) is less effective than engineering and administrative controls, but can help prevent certain exposures.
All types of personal protective equipment must be selected based on the worker ' s risk, proper suitability as appropriate (e.g. respirators), continuous and proper wear, regular inspection, maintenance and replacement, as necessary, removal, cleaning and storage, or proper disposal to avoid contamination.
According to the U.S. Department of Occupational Safety and Health (OSHA), jobs that include lower risk exposure involve minimal communication with the public and other co-workers.
Basic measures for the prevention of infection recommended for all workplaces include frequent and complete handwashing, encouraging workers to stay at home if they are ill, taking into account coughing and sneezing etiquette including mouth and nose covering when coughing and sneezing, providing paper towels and garbage containers, preparing to work remotely or organizing consecutive shifts if necessary, discouraging workers from using other people's tools and equipment, and maintaining routine cleaning and cleaning of the work environment.
The immediate identification of individuals likely to be infected and isolated is a crucial step in protecting workers, customers, visitors and others in the workplace.
The American Centers for Disease Control and Prevention (CDC) recommend that staff with acute respiratory diseases remain at home until fever, signs of fever and any other symptoms cease to exist for at least 24 hours without the use of fever-based medication or other medications that improve symptoms, that sick leave policies be flexible, that staff members be allowed to stay at home to care for a sick family member, and that staff be aware of these policies.
According to the Occupational Safety and Health Department, jobs with a moderate exposure risk include those that require frequent or close communication within a distance of six feet (1.8 m) of unknown or suspected individuals with a code 19, but may be infected with a sars-coff-2 due to the continuous transmission of infection in the community around the workplace, or because of a person's recent international travel to a location where the transmission of a code 19 is widespread.
Engineering controls include installing high-quality air filters, increasing ventilation rates, installing physical barriers such as transparent plastic sneeze protections, and installing windows to serve customers who shop without leaving the car. Administrative controls include encouraging sick workers to stay at home, replacing face-to-face meetings with virtual contacts, creating successively organized work shifts, stopping unnecessary travel to locations where there is a constant outbreak of 19, developing emergency communication plans including a forum to respond to workers’ concerns, providing workers with updated education and training on risk factors and preventive behaviors related to a child-19, training workers who need to use clothing and protective equipment on how to use them, providing resources and a working environment that encourage personal hygiene, requiring regular handwashing, limiting the access of customers and the public to the workplace, and publishing banners on handwashing and other protective measures related to a child-19.
Workers in this hazard group rarely need to use respirators.
If a person becomes ill while on an aircraft, appropriate protective controls are included to protect workers and other passengers by keeping the sick passenger 6 feet away from others, assigning one member of the aircraft team to serve the sick person, providing the sick person with a face mask or requiring the sick person to cover his mouth and nose with handkerchiefs when coughing or sneezing.
The crew of the aircraft must wear medical gloves that can be disposed of when dealing with a sick passenger or touching contaminated body fluids or surfaces, and possibly use additional personal protective equipment if the sick passenger suffers from fever, constant cough or difficulty breathing.
Gloves and other disposable purposes must be disposed of in a biohazard prevention bag, and contaminated surfaces must be cleaned and sterilized thereafter. For commercial shipping, including cruise ships and other passenger ships, risk controls include a stay of travel upon illness, self-insulation and immediate notification to the medical centre on board if a person is infected with fever or other symptoms while on board.
For schools and childcare facilities, the Center for Disease Control and Prevention recommends short-term clean-up or clean-up if the infected person is in the school building regardless of the spread in society.
When there is a limit to transmission in society ranging from limited to moderate, social spacing strategies can be implemented such as cancelling field trips, gatherings, other large gatherings such as physical education classes, band lessons or meals in the canteen, increasing distances between offices, organizing consecutive attendance and departure times, reducing unnecessary visitors, and using a separate health office for children with flu-like symptoms.
When there is a major transmission of infection in the community, in addition to social spacing strategies, the extension of school departures can be taken into account. For law enforcement officials who carry out routine daily activities, direct health risks are considered low by the CDC.
Law enforcement officials who must communicate with individuals who have been confirmed or suspected of having been exposed to code 19 are advised to follow the same guidance as medical emergency technicians, including appropriate personal protection equipment.
In the event of direct contact during arrest, workers should clean and clean up work belts and tools before reuse using a spray or household cleaning mop, and follow standard operating procedures to deal with pollution and dispose of personal protective equipment used and to collect and wash clothing.
According to the Occupational Safety and Health Department, some health-care workers and the Body Keeper fall into categories with high or very high risk levels.
Posts with a high risk exposure include health care providers, support, laboratories and medical transport for known or suspected patients with code-19.
These become very high risk exposures if workers perform aerosol generation procedures, as well as collecting samples from or dealing with confirmed or suspected patients with code-19.
The procedures for the generation of aerosols include intubation, coughing procedures, retorts, some dental procedures and tests, or the collection of invasive samples.
The functions of a high-risk body preserve include workers involved in the preparation of the bodies of confirmed or suspected persons with code 19 at the time of their death; those with a very high risk exposure level if they perform an autopsy; additional engineering controls for these high-risk groups include isolation rooms for known or suspected patients with code 19, including in the implementation of aerosol generation procedures.
Specialized passive pressure ventilation may be appropriate in some health care settings and the preservation of dead bodies.
Samples have to be handled following Level 3 biosafety precautions.
The World Health Organization (WHO) recommends that patients arriving in separate waiting areas be isolated based on whether they are suspected of having been exposed to CF-19 or not. In addition to other personal protective equipment, the Occupational Safety and Health Department recommends the use of respirators for those who work 6 feet away from known or suspected patients Saars-Coff-2, and those who perform aerosol-generation procedures.
In the United States, N95-type N95-type masked respirators, approved by the National Institute for Occupational Safety and Health, or better, must be used in the context of the comprehensive written respiratory protection programme, which includes composition and suitability testing, training and medical examinations.
Other types of respirators can provide greater protection and improve worker comfort. The World Health Organization does not recommend the use of aprons, because Coved-19 is respiratory disease instead of being transmitted by body fluids.
WHO only recommends the use of a surgical mask for examination staff at the entry point.
For those who collect respiratory samples from Coved-19 patients, take care of them, or transport them without any action to generate aerosols, WHO recommends the use of surgical mask, protective glasses, facial protection, squadrons and gloves.
If an aerosol generation procedure is implemented, the face mask is replaced by a N95 or FFP2 breathing mask.
Given that the global supply of personal protection equipment is inadequate, WHO recommends reducing the need for personal protective equipment through telemedicine, physical barriers such as transparent windows, allowing only those involved in direct care to enter a room with a patient with a code 19, using only personal protective equipment necessary for the specific task, continuing to use the same breathing mask without removing it while caring for many patients with the same diagnosis and monitoring and coordinating the supply chain of personal protective equipment, and discouraging the use of masks for individuals without symptoms.
From: Catherine Maher, Executive Director, Wikimedia Foundation
To: All employees of the Wikimedia Foundation
Subject line: [Coved 19] Relieving burden and preparing for the future
Date/time of transmission: March 14, 2020, 00:24 World Standard Time
Licensing: CC0: No reserved rights
We have found ourselves in the midst of extraordinary circumstances this month.
The Covide 19 pandemic has become a clear manifestation of the global human interdependence and of our responsibilities to others.
Our history has never seen similar challenges, but we know for sure that the best response depends on a kind of global sympathy, cooperation and community-building, which are the elements that are at the heart of this institution.
The great friendship and care that we have witnessed among all our colleagues through e-mails, calls and conversations is an amazing demonstration of the amazing human feelings surrounding, fortunately, the way we work.
I am very grateful and deeply proud to have you as real colleagues.
Last week, someone sent me a letter expressing appreciation for our work.
They reminded me of how important it is for the world to be able to move towards Wikipedia right now, and of the powerful symbolism that this critical resource remains available online and a kiss that is available to all individuals.
Your efforts have made it possible, whether it be through the continued operation of the sites, our colleagues getting paid, or the safety of our communities.
The world has become more in dire need of the information available in Wikipedia than ever before.
It is a moment when the positive impact in the world is not limited to our efforts, but also to the way it is done.
Because of the importance of this mission and your role in it, we will make major adjustments in how we work together starting next week.
Adjustments to the modus operandi and timetables
As Rubin said earlier, Team J met yesterday to discuss our way and schedule for the days and months ahead.
In that debate, we considered what we thought could be an appropriate response to what we are facing, and the ideal way to maintain the sustainability of the work of the institution during this period.
We wanted to get rid of stress and stress, and to support our long-term mission.
If you want to reduce burdens and tasks, that's fine.
All workers, contractors and contract workers:
The expected daily working time is 4 hours a day, or 20 hours a week until further notice.
We're not about to announce a vacation, and if you can work longer than normal working hours, you might add your efforts to the task.
However, the world has become unpredictable at the moment, and whether you want to take care of your loved ones, get the goods from the grocery store or go to the doctor, your safety is our top priority.
We don't track your times.
If you're sick, don't work.
It should be understood to allow this without expressing it, but we certainly remember it.
Sick leave or paid leave is not required. You only have to inform your manager and help your team review calendars and schedules to ensure that key areas of work are covered.
(If the doctor diagnoses you as having a positive Kovid-19 disease, please inform Brian in the Department of Training and Certificates so that the Department of Training and Assistant Certificates can provide support and ensure that your condition is properly taken care of by the Department.)
Fellows employed by the hour receive their full wages.
We have already mentioned that, and we renew this commitment to our contractors and fellow hourly workers.
Each employee will be paid on the basis of normal working hours during normal conditions.
This includes whether the employee is ill or unable to work.
If you want to work, we support you.
Many individuals are using action to overcome the pressures that are spreading around the world.
What we can do will be amazingly productive, especially during difficult times like this.
Again, it's about caring for oneself.
We only ask you to contact your manager so that he can know what to expect and adjust the procedures accordingly.
Some actions are necessary.
There are also some things that we must keep going.
Site reliability engineering teams, human resources operations, trust, trust, fund-raising (and others) are doing very important work, which may require further support.
We will begin a process in cooperation with all departments to assess current objectives and shift our focus to supporting the elements necessary to achieve our mission.
There's a lot of work we all need to do, and we'll just focus on the most important projects.
Go slower now. It won't hurt us later.
We're not planning to "double the time of work to make up for the loss" after the pandemic.
We're not expected to work extra hours to meet the deadlines that are currently unrealistic.
We accept the fact that those circumstances have changed, and we will work to set new goals and timetables as soon as it becomes appropriate.
What happens in annual APP planning?
To adapt to the new reality and the expectations of daily working hours, we intend to adjust our delivery schedule for our 2020-2021 annual planning.
We intend to propose an extension of our 2019-2020 plan to allow more time to design the budget to allow staff to prioritize critical work, self-care and loving care while reconciling those who need or want to work within a reduced schedule of working hours within the next few weeks.
This timetable extension eases the current planning workload and pressure across the entire institution.
We will submit our proposal to the Governing Council next week and will update delegates and teams on the next steps as soon as confirmation is obtained.
We thank the annual planning team for its leading role in this matter.
Office status, exposure and clean-up
Last week, we learned that one of our colleagues working in San Francisco might have been infected with the CFD-19 virus.
However, starting with extreme caution and prohibition, we hired a viral clean-up team to clear all surfaces in the San Francisco office.
The team has used the grade-level virus resistance solution used in hospitals to clear all surfaces, in addition to the lobby and elevator units that lead to our own floor.
The building applied its own duty-of-care protocol using products that support the safety of tenants.
We're relieved that the office is properly ready until we decide to get back to work.
Our Washington D.C. office is located in a Weework building, which has shared our own Covide-19 protocol and with all the members of our Washington D.C.-based working group.
Starting last week, our Washington D.C. office moved to a completely remote location according to co-direction with our San Francisco office.
As some of our colleagues at our headquarters in New York City know, we have had a discussion about renting a place in Brooklyn.
Those discussions continue but may be delayed for some time.
Some of our colleagues work remotely for the first time.
Our long-time teleworking colleagues know it may be an adjustment, and they wanted to give you some advice:
Meetings should be limited to a maximum of one hour or a gradual increase of up to two hours.
If longer sessions are required, thought should be given to how to divide them over several days.
The meeting should be clearly defined, an agenda prepared, and reading materials sent in advance.
Video should be made the default solution, and tools such as Google Docs and Zoom should be used to facilitate collaboration and direct communication.
Each meeting should be facilitated, with one person monitoring the conversation to learn questions and track the list of speakers, and another to help take notes (or implement the collaborative process of taking notes).
An e-mail should be sent to technical support when comfortable headphones are required.
The health and safety compensation program can be used to obtain the cost of snacks.
You can join #remoties Channel in the Slack application to talk to colleagues about the distributed work
The Human Resources Operations Group is seeking guidance for user-friendly elements based on online meetings, to support the increase in work distributed across our institution.
Over the past week, we have asked all community grantees to cancel all public events funded by Wikimedia, such as those of web editors edathon until the World Health Organization (WHO) announces the end of the pandemic.
We told them that we understand that our request for cancellations and other restrictions may make it impossible to complete agreed grant activities, and that no one will be fined for having to delay or modify these goals.
Next week, we will issue additional follow-up guidance on Buikimedia and other regional and thematic community conferences.
The general feelings of the world community are floundering between the grief of the turmoil and the satisfaction of clarity and the ability to focus on their societies, Wikipedia and others.
In light of the progress of these actions, the Crisis Response Team is designing a page in Meta Wiki to provide space for the community to monitor the impact and follow up on all contacts with him.
Keeping up to date on topics related to the 19th Coved
We will send an invitation to your calendars next Thursday, 14:00 UTC, 07:00 Pacific time for the meeting of the Working Group.
We'll use this time to share additional updates, answer questions and spend time communicating with us.
We're going through this together, and we're always willing to help as much as possible.
In the meantime, we can continue to obtain information from this e-mail, and all other necessary information concerning the 19-Covide available in Oves Wiki.
The Crisis Response Team will keep these pages updated and keep all information in one place.
We are also in the process of maintaining regular contacts with workers residing in the most seriously affected States.
If you have any questions about travel, events, key areas of work, coverage challenges or anything else you need help with, please do not hesitate to inform us and cooperate with the Crisis Response Team.
We are always willing to provide support and communication as necessary.
If you have a confidential or sensitive matter, please send an e-mail to Brian Gooden, Director of International Human Resources Operations.
None of these changes shall be regarded as a renunciation of our work or of our obligations.
Instead, it is a realization at this moment, our work and our commitments are in a great need to adapt to the situation in a way that we have never before.
We believe that these steps are necessary to support each other, so that we can continue to work, provide our workers with the support they need, and provide the world with the service on which they depend.
The work we have planned will be waiting for us when it comes to completion.
Now is the time for everyone to help each other and to create space for the important work that comes in the coming weeks and months.
We need you all to make this happen, so we need you all to take care of yourselves and your families to be at your best when the time comes for your efforts.
Please now wash your hands and not touch the face!
Catherine, Director, Crisis Response Team (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jimmy V, Joel El, Linette L, Ryan M and Tony S), and the other members of the leadership team (Grant I, Heather W, Jimmy V, Janine U, Lisa S, Robin A, Ryan M and Toby N).
The converted enzyme of angiotensines 2 (ACE2) is associated with the outer surface (cellular membranes) of cells in the lung, arteries, heart, kidney, as well as intestine.
The angiotensis-transformed enzyme 2 counters the work of the angiotensis-transformed enzyme (ACE) by reducing the amount of angiotensine 2 and increasing angiotensines (1-7); making it a promising drug in the treatment of cardiovascular diseases. It is also an entry for some types of coronary viruses into cells.
The human version of the enzyme is often referred to as hACE2.
The converted enzyme of angiotensine 2 is known as a metallic enzyme containing the zinc element and located on the surface of the blanket cells and other cells.
The enzyme-transformed protein of angiotensis 2 on the peptidez M2 scale has an amino tip, and the colictrini carboxicilli-party chain is a vector of renal amino acids.
The enzyme converted to angiotensisine 2 is a type 1 pass single membrane protein, and has active enzyme receptors found on the surface of lung cells and other tissues.
The outer portion of the cell range of the enzyme converted to angiotensisine 2 is separated from the range via the membrane by an enzyme called chidaz, resulting in the release of a soluble protein in the bloodstream and then exits through urine.
The angiotensis-transformed enzyme is found in most organs of the body: it is associated with the cellular membrane of type 2 schizophrenia cells in the lung, in the intestinal cells of the microintestinal, and in the blanket cells of the arteries and veins, as well as in muscle cells that are filled with arterial wall in most organs.
Rebuzzi's sent DNA for an angiotensisine-transformed enzyme 2 is found in the cerebral cortex, the scheme, an area under the hypothalamus, and the brain stem.
The essential function of an enzyme converted to angiotensisine 2 is to act as a counterbalance to an enzyme converted to angiotensisin.
The angiotensis-transformed enzyme induces the conversion of angiotensines 1 hormone to angiotensines2 holding blood vessels.
In contrast, the converted enzyme of angiotensine 2 separates the amino acid-containing carboxicillic end phenyl lanin from angiotene 2 (aspartite-argenine-valin-tairosin-isulucene-histdine-prolene-phenyl Alanin) and analyses it by converting it to angiotins (1-7), (histideen-aspartine-valin-tairosin-isuliusin-histdine-proline-phenyl Alanin).
The angiotensis converted enzyme 2 separates into a number of other peptides including [dis-Argen9] - Bradrikinin, Ablin, Neurotincin, Dynorvin A, and Greline.
The angiotensis converted enzyme 2 also regulates the membrane passage of a neutral amino acid equivalent transporter SLC6A19, and also has a role in Hartenpe's disease.
As a protein via my membrane, the angiotensis-transformed enzyme is the main entry point to cells for some coronary viruses, which include the NL63 human coronavirus, Sars Cove (the virus that causes carcinogenesis), and Sars Cove-2 (the virus that causes Covid-19 disease).
In particular, the association of Spike's S1 protein with the SARS Cove and SARS Cove-2 virus with the enzyme range of the angiotensine-transformed enzyme 2 on the cell surface leads to cellular insulation and the transmission of the virus and the enzyme to internal particles located in the cells.
This input process requires the development of a S protein by a protein enzyme across the membrane, Cyrene2 of the host, whose inhibitor is still being tested as a possible cure. This makes some assume that reducing the levels of the enzyme converted to angiotensines 2 in cells may help to resist infection.
However, many specialized associations and self-regulatory bodies recommend the continued use of the standard angiotensis-transformed enzyme inhibitors, and engiotincin receptor blockades as treatment.
A systematic study and synthesis published on July 11, 2012 showed that "the use of angiotensis-transformed enzyme inhibitors was accompanied by a clear reduction in the risk of pneumonia by 34% compared to the reference set".
Furthermore, "the risk of pneumonia has decreased among patients who have received treatment with endocrine-transformed enzyme inhibitors, and who have been more at risk of pneumonia, especially those with stroke or heart failure.
The use of endocrine-transformed enzyme inhibitors has led to a decrease in the mortality rate from pneumonia, although the results have been less robust than the overall risk of pneumonia".
It is believed that the converted enzyme of human angiotensicin 2 (RhACE2) will be a new treatment for acute lung injuries, found to improve the distribution of pulmonary blood, as well as oxygen saturation in pigs suffering from acute respiratory distress syndrome induced by multiple fatty sugars.
The half-life of an enzyme converted to the damaged angiotincin 2 is approximately 10 hours, while it starts in 30 minutes, in addition to continuing to be effective (time period) until 24 hours.
There are several indications that the damaged angiotensisine 2-transformed enzyme may be a promising remedy for those suffering from the unbearance of traditional resonance inhibitors (RAS) and in diseases associated with an increase in angiotensinesin 2 in blood. Clinical experiments are under evaluation, about the effect of the released enzyme of angiotensine 2 on the treatment of acute respiratory distress syndrome.
Covid-19 applications are mobile software applications designed specifically to help track people mixed in in response to the 2019-20 coronavirus pandemic, meaning the process of identifying people ("mixers") who may have mixed someone infected.
Many applications have been designed or proposed with official government support in some regions and jurisdictions.
Several frameworks have been developed to design applications to track mixtures.
Many have expressed concerns about privacy, especially about systems that rely on tracking the geographical location of application users.
Less invasive alternatives include the use of Bluetooth signals to record the user's proximity to other cell phones.
On April 10, 2020, Google and Apple announced together that they might integrate a function that supports these Bluetooth-based applications, directly into their Android and IOS operating systems.
In China, the Chinese government, in collaboration with Alibay, published an application that allows citizens to verify whether they have mixed people with a code-19.
It is an application used by individuals in more than 200 Chinese cities. In Singapore, individuals use an application called TraceTogether.
The application has been designed by a local information technology association, released as an open source application and is to be handed over to the Government. "StopKorona", a Bluetooth-based application to track exposure to potential infection individuals and provide rapid response to health-care authorities, has been launched by northern Macedonia.
The Ministry of Communications and Technology, in cooperation with the Ministry of Health, has designed the application.
On April 14, 2020, the app was still awaiting approval of Google Play and App Store of Apple.
On April 12, the government stated that the mix tracking application was in the advanced stage of development, and may become available for distribution within weeks. Ireland and France are planning to launch a similar application, "StopCovid".
Australia and New Zealand are both considering designing applications based on the TraceTogether application launched by Singapore, as well as the BlueTres Protocol. Russia intends to introduce an application that uses the geographic virtual perimeter of patients diagnosed by doctors with a code-19 from Moscow residents, and is designed to make sure they don't leave home.
Ross Anderson, Professor of Security Engineering at Cambridge University, has mentioned a number of potential practical problems surrounding application-based systems, including false positive cases and a possible lack of effectiveness if applications are used only by a small segment of the population.
To deal with concerns about the spread of misleading or harmful coronavirus applications, Apple imposed restrictions on the types of organizations that could add their corona-related applications to their application store; this was limited to "official" or other organizations of good reputation only.
Google and Amazon have implemented similar restrictions.
Proponents of privacy have expressed concerns about the consequences of mass surveillance resulting from the use of coronavirus applications, particularly as regards whether the control infrastructure designed to deal with the coronavirus pandemic will disappear as soon as the threat is over.
Amnesty International and more than 100 other organizations have issued a statement calling for restrictions on this type of surveillance.
Organizations have also announced eight conditions for government projects:
Surveillance should be "legal, necessary and proportionate";
Extensions of monitoring and control should include provisions for determining the time of their suspension;
The use of data should be limited to the purposes of code 19;
Data security and the confidentiality of the identity of the holders of the data should be protected and proven based on evidence;
Digital surveillance should avoid increasing discrimination and marginalization;
Any sharing of data with outside parties to the law should be specified;
Protections against abuse and protection of citizens ' rights should be in place to address abuses;
“Effective participation” is required from all “stakeholders involved”, including public health experts and marginalized groups. The Chaos Computer Club (CCC) German and Reporters Without Borders (RSF) have also issued checklists.
The proposed Google/Apple plan aims to deal with the ongoing control problem by removing the tracking mechanism from the hardware operating systems as soon as they are needed.
Some States have used network-based site tracking rather than applications, eliminating both the need to download the application and the possibility of avoiding tracking.
In Israel, officials have adopted network-based tracking.
However, network-based solutions that have access to initial site data have significant potential privacy problems.
However, not all central server systems need access to personal location data; a number of privacy preservation systems using only central interface servers have been established (see the following section below).
In South Korea, officials used a non-appliance-based system to implement mesh-tracking operations.
Instead of using an ad hoc application, the system collects tracking information from various sources, including mobile tracking data and card transaction data, and combines these data to send notices via text messages to individuals with potential infection.
In addition to using this information to alert potential mixtures, the government made site information publicly available as well, which was allowed by extensive changes in information privacy laws following the outbreak of the Corona virus causing respiratory Middle East syndrome in that country.
This information is available to the public through a number of applications and websites. States, including Germany, have considered using both centralized and privacy systems.
On April 6, 2020, the details on this matter have not yet been released.
The tracking of privacy-conservative mixtures is an applied and successful concept supported by powerful research literature dating back to at least 2013. On April 7, 2020, more than a dozen groups of experts worked on solutions that correspond to privacy, such as low-energy Bluetooth (BLE) to record the user's proximity to other cell phones.
However, PBB-PT was a coordination effort that contained both centralized approaches and decentralization, not an individual protocol. Decentralization-based protocols include tracking decentralized approaches to privacy (DP-BBT/DP3T), interim contact numbers (TCN, formerly known as contact event numbers, CEN), privacy-sensitive protocols, and mechanisms for tracking mobile mixtures (BAT), etc.
In these protocols, personal identifier data do not leave the device, and all matching processes occur on the device.
The MIT Media Lab privacy group was working on the development of SavePaths, a platform for the use of privacy-conservative techniques when collecting or using site data or junction tracks to track the spread of Covide-19.
Depends on the research from the March 2020 "The Evil Face of Applications: Maintaining Personal Privacy in the Shadow of the Epidemic" report. The SaveTrace platform of Enigma MPC, a company that develops privacy technologies that also originated at MIT Media Lab, is another similar effort.
SafeTrace uses secure hardware techniques to allow users to share sensitive site and health data with other users and officials without compromising the privacy of the data.
On April 5, 2020, the Global Contact Number Tracking Coalition was founded by groups focused on what was essentially a similar approach and highly overlapping protocols, with the aim of reducing dispersion and enabling global interoperability between tracking and alert applications, a key feature of widespread use.
On April 9, 2020, the Singapore government announced that it had made the Blue Trace Protocol, used by the official government application, open source.
On April 10, 2020, Google and Apple, the companies that control the mobile android and IOS operating systems, announced an initiative to track mixtures; they claimed they would maintain privacy by relying on the combination of low-energy Bluetooth and privacy encryption.
They also published the specifications of the main techniques used in the system.
According to Apple and Google, the goal is to launch the system in three stages:
Tools are put in place to enable governments to create formal, privacy-based applications to track Corona's virus
Integration of this function directly into the Android and IOS system as Google and Apple plan to solve ongoing use and control problems by distributing systems first through operating system updates and then by removing them in the same way as the threat ends.
The recycling of the drug (also known as reuse, reallocation, change of purpose or therapeutic transformation of the drug) is a redefinition of the use of an approved drug to treat a different disease or medical condition than was originally designed for its treatment.
This is a method of scientific research currently being pursued by researchers to develop safe and effective remedies for Coved-19.
Other research trends include the development of the Coved-19 vaccine and the transfer of pure plasma. The Sars Cove-2 virus contains approximately 66 drug-treated proteins, each of which contains multi-linked sites of the ribites.
Analysis of these associated sites provides the reasonable plan for the development of an effective antiviral drug that eliminates Covid-19 proteins.
Among the most important target proteins for Sars Kove-2 is the two-door protease, ribozy DNA-dependent polymerase, helicase, protein S, and ribophosphatase for diphosin.
Hussein AA, et al., has studied several candidate compounds that have since undergone improvement and analysis to match their structure with the most similar approved drugs and this is with a view to accelerating the development of a strong anti-Sars Cove-2 drug in his pre-clinical study to recommend it in the design of a clinical study.
Chloroquin is a malaria drug that doctors also use to treat certain autoimmune diseases.
On March 18, a World Health Organization announced that chloroquine and associated hydroxychloroquine could be among the four drugs under study as part of the clinical solidarity experiment.
New York Governor Andrew Como has announced that New York State experiments on chloroquine and hydroxychloroquine may begin on March 24. On March 28, the Food and Drug Administration authorized the use of chloroquine sulfate and chloroquine phosphate under an emergency use permit (EUA).
Treatment by clinical trial process was not approved by the Food and Drug Department and licensed under an emergency employment permit only as an experimental emergency treatment for patients who have been hospitalized but cannot receive treatment in clinical trial.
CDC announced that it had not yet been determined "the use of hydroxychloroquine to prevent or treat SARS Cove-2 virus infection, dosages or period".
Doctors said they use the drug when "there's no other option."
A Turkish research team in Istanbul is currently conducting a small study on the use of chlorine in addition to zinc, vitamin A, vitamin C and vitamin D.
Major studies are conducted at Duke University and Oxford University.
The University of New York Langon Medical School is experimenting with the safety and effectiveness of the preventive use of hydroxychloroquine.
Chinese clinical trials in Wuhan and Schengen have claimed that Favebiravir was "clearly active".
Of 35 patients in Schengen, the test results were negative on average of 4 days, while the illness period was 11 days in 45 patients who did not receive it.
In a study conducted in Wuhan on 240 patients suffering from pneumonia, half of them were given faveperavir and the other half received Omivinuvier.
The Italian Drug Agency has alerted people that the existing evidence supporting the drug is incomplete and primary.
On April 2, Germany announced that it would buy the drug from Japan to include it in its reserve stock, and would use the army to deliver the drug to university hospitals, where the drug would be used to treat Covide-19 patients.
According to the South China Morning Journal, Shinzu Abe had preliminary talks with the Trump administration about buying the drug. The drug may have less impact on the treatment of the most severe cases where the virus has already doubled.
It may not be safe for pregnant women or women who wish to get pregnant.
One of the studies that used Lubinavir/Retunavir (Calitra), a combination of antivirals Lubinavir and Retunavir, stated that the results "did not detect any benefit".
Drugs were designed to inhibit HIV to prevent it from replicating by linking it to protein.
A team of researchers at the University of Colorado is trying to adjust drugs to access a compound associated with the Sars Cove-2 protein. The scientific community is witnessing a state of criticism about directing resources to redefine drug purposes specifically designed to treat HIV/AIDS.
The World Health Organization has added Lubinavir/Retunavir in the International Solidarity Experience.
Gilead Sciences has developed the Rimdecivir drug as a cure for Ebola virus disease and the infection of the Marburg virus. Gilead Sciences later discovered that Rimdecifer has antiviral activity in the laboratory against many filamentary viruses, mucoviruses, and coronaviruses.
One of the problems with antiretroviral therapy is the development of resistance through transformations that can lead to more serious diseases and their transmission.
Some early pre-clinical studies suggest that Rimdecifer may have a high genetic barrier to resistance. There are many current clinical trials, including two conducted by Cleveland University hospitals; one is about patients with moderate disease, and the other is intended for patients with the most severe disease.
There are three clinical trials about vitamin C antivirals on patients who have been hospitalized and suffer from severe illness due to Coved-19, as well as two experiments controlled by the use of imaginary medication (China, Canada) and an uncontrollable experiment (Italy).
The New York State began experiments on the effect of antibiotic azithromycin on March 24, 2020.
The Japanese National Center for Public Health and Medicine (NCGM) is planning to carry out a clinical trial on the use of Elvisco (Siclesonide) produced by Teijin, a inhaling Corticosteroid for asthma treatment, to treat patients with the new Corona virus before symptoms appear.
A second-stage experiment is currently being conducted using a form of an angiotensisine-transformed enzyme 2 to 200 patients required to join the experiment from acute cases that have been hospitalized in Denmark, Germany, and Austria to determine the efficacy of treatment.
Researchers from the Montreal Heart Institute in Canada are currently studying the role of Colchisin in reducing pneumonia and pneumonia in patients with mild symptoms of a 19-coved infection.
The study, with the name Kolkoruna, includes 6,000 adults aged 40 and over who were diagnosed with a code 19 and suffered mild symptoms without having to be hospitalized.
Pregnant women, breastfeeding women or women without an effective contraceptive method are not considered eligible.
Many anticoagulants are also tested in Italy.
Hyparin is currently widely used for treating patients, which requires the Italian Drug Agency to publish guidance on its use.
A multi-centre study was announced in Italy on 300 patients to research the use of sodium oxysparin with disease prevention doses and treatment doses on April 14.
Given that Sars Cove-2 is a virus, great scientific attention has been given to the re-use of approved anti-virus drugs designed to deal with past outbreaks such as the March virus, Sars and the Western Nile virus.
Repaverine: Specialists recommended the use of Repaverine to treat Covide-19 in accordance with the 7th issue of the Chinese Directives
Omyvinover: Specialists recommended the use of Omyvinover to treat Coved-19 in accordance with the 7th issue of the Chinese Directives
Some antibiotics identified by specialists include the possibility of reusability as remedies for code-19:
Tusilizomap (receiver of Interloquin 6): Certified from China.
Experiences in Italy and China as well. See Tusilizomap#Covid-19.
Coved-19 is an assumed vaccine against Coronavirus disease 2019 (Coved-19)
Although no vaccines have been completed for clinical trials, many attempts are under way to develop this vaccine.
In late February 2020, the World Health Organization (WHO) (WH-O) said that it did not expect to have a vaccine against Sars-Koff-2, the virus causing, in less than 18 months.
There were five candidate vaccines in the first phase of safety studies in April.
Coved-19 was identified in December 2019.
A major outbreak spread worldwide in 2020, resulting in significant investments and research activity to develop a vaccine.
Many published genome organizations are used to develop potential vaccines against Sars-Kov-2.
The requirements of the Epidemic Preparedness Initiative for Vaccine Development, announced in April, are speed, manufacturing capacity, widespread deployment and global access.
In April, Coalition scientists on Epidemic Preparedness Innovations reported that 10 different technical platforms were under research and development during early 2020 to create an effective vaccine against Covide-19.
The main objectives of the platform advanced to the first phase of safety studies include:
DNA (deoxygenic ribosy acid and ribosi DNA) (first stage developer and candidate vaccine: Moderna, and MRNA-1273)
Viral Carrier (Phase I developer and candidate vaccine: Moderna, Type 5 gynaecological virus carrier)
According to the scientists of the Epidemic Preparedness Coalition in April, there are 115 total vaccine candidates in the early stages of development, with 78 active projects confirmed (79, according to the Melkin Institute) and 37 others announced, but with little public information available (presumably in the planning or design stage).
Phase I and phase II experiments perform a preliminary safety and immune test, usually random, controlled by oblivion, and in multiple locations, with more accurate and effective doses determined.
Phase III experiments typically include more participants, including the reference group, and a vaccine effectiveness test for disease prevention, with control of the negative effects of the optimal dose.
Out of 79 candidate vaccines under active development (confirmed as of early April 2020), 74 were not yet under human assessment (still under "pre-clinical" research).
On approximately January 24, 2020 in Australia, the University of Queensland announced that it was investigating the possibility of a molecular clamp vaccine that would genetically modify viral proteins in order to stimulate an immune reaction.
On approximately January 24, 2020 in Canada, the International Vaccine Center (VIDO-InterVac) at the University of Saskatchewan announced the start of work on a vaccine, with the goal of starting tests in humans in 2021.
Vaccine development projects were announced at the China Center for Disease Control and Prevention on January 26, 2020, and at the University of Hong Kong on January 28.
On approximately January 29, 2020, Jansen Pharmaceuticals, led by Hannicki Schwetmiker, announced that they had begun work on the development of a vaccine.
Jansen is involved in the development of an oral vaccine with her biotech partner, Vaxart.
On March 18, 2020, Emergent BioSulums announced a manufacturing partnership with Vaxart to develop the vaccine.
On February 8, 2020, the OncoGen Laboratory in Romania published a study on the design of a vaccine with a technology similar to that used for cancer treatment with an antigen vaccine introduced.
On March 25, the head of the Research Institute announced that they had finished manufacturing the vaccine and were starting to run tests.
On February 27, 2020, Nugenerex Immuno-Oncology, a subsidiary of Generex, announced that it had begun a vaccine project to create the Ii-Key Peptide vaccine against Coved-19.
They wanted to produce a candidate vaccine that could be tested in humans "within 90 days".
On March 5, 2020, Washington University in St. Louis announced its vaccine development projects.
On March 5, 2020, the U.S. Army Medical Research and Equipment Command at Fort Derek and Walter Reed Military Research Institute at Silver Spring, both in West Maryland, announced that they were working on a vaccine.
On approximately March 10, 2020, Emergent Biosulations announced that they had formed a team with Novax Inc.
In the development and manufacture of a vaccine.
Partners also announced plans for pre-clinical and first-stage clinical tests by July 2020.
On March 12, 2020, the Indian Ministry of Health announced that it was working with 11 isolated cases, and that even as the pace of work accelerated it would take at least a year and a half to almost two years to develop a vaccine.
On March 12, 2020, Medico, a biotech company in Quebec City, reported that it was a significant development similar to the Corona virus with partial funding from Canadian health research institutes.
The candidate vaccine is subject to laboratory research, with human testing plans in July or August 2020.
Earlier that week, the Guardian reported that U.S. President Donald Trump had offered CureVac "significant amounts of money" for exclusive access to the Covide-19 vaccine, which the German government needed.
On March 17, 2020, the American pharmaceutical company Pfizer announced a partnership with German Biotech to participate in the development of a DNA-based vaccine sent out.
The DNA-based vaccine sent by candidate BNT162, is currently undergoing pre-clinical testing with clinical trials expected to start in April 2020.
In Italy on March 17, 2020, Takis Biotech, an Italian biotech company, announced that it would receive pre-clinical test results in April 2020 and the final candidate vaccine could start with tests in humans by autumn.
In France on March 19, 2020, the Epidemiological Preparedness Innovations Coalition (CEPA) announced an investment of US$ 4.9 million in a consortium of Covide-19 vaccine research that includes the Pasteur Institute, Themis Bioscience (Vienna, Austria) and the University of Pittsburgh, which pushed the total investment of the Epidemic Innovations Alliance in the development of the Covide-19 vaccine to US$ 29 million.
Coalition Partners on Epidemiological Preparedness Innovations for the Development of Coved-19 Vaccines are Moderna, Curevac, Novax, University of Hong Kong, University of Oxford, and University of Queensland.
On March 20, 2020, Russian health officials announced that scientists had started animal testing for six different candidate vaccines.
Imperial College Researchers in London announced on March 20, 2020 that they were developing a rebuzzi DNA vaccine in self-inflation for Coved-19.
The candidate vaccine was developed within 14 days of receiving the sequence from China.
In late March, the Canadian government announced $275 million in funding for 96 research projects on anti-coved-19 medical measures, including several candidate vaccines in Canadian companies and universities, such as Medicago and University of Saskatchewan initiatives.
At the same time, the Canadian government has announced $192 million specifically for the development of the Covid-19 vaccine, with plans to establish a national vaccine bank from several new vaccines that could be used in the event of another outbreak of the Corona virus.
On April 2, 2020, researchers at the University of Pittsburgh School of Medicine reported tests for PetCoVac, possible vaccine for Coved-19 in mice, where they stated that "S1 subunit vaccines for SARS-Coff-2 microscopic needles triggered strong responses to specific antibodies [in mice] that were visible starting 2 weeks after vaccination."
In Canada on April 16, 2020, the University of Waterloo College of Pharmacy announced the design of a candidate vaccine based on DNA degenerative oxygen as a possible nasal spray.
Using moths, hypogenic ribosi DNA will be designed for transcription within human bacteria to produce non-infective particles similar to the virus, which may stimulate the immune system to produce antibodies to the SARS-COV-2 virus.
In March 2020, the U.S. government, industry, and three universities pooled resources to access the giant computers of IBM, along with cloud computing resources from Hewlett Packard Enterprise, Amazon, Microsoft, and Google.
Some vaccines have different effects, and are also called unspecified effects.
That means she can have benefits beyond the disease she's fighting.
Another randomized experience in Australia seeks to register 4,170 health care workers.
Vaccines under development are likely not to be safe or effective.
Early research to assess vaccine effectiveness using specific animal models of Coved-19, such as genetically modified mice with angiotensine-transformed enzyme 2, other laboratory animals and non-human heads, suggests the need for level 3 biological safety containment measures to deal with live viruses, and international coordination to ensure uniform safety procedures.
Anti-Sars and Middle East Respiratory Syndrome vaccines were tested on non-human animal models.
As of 2020, there is no treatment or preventive vaccine for a knight that has proved to be both safe and effective in humans.
According to research papers published in 2005 and 2006, the identification and development of new vaccines and medicines for SARS treatment was a priority for governments and public health agencies around the world. There is also no approved vaccine against Middle East Respiratory Syndrome.
When March spread, it was thought that existing research around Sars might provide a useful model for the development of vaccines and treatments against the March-Coff infection.
As of March 2020, there was one Middle East Respiratory Syndrome vaccine (based on DNA) that completed the first stage of clinical trials in humans, and three other vaccines under development, all of which were virus-oriented vaccines, two GT-oriented vaccines (ChADOX-1-MERS, BVRS-GamVAC) and one MVA-MERS-S.
Social media publications evoked the conspiracy theory that the virus causing Coved-19 was known and that the vaccine was already available.
Patents cited by many social media publications refer to existing patents for gene sequences and vaccines for other strains of Corona viruses such as the Corona virus causing SARS.
Coronavirus disease 2019 (Coved-19) is an anaphylaxis caused by Coronavirus 2 associated with SARS Cove-2.
Common symptoms include fever, cough, and respiratory distress.
Other symptoms may include fatigue, muscle pain, diarrhoea, throat inflammation, loss of smell sense, and abdominal pain.
The period between exposure to infection and symptoms usually amounts to about five days, but may range from two to fourteen days.
Although most cases show mild symptoms, some develop into viral pneumonia and multiple organ failure.
On April 17, 2020, more than 2.24 million people were reported injured in 210 countries and territories, resulting in more than 153,000 deaths.
More than 568,000 people recovered. The virus spreads mainly among people during mixing, mostly by spattering spray at coughing, sneezing, or talking.
When spray is scattered during the exhalation process, it usually falls on the ground or on the surfaces instead of being contagious over long distances.
People may also get hurt when they touch a contaminated surface and then touch their eyes, noses, or mouths.
The virus can survive on the surfaces until 72 hours.
The standard method of diagnosis is the serial polymerase reaction of the instant reverse transcription RRT-PCR via a nasal floating swab.
It is recommended that masks be used for those suspected of HIV infection and their caregivers.
The recommendations for the use of masks by the general public vary, with some authorities recommending not to use them, some believing otherwise and others requiring their use.
Currently, there is no specific vaccine or antiviral treatment for Coved-19.
Local-level transmission of the disease has been reported in most countries in all six WHO regions.
There may not be symptoms on people living with HIV or flu-like symptoms such as fever, cough, fatigue and respiratory distress.
Immediate medical care is advised if emergency symptoms of breathing difficulty, pain or constant pressure in the chest area, disorder, difficulty waking up, or blue face or lips appear.
In less common cases, upper respiratory symptoms such as sneezing, nasal gonorrhoea or throat infection may be observed.
Symptoms of the digestive system such as nausea, vomiting and diarrhoea have been observed at varying proportions.
Initially, some cases in China suffered from chest cramps and strokes only.
In some, the disease may develop into pneumonia, multiple organ failure, and death.
It's called foster care.
The custody period for Koved-19 is usually five to six days, but may range from two to 14 days.
97.5% of those with symptoms will do so within 11.5 days of infection. Reports indicate that symptoms may not appear on all those affected.
The role of disease carriers without symptoms in transmission has not yet been fully identified; however, preliminary evidence suggests the likelihood of their contribution to the spread of the disease.
The proportion of people with no symptoms is currently unknown and is under study, and KCDC reports that 20% of all confirmed cases did not show symptoms while in hospital.
China’s National Health Commission began including cases with no symptoms in the daily intake on April 1; out of 166 cases on that day, 130 (78%) of these cases did not show symptoms on the test.
Pygmies and saliva may carry large proportions of the virus.
Speaking loud results in more spray than talking naturally.
A study in Singapore showed that coughing without mouth cover could lead to spray scattered up to 4.5 metres (15 ft).
Although the virus is not usually transmitted by air, the National Academy of Sciences has indicated that it can be transmitted through bio-aerosol aerosols, and the examination of samples of air complexes in the lobby outside the individual rooms has yielded positive results for viral ribozy acid.
Some medical procedures such as CBR intubation and CPR may cause respiratory discharges to be released in the form of spray, and then the virus spreads by air.
Although there are fears that it may spread by feces, it is believed that the risk is limited. The virus is more contagious when people suffer from symptoms; while it may spread before symptoms appear, the risk is less.
The European Center for Disease Prevention and Control (ECCDC) says that despite some ambiguity about how easily the disease spreads, one person can be infected from two to three more in general. The virus remains stuck on the surfaces from hours to days.
Specifically, the virus was found to be present for one day on cardboard and up to three days on plastic (Polyproplin) and stainless steel (AISI 304), and up to four hours on copper 99%.
However, this varies based on humidity and temperature.
Soap and disinfectants are also effective on condition that they are properly used; soap melts the virus's protective lipid membrane and shuts it down, in addition to ridding the skin and other surfaces of it.
Other solutions, such as benzalconium chloride and chlorohyxidine glucone (surgical disinfection), are less effective. In a study in Hong Kong, saliva samples were taken after an average of two days of transport to hospital.
In five out of six patients, the first sample showed the highest viral load, and on the second day of the test the sixth patient showed up with the highest viral load.
The Corona 2 virus associated with severe acute respiratory syndrome (SARS Cove-2) is a new Corona virus associated with severe acute respiratory syndrome, where it was first isolated from three people suffering from pneumonia in the group of acute respiratory disease cases in Wuhan.
The new SARS Cove-2 virus shares its properties with the related Corona viruses found in nature.
Outside the body, home soap eliminates the virus, destroying its protective membrane. Sars Cove-2 is closely associated with the original Sars Cove.
Lungs are the most affected organ of Coved-19 because the virus enters host cells by the angiotensis-transformed enzyme 2 (ACE2), the most abundant of type II synapse cells present in the lung.
The virus uses a special surface sugar protein called the Spike (volver) to connect to the ACE2 and enter the host cell.
12% of the injured people admitted to the hospital in Wuhan, China, suffered severe heart attacks, and were more frequent in critical situations.
Symptom rates are high, due to the systemic inflammation response and immune system disorders during the development of the disease, but acute heart muscle injury may also be associated with ACE2 receptors in the heart.
ACE2 receptors play a very important role in the heart and share its functions.
The rate of clots (31%) and venous blood clots (25%) of patients in the ICU with C4-19 may be associated with poor prediction of what the condition will become. An autopsy of the bodies of individuals who died from CFD-19 found damage to a dispersive schizophrenia (DED), and an inflammation containing lymphocytes within the lung.
Despite Sars-Koff-2's orientation towards epithelial cells expressed as ACE2 in the respiratory system, extreme Coved-19 patients suffer from symptoms of hyperarterial inflammation.
In particular, T cells that secrete GMSF pathogens have been found to be associated with bringing in the only cells that secrete Interloquin 6 causes inflammation and pneumothorax disease in Coved-19 patients.
It was also reported that there was a lymphal filtration at the autopsy.
WHO published several testing protocols for the disease.
The sequenced polymerase reaction of the instant reverse transcription RRT-PCR is the standard method of testing.
The test is usually performed using respiratory samples taken from a nasal float; however, a nasal swab or a blood sample can also be used.
Results are generally available within a few hours to two days.
Blood tests can be used, but this requires taking two blood samples by two weeks and the results are of simple direct value.
Chinese scientists were able to isolate a strain of the Corona virus and spread genetic sequence so that laboratories around the world could independently develop PCR tests for HIV infection.
On April 4, 2020, antibody tests (which may detect active infection and whether a person has been infected in the past) were under development, but have not yet been widely used.
The Chinese test experience showed that accuracy ranges from 60 to 70 percent.
The U.S. Food and Drug Administration approved the first clinical-care point test on March 21, 2020 for use at the end of that month. Diagnostic guidance from the Chongenan Hospital at Wuhan University suggested ways to detect infection based on clinical characteristics and epidemiological hazards.
Multi-sectioned glass floats with an oceanic, asymmetric and posterior spread are common features at the onset of the injury.
An underside spread and a stone rectangular form (the thickness of the schizophrenic barrier with an irregular synth filling) may be shown and integrated with the development of the disease.
Few data are available on microscopic pests and pathological physiology of Coved-19.
Main pathological findings from autopsy:
Microscopic examination: herpesitis, tamuritis, lung inflation and pulmonary edema
Four types of viral pneumonia severity can be observed:
Light pneumonia: pulmonary edema, hypertensive pulmonary cells, large, non-model schizophrenia cells, inflammation during me with lymphocytosis and the formation of multi-cellular giant cells
Severe pneumonia: Dispersed cylindrical damage (DEAD) with widespread synthesis secretions.
Widespread synapse damage causes acute respiratory stress syndrome (ARDS) and acute hypoxicity.
Treatment of pneumonia: regulation of secretions in senile cavities and cellular pulmonary fibrosis
Blood: D.I.C. clotting; white blood cell reaction
Preventive measures to reduce the risk of infection include staying at home, avoiding crowded places, washing hands with soap and water for at least 20 seconds, exercising good hygiene of the respiratory system, and avoiding touching the eye, nose or mouth with unwashed hands.
CDC recommends covering mouth and nose with a handkerchief when coughing or sneezing, and recommends using the inner part of the facility if no handkerchief is available.
It is recommended that the hands be cleaned well after any cough or sneeze.
CDC recommended the use of cloth face covers in public places, partly aimed at reducing the transmission of unsuspecting people. Social spacing strategies aim to reduce mixing of people with large groups by closing schools and workplaces, restricting travel and cancelling large public gatherings.
Divergent instructions also require people to be at least 6 feet (1.8 m) apart from one another.
There is no drug known for its effectiveness in preventing Coved-19. Given that no vaccine was expected to be invented until 2021 at the earliest, the main part of the control of Coved-19 is to try to reduce the peak of the epidemic, the so-called "crushing of the curve".
CDC also recommends that people repeatedly wash their hands with soap and water for at least 20 seconds, especially after going to the toilet or when the hands are clearly dirty, before eating, and after cleaning the nose, cough or sneeze.
It also recommends that alcohol-containing hand sterilizers be used at least 60%, when soap and water are not available only. For areas where commercial hand sanitizers are not readily available, WHO offers two formulations for local production.
Antimicrobial activity in these two formulations originates from ethanol or isopropanol.
Hydrogen peroxide is used to help eliminate bacterial apogees in alcohol; it is "not an effective substance to cleanse hands".
Add glycerol as moisturized.
People receive supportive care, which may include fluid therapy, oxygen support, and other vital organ support affected.
CDC recommends that those suspected of being infected with the virus wear a simple face mask.
Out-body membrane oxygen (ACMO) is used to address the problem of respiratory failure, but its benefits are still being studied.
Personal hygiene and a healthy lifestyle and diet are recommended to improve immunity.
Supportive treatments may benefit those with mild symptoms during the early stage of infection. WHO and the China National Health Commission published recommendations to care for those who were taken to hospital because of Coved-19.
U.S. intensive care specialists and lung pathologists collected treatment recommendations from various bodies in a free supply, the critical case care book available online.
As of April 2020, there was no specific treatment available to Coved-19.
For symptoms, some specialist doctors recommend the use of paracetamol (Acetaminophen) instead of ibuprofen as the first treatment.
Precautions must be taken to minimize risks of HIV transmission, especially in health-care settings when implementing actions that may result in spray, such as intubation or manual breathing.
For health-care professionals who take care of those who are affected by Coved-19, cdc recommends placing the person in the airborne insulation room (eIIR) in addition to the use of standard precautions, mixing precautions and airborne disease precautions. cdc explains the guidance for the use of personal protective equipment (PPE) during the pandemic.
Recommended tools: personal protective equipment aprons, respiratory device or face mask, eye block, medical gloves. Respiratory devices (instead of facial masks) are preferred as they become available.
N95 ventors were approved for industrial installations, but the Food and Drug Administration authorized the use of masks under the Emergency Use License (EUA).
They are designed to protect against airborne molecules such as dust, but their effectiveness against a particular biological agent is uncertain in the case of uses for other unspecified purposes.
When masks are not available, CDC recommends using facial protections, or homemade masks as the last solution.
Most Kovid-19 cases are not so degraded as to require artificial breathing or alternatives, but some cases need to.
The type of respiratory support provided to those suffering from respiratory failure associated with Coved-19 is actively studied for those in hospitals, with some evidence that intubation can be avoided by using a high-flow nasal canal or positive double-level airway pressure.
It is not known whether either option is equally beneficial to those with a critical condition of illness.
Some doctors prefer to continue using gaseous industrial breathing when it is available because this technique limits the spread of aerosol particles compared to high flow nasal canals. There are many critical situations among older persons (those over 60 years of age, especially those over 80 years of age).
Many developed countries do not have enough hospital beds relative to the population, restricting the ability of the health system to cope with the sudden rise in the number of high-risk Kovid-19 cases requiring hospitalization.
One study in China found that 5% of cases were admitted to ICUs, 2.3% needed artificial respiratory support, and 1.4% died.
In China, nearly 30% of those who were taken to hospitals because of Coved-19 eventually enter intensive care units.
Industrial respiration becomes more complex with the development of acute respiratory stress syndrome (ARDS) in those affected by Coved-19 and the supply of oxygen becomes more difficult.
Respiratory devices need to be characterized by pressure control conditions and high end-of-pipe positive pressure to maximize oxygen delivery while minimizing the risk of lung injury associated with respiratory and thoracic rectangles.
High positive end-of-pipe pressure may not be available in old respirators.
The search for possible treatments began in January 2020, and many antiviral drugs are in the clinical trial stage.
Looks like Rhymsieveer's the most promising of all.
Although new medicines may take until 2021 to develop, many tested medicines have already obtained approval for other uses or are already in an advanced stage of testing.
Antiviral drugs can be tried on those who have a critical condition.
The World Health Organization (WHO) recommended volunteers to participate in trials of the efficacy and safety of possible treatments.[citation needed] The Food and Drug Administration granted a temporary license to use a sanitizer plasma as an experimental treatment in cases where a person's life is seriously or directly threatened.
He did not undergo the necessary clinical studies to prove that he was safe and effective against the disease.
In February 2020, China launched a mobile phone application to deal with the outbreak.
Users are required to enter the name and ID number.
The application is able to detect 'mixers' using surveillance data and thus the potential risk of infection.
Each user can also verify the status of three other users.
If a potential danger is discovered, the application not only recommends self- quarantine, but also alerts local health officials. Large data analyses of mobile data, facial recognition technique, mobile phone tracking, and artificial intelligence are used to track down those infected and mixed in South Korea, Taiwan, and Singapore.
In March 2020, the Israeli government enabled the security services to track mobile phone data of those presumed to be infected with the Corona virus.
Action has been taken to impose quarantine and protect potential mixers of infected citizens.
Also in March 2020, Deutsche Telekom shared the combined phone location data with the German Federal Government Agency, the Robert Coch Institute, for research and prevention of the spread of the virus.
Russia used facial recognition technique to detect quarantine violators.
The Italian Regional Health Commissioner, Mr. Giulio Galera, stated that mobile phone companies had informed him that "40 percent of people still travel everywhere".
The German government ran Hakathon for 48 hours on the weekend in which more than 4,000 people participated.
The President of Estonia, Ms. Kirsti Kaliolaid, also made a global call to present innovative solutions to prevent the spread of the Corona virus.
Individuals may feel upset due to quarantine, travel restrictions, side effects of treatment or fear of injury itself.
BBC published a saying to Rory O'Connor that "an increase in social isolation, unity, anxiety about health, tension and economic stagnation is a severe storm that harms people's mental health and well-being."
The disease may take a light cycle with minor or no symptoms, in which it is similar to other common upper respiratory diseases such as the cold.
Simple cases usually recover within two weeks, while severe or critical cases take three to six weeks to recover.
Pregnant women may be more likely to be severely affected by Coved-19 based on data for other similar viruses, such as Sars and Mers, but there is still a lack of data for Coved-19. Coved-19 may affect the lungs in some people by causing pneumonia.
Coved-19 may develop in the most rapidly affected to acute respiratory stress syndrome (ARDS) leading to respiratory failure, infection shock or multiple organ failure.
Coved-19 complications are septic, abnormal blood clotting, and heart, kidney and liver damage.
6% of those who were transferred to the hospital were diagnosed with blood clotting abnormalities, specifically an increase in prothrombin time, while 4% of them were observed to have kidney dysfunction.
Nearly 20-30% of those with C4-19 showed elevated levels of liver enzymes (amino vectors).
According to the same report, the average period between symptoms and death was 10 days, including five days in the hospital.
However, the average time for those transferred to the ICU between hospitalization and death was seven days.
In a study of early cases, the average period from initial symptoms to death was 14 days, and the total number of cases was from 6 to 41 days.
In a study conducted by the National Health Commission (NHC) of China, the mortality rate for men was 2.8% while the mortality rate for women was 1.7%.
Tissue pathological anatomy tests of postmortem lung samples show widespread synaptic damage with cellular fibromoxide secretions in both lungs.
Changes in viral cellular morbidity have been observed in synthetic cells.
The lung image shows acute respiratory stress syndrome (ARDS).
Heart damage due to elevated troponin levels or cardiac arrest was observed in 11.8% of deaths declared by China's National Health Commission.
According to data from the United States in March, 89% of those who were hospitalized had previous illness. The availability of medical resources and the socio-economic status of the region may also affect deaths.
Estimates of mortality from the condition vary as a result of these differences between regions, but also because of methodological difficulties.
The under-counting of simple cases may lead to a higher assessment of the mortality rate than the truth.
However, the fact that previous deaths were caused may suggest that the current mortality rate is lower than the fact.
Smokers are 1.4 times more likely to suffer from severe Coved-19 symptoms and 2.4 times more in need of intensive care and 2.4 times more likely to die than non-smokers. Concerns have been raised about long-term complications of the disease.
The Hong Kong Hospital Authority revealed a 20% to 30% reduction in lung capacity in some of the patients, and lung tests indicated damage.
This may also cause post-censorship syndrome after healing.
As of March 2020, it was unknown whether or not the previous infection would bring effective and long-term immunity to those recovering from the disease.
Immune acquisition is seen as possible, based on the behavior of other Corona viruses, but it was announced that there were rebounds from Coved-19 and later contracted again.
These cases are believed to be aggravated more if infection persists than when it is repeated.
The virus is thought to be natural and of animal origin, given the prevalence of infection.
The actual origin is unknown, but by December 2019, the spread of infection was largely the result of its human-to-human transmission.
A study of the first 41 confirmed cases of Coved-19, published in January 2020 in The Lancet, revealed that December 1, 2019 was the first date of symptoms.
Official WHO publications reported that December 8, 2019 was the first date of symptoms.
Many actions are usually taken to determine the numbers of deaths.
These figures vary by region and over time and are influenced by the size of the tests, the quality of the health care system, treatment options, the time taken since the onset of the disease and the characteristics of the population such as age, sex and public health.
In late 2019, as part of the 10th revision of the International Classification of Diseases, the World Health Organization (WHO) devoted U 07.1 to laboratoryly confirmed deaths of the SARS Cove-2 infection and U07.2 to the Koved-19 deaths diagnosed with SAR Cove-2 clinical or epidemiological without laboratory confirmation of HIV infection. The mortality ratio from infections is expressed in terms of the number of deaths divided by the number of diagnosed cases over a given period of time.
Based on Johns Hopkins University statistics, the global mortality rate for injuries is 6.9% (153,822/2,240,191), as of April 17, 2020.
The number varies by region. Other measures include the CFR case mortality rate, which reflects the percentage of those detected and died of a disease, and the IFR rate, which reflects the percentage of those injured (those detected and undetected) and those who died of a disease.
These statistics do not have a time frame, and they also follow a specific population from injury until the fate of the situation is known.
Although antibodies may not be produced by the bodies of all injured, their existence may provide information about the number of injured.
At the epicentre of the outbreak in Italy, Castileoni de Ada, a small village with a population of 4,600, 80 people (1.7%) have already died.
In Ganglet, the disease spread due to carnival festivals, and moved to young people, causing a lower relative mortality rate, and perhaps not all Covide-19 deaths were officially classified as its result.
Furthermore, the German health system has not been exhausted.
In the Netherlands, I may have about 3% antibodies, according to a blood donor assessment.
I have confirmed the death of 69 (0.004% of the population) due to Covid-19.
The impact of the pandemic and the resulting mortality rate vary between men and women.
The mortality rate is higher among men in studies in China and Italy.
The maximum risk for men is at 50 years of age, with the difference between men and women fading at the age of only 90.
In China, the mortality rate was 2.8 per cent for men and 1.7 per cent for women.
The exact causes of these sexual differences are unknown, but genetic and behavioral factors may be a cause.
Gender-based immune differences, the non-prevalence of smoking among women and the concurrent morbidity of men, such as hypertension at a younger age than women, may have contributed to the high mortality rate among men.
In Europe, 57% of the infected were men and 72% of those who died because of Coved-19 were men.
As of April 2020, the U.S. government does not track sex-disaggregated data for Covid-19 injuries.
Research has shown that viral diseases such as Ebola, HIV, influenza and SAR affect men and women differently.
The highest proportion of health workers, especially nurses, are women, and they are more vulnerable to HIV infection.
On February 11, 2020, the World Health Organization announced that the official name of the disease was "Covid-19".
The Director-General of the World Health Organization (WHO), Tidros Adhanom Gibresus, explained that Coo is an acronym for the word Corona, and in abbreviated for a virus and abbreviated for a disease 19 refers to the first-time outbreak detection year: December 31, 2019.
The name was chosen to avoid referring to a specific geographical location (e.g. China), animal species or group of people, in line with international naming recommendations aimed at preventing stigma. The virus that causes Covide-19 is called the Corona 2 virus associated with SARS Cove-2.
In addition, WHO uses the terms "Covid-19 virus" and "Covid-19 virus" in public statements.
The disease and the virus are commonly referred to as the Coronavirus.
During the first outbreak in Wuhan, China, the virus and disease were commonly referred to as the "Koronavirus" and the "Korona Wuhan virus".
In January 2020, the World Health Organization (WHO) recommended the use of the new Corona virus 2019 and the acute respiratory disease associated with the new Corona virus 2019 as temporary names for the virus and disease in accordance with the 2015 guidance preventing sites from being used in the names of diseases and viruses.
The official names Coved-19 and Saras Cove-2 were released on February 11, 2020.
Due to capacity limitations in standard supply chains, digital industrial companies issue health care materials such as nose swabs and respiratory parts.
One example, when an Italian hospital urgently needed a ventilator valve, and the supplier could not deliver in time, a local startup firm reversed its engineering and released the required 100 valves in one night.
After the first outbreak of Coved-19, conspiracy theories, false information and misinformation emerged regarding the origin of the disease, its scope, prevention, treatment and other aspects and quickly spread online.
Humans seem to be able to transmit the virus to some other animals.
The study failed to find evidence of virus reproduction in pigs, ducks, and chickens.
There are no approved medicines or vaccines to treat the disease.
Government institutions, academic groups and industry researchers conduct international research on vaccines and medicines for Koved-19.
In March, the World Health Organization (WHO) launched the "Solidarity Experience" to assess the therapeutic effects of four existing anti-virus compounds that have the most promising effectiveness.
There is no vaccine available, but various bodies are actively developing candidate vaccines.
Previous studies on SARS Cove are used because it resembles SARS Cove-2 in the use of ACE2 receptors to enter human cells.
Three vaccination strategies are under study.
First, researchers aim to create a complete vaccine for the virus.
The use of such a virus, whether inactive or dead, is intended to trigger an immediate immune response in the human body against a new Coved-19 infection.
The second strategy, micro-unit vaccine, aims to create a vaccine that makes the immune system sensitive to some micro-units of the virus.
In the case of Sars Cove-2, this research focuses on SpikeS protein that helps the virus break into ACE2 enzyme receptors.
The third strategy is DNA vaccines (DNA or RNA vaccines, a new vaccine innovation technique).
Experimental vaccines resulting from any of these strategies must be tested for safety and effectiveness. On March 16, 2020, the first clinical vaccine trial began on four volunteers in Seattle.
The vaccine contains a harmless genetic code copied from the virus that causes the disease. Antibody-dependent pride was cited as a potential challenge to the innovation of the Sars Cove-2 vaccine, but this is controversial.
There are over 300 active clinical trials underway starting in April 2020.
Seven trials of already approved treatments for malaria were evaluated, of which four were studies relating to hydroxychloroquine or chloroquine.
The proposed re-use of anti-virus drugs in the treatment of the new disease forms most of the Chinese research, through nine third-stage experiments on Rimdecifer across several countries whose results are due to be reported by the end of April.
A dynamic review of the clinical development of potential Coved-19 vaccines and real estate was carried out as of April 2020. Many existing antiviral properties are being evaluated for the treatment of Coved-19, including remodecyver, chloroquine, hydroxychloroquine, lupinavir/retunavir and lubinavir/tonavir integrated with interviron beta.
There is initial evidence of the effectiveness of the Rhymedsevir, as of March 2020.
Clinical improvement has been observed in patients treated with Rhymedicine for euthanasia.
Phase III clinical trials are conducted in the United States, China, and Italy. Chloroquin, formerly used for malaria treatment, was studied in China in February 2020, and has preliminary results.
However, there are calls for peer review to be conducted.
The Korean and Chinese health authorities recommend the use of chloroquine.
However, the Wuhan Institute of Virus Research notes that despite recommending a one-gram dose, the weakness of this dose is extremely serious and may cause death.
On March 28, 2020, the Food and Drug Administration issued an emergency license for chloroquine and chloroquine hydroxy and chloroquine at the discretion of treating doctors for those suffering from Coffide-19. The 7th issue of the Chinese guidelines also includes interferon, ribavirin or omephenophyr for use to treat Coffide-19.
Preliminary data indicate that high doses of ribavirin are necessary to inhibit Sars Cove-2 in the laboratory.
It was recommended that further study be undertaken of the effect of nitazoxaned on organisms after proving its inhibition of the low concentration of Sars Kove-2. Studies have shown that the initial configuration of the Spyke protein via the trans-fibular serene protein 2 (TMPRS2) is necessary to enter Sars Cove-2 via interaction with the future of ACE2.
Studies of chloroquine and hydroxychloroquine with or without azithromycin involve significant deficiencies that prevented the medical community from accepting these treatments without further study. Osyltamivir Sars Cove-2 is not discouraged in the laboratory and has no known role in the Covide-19 treatment.
The cytokin storm may represent one of the complications in the late stages of severe Coved-19.
There is evidence that chloroquine hydroxy may have anti-cytokin storm properties. The Chinese National Health Commission added Tusilizomap to the treatment guidelines after completing a small study.
He is tested for stage 2 non-random at the national level in Italy after showing positive results for those suffering from severe illness.
In addition to being used to test the vertein in the blood serum to determine cytokin storms, it aims to counter such developments, which are believed to be the cause of death in some of the injured.
The Department of Food and Medicine adopted the Interloquin 6 anti-reception antigen, the treatment with receptor T-cells for the pyramid antigen, based on retrospective case studies for the treatment of cytokin secretion syndrome for non-responsive steroids that had a different cause in 2017.
So far, there is no disciplined evidence nesting that Tusilizomap is an effective treatment for cytokin ephemerase syndrome.
The method of transfer of refined and concentrated antibodies produced by Covide-19 immune systems to those who need them is subject to study as a non-vaccinative method of negative pollination.
This strategy was tested on Sars and its results were inconclusive.
The neutralization of the virus represents the expected mechanism of action through which passive antibody therapy can act as a defence medium against Sars Cove-2.
However, other mechanisms, such as cellular toxicity based on antibodies or muzzles or both, may be used.
There are other forms of passive antibodies therapy, such as the use of manufactured single-chip antibodies, under development.
The production of pure serum, which consists of the liquid part of the recovered patient's blood and contains antibodies specific to this virus, can be increased for faster dissemination.
Coronavirus diseases, a group of closely related syndromes
Lee Win Liang, a doctor at Wuhan Central Hospital, was subsequently injured and died of Covide-19 after raising attention to the spread of the virus.
